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Abstract 
 
Molecular modelling has become widely used in chemistry and biology. The 
aim of this project is to use a range of molecular modelling techniques to 
study enzymic actions. This thesis consists of two parts.  
 
Part A of this thesis describes computational studies conducted for the 
calpain-calpastatin system. Calpain is a cysteine protease. Over-expression of 
calpain is associated with many diseases. Calpastatin is the naturally 
occurring specific regulator of calpain activity. In this part of the thesis, the 
dynamic conformational preferences of region B of the inhibitory domain in 
calpastatin were examined in detail by using molecular dynamics simulations 
and stochastic dynamic simulations with Monte Carlo sampling.  
 
Part B of the thesis explores the structure and function of the enzyme 
3-dexoy-D-arabino-heptulosonate 7-phosphate synthase from 
Mycobacterium tuberculosis (MtuDAH7PS). MtuDAH7PS catalyses the first 
reaction of the shikimate pathway and is a target for the development of 
anti-tuberculosis drugs. MtuDAH7PS is found to be synergistically inhibited 
by combinations of aromatic amino acids (Trp+Phe or Trp+Tyr), but not by 
any single aromatic amino acids. In this part of the thesis, this unique 
mechanism of allosteric regulation in MtuDAH7PS was investigated by using 
a range molecular modelling techniques. Firstly protein crystal structure 
refinements were conducted and those crystal structures of MtuDAH7PS in 
complex with various ligand molecules are described in Chapter 4. Secondly, 
the reaction mechanism and roles of active site residues were investigated in 
Chapter 5, through docking calculations (both rigid docking and induced fit 
docking) of a series of designed active site inhibitors. Finally, Chapter 6 
discusses the molecular basis of the communication mechanism of allosteric 
regulation in MtuDAH7PS. 
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Part A:  
The calpain-calpastatin system 
  
2 
 
Chapter 1: Introduction to calpain and calpastatin 
 
1.1 Calpain 
 
Calpain is a cysteine protease that is responsible for catalysing the hydrolysis 
of the peptide bonds within a number of guest substrates. Substrates for 
calpain protease include calmodulin-binding proteins, the cytoskeletal 
proteins and the G-proteins (1-6). The active site of calpain contains a highly 
conserved catalytic triad, which is made up by Cys115, His272, and Asn296 
(µ-calpain numbering). The sulphydryl group of Cys115 acts as the 
nucleophile facilitating the peptide bond cleavage. 
 
Calpain requires the presence of calcium ions in order to be activated (7). 
The two major isoforms of calpain are the µ- and m-calpain (also named as 
calpain 1 and 2 respectively) and they mostly differ in calcium requirements 
for activation. µ-Calpain requires micro molar concentration of calcium ions 
to be activated, and m-calpain requires milli molar calcium concentration to 
be activated in vitro. Over-expression of calpain is associated with many 
diseases including brain trauma, spinal cord injury, Alzheimer’s disease, 
Parkinson’s disease, muscular dystrophy, arthritis, and cataract (8, 9). In 
recent years, considerable effort has gone into developing small molecule 
inhibitors that are potent and selective for calpain as the pharmaceutical 
target (8). 
 
1.1.1 Structural features of human m-calpain 
 
The crystal structure of the inactive calcium-free human m-calpain has been 
reported (10). The protein consists of six domains (Figure 1. 1), and these 
domains can be grouped into two subunits. The large subunit contains 
Domain I (DI) to Domain IV (DIV), and the small subunit contains Domain 
V (DV) and Domain VI (DVI). Domain II (DII) is the catalytic domain of 
calpain, and contains the active site residues. DII can be further subdivided 
3 
 
into two subdomains, Domain IIa (DIIa) and Domain IIb (DIIb) and both 
these subdomains contribute to the active site. DI is embedded in DVI of the 
small subunit, helping hold the two subunits of the calpain molecule together 
in the inactive form. DIV and DVI are the calcium binding domains. They 
each contain five EF-hands, which are typically helix-loop-helix 
sub-structures. Four of the five EF-hands can bind to calcium ions, and the 
fifth EF-hand in each of DIV and DVI interacts with each other to form the 
heterodimer interface between the large and small subunits of calpain. 
 
 
Figure	  1.	  1.	  The	  crystal	  structure	  of	  calcium-­‐free	  human	  m-­‐calpain	  (10).	  
 
DIIb is connected to DIII, and the short helix near the end of DIIb interacts 
with the acidic loop in DIII (highlighted in the green box in Figure 1. 1). The 
acidic loop contains many acidic residues, which normally interact with the 
basic residues in the nearby helix in DIIb (Figure 1. 2). These salt bridge 
interactions can help in holding DIIb away from DIIa, and keep calpain in its 
inactive form. 
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Figure	  1.	  2.	  Interactions	  between	  DIIb	  short	  helix	  (rich	  in	  basic	  Lys	  residues)	  and	  DIII	  acidic	  loop	  (rich	  in	  acidic	  Glu	  and	  Asp	  residues).	  
 
1.1.2 Activation of calpain in the presence of calcium ions 
 
DII, DIV and DVI all can bind to calcium ions when they are present. The 
binding of calcium ions causes an overall conformational change in the 
molecule which leads to the activation of calpain. Firstly the binding of 
calcium ions to DVI causes conformational changes within this domain, and 
this leads to the release of DI helix and DIIa from DVI facilitated by 
autolysis1 of DI. Secondly the associative interaction between the DIII acidic 
loop and DIIb short helix is broken due to binding of calcium ion in DIV, 
because the conformational changes in DIV leads to pulling of the 
“transducer” peptide (Figure 1. 1) that connects DIVand DIII, and hence 
helps the separation of DIII away from DIIb (11, 12).  
 
After a series of conformational changes that occur within the calpain 
molecule upon binding of calcium ions, the two subdomains of DII, DIIa and 
DIIb, are released from the structural constraints that were holding them 
away from each other. The two subdomains then move closer to form the 
complete active site (Figure 1. 3). 
                                                        
1 DI is cut off from the attached calpain molecule by another calpain molecule. 
2 The amino acid sequence for this 27-mer peptide is: DPMSSTYIEELGKREVTIPPKYRELLA 
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Figure	   1.	   3.	   Superposition	   of	   calpain	   DII	   in	   its	   active	   and	   inactive	   form.	   The	   active	  calpain	   catalytic	  domain	   is	   taken	   from	   the	   crystal	   structure	  1KXR	   (rat	  µ-­‐calpain)	   and	  the	   inactive	   calpain	   catalytic	   domain	   is	   taken	   from	   the	   crystal	   structure	   1MDW	   (rat	  m-­‐calpain).	   The	   two	   subdomains	  DIIa	   and	  DIIb	   are	   closer	   to	   each	  other	   in	   the	   active	  form	  than	  in	  the	  inactive	  form.	  	  
1.1.3 Active site of calpain 
 
The active site of calpain consists of a highly conserved catalytic triad, which 
includes the active site cysteine, histidine and an asparagine residue (Figure 1. 
4). When calpain is in the inactive form, the two catalytic subdomains are 
apart from each other, and the distance between the active site cysteine and 
histidine is about 8 Å (Figure 1. 4). After activation by calcium ions, the two 
subdomains close up and complete the active site, and the distance between 
the active site cysteine and histidine becomes much closer, about 3 Å ~ 4 Å 
(Figure 1. 4). The close distance allows for the histidine side chain to 
deprotonate the cysteine sulphydryl group, assisting its nucleophilic role in 
the hydrolysis of an encapsulated peptide bond of the substrate. 
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Figure	  1.	  4.	  The	  catalytic	  triad	  of	  calpain	  before	  and	  after	  activation	  by	  calcium.	  
 
1.2 Calpastatin 
 
Calpastatin is the naturally occurring regulator of calpain. It co-exists with 
calpain in the cell and interacts specifically with calpain but no other cysteine 
proteases. The amino acid sequence is unique; there is no homology in amino 
acid sequence of calpastatin with any other proteins known to date (13). The 
calpastatin sequence is rich in polar and charged residues, and poor in 
hydrophobic residues.  
 
1.2.1 Amino acid sequences of calpastatin 
 
Amino acid sequences of mammalian calpastatins have been determined by 
cDNA cloning. The deduced amino acid sequences of human, pig, rabbit, 
cow, and sheep calpastatins consist of 708, 713, 718, 705, and 723 residues, 
respectively (14-18). Human calpastatin has five domains (shown 
schematically in Figure 1. 5). The L domain is at the N-terminus. Biological 
assays of the recombinant protein composed of the domain L show that this 
domain does not inhibit either µ- and m-calpain (19-21). Domains 1 to 4 are 
four repetitive inhibitory domains and each contains three highly conserved 
regions A, B and C. The calpastatin molecule contains little secondary 
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structure, with only regions A and C in each inhibitory domain having a 
tendency to form α-helical structures (22). 
 
 
Figure	  1.	  5.	  Schematic	  structure	  of	  human	  calpastatin.	  	  
1.2.2 Regions A and C of the inhibitory domains of calpastatin 
 
The four inhibitory domains of calpastatin are repetitive and mutually 
homologous, each containing about 140 amino acid residues. These four 
domains have been individually expressed and assayed against calpain and 
have been shown to inhibit calpain independently (23-25). Therefore, one 
calpastatin molecule can bind four calpain molecules corresponding to the 
number of inhibitory domains in calpastatin. There are three highly 
conserved regions in each inhibitory domain, called A, B, and C. Regions A 
and C are found to bind to calpain DIV and DVI respectively, and region B 
binds in the active site to inhibit calpain (26, 27). 
 
 
Figure	   1.	   6.	   Crystal	   structure	  of	   calpastatin	   inhibitory	  Domain	  1	   region	  C	  binding	   to	  calpain	  DVI	  (PDB	  1NX1).	  
 
The crystal structure of calpain DVI interacting with a fragment of 
8 
 
calpastatin corresponding to region C of inhibitory Domain 1 has been 
reported (26). Calpain DVI binds four calcium ions with four of its EF hands. 
Region C adopts a helical structure upon binding to calpain (Figure 1. 6). The 
side chains of the hydrophobic residues Phe, Leu, Ile, and Ala in the 
calpastatin fragment interact with the corresponding binding pockets formed 
in DVI of calpain when calcium ions are bound (Figure 1. 7).  
 
 
Figure	   1.	   7.	   Crystal	   structure	   of	   calpastatin	   inhibitory	  Domain	  1	   region	  C	   (shown	   in	  stick	  representation)	  binding	  to	  calpain	  DVI	  with	  surface	  of	  DVI	  displayed.	  
 
The interactions between region C of calpastatin and DVI of calpain have 
been studied with crystal structure data, from which these interactions can be 
examined at the molecular level. DIV, the calcium binding domain in calpain 
large subunit is very similar to DVI, and is therefore expected to show 
similar type of interactions with region A of calpastatin inhibitory domain 
(26).  
 
1.2.3 Region B of calpastatin inhibitory domain 
 
In 1999, Ma et al. studied the functions of the three conserved regions (A, B 
and C) in calpastatin inhibitory domain using site directed mutagenesis (28), 
and they demonstrated that when region B is completely removed from the 
calpastatin fragment, the inhibition activity of calpastatin is completely 
eliminated, while the binding affinity for calpain DIV is still retained. It is 
also shown that region B on its own still retains half of the calpain inhibition 
activity although it does not bind to DIV of calpain. This result clearly shows 
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that region B of the calpastatin inhibitory domain is essential for inhibition 
and regions A and C can help to increase inhibition efficiency by binding to 
calpain regulatory domains and bring region B into close proximity to 
calpain active site. 
 
1.3 Overall interactions between calpastatin and calpain 
 
In 2008, Moldoveanu et al. and Hanna et al. reported two crystal structures 
of the calpain-calpastatin complex (29, 30). For the first time, the overall 
binding mode of calpastatin on calpain is revealed at atomic level detail. 
These two structures also revealed the binding site and binding mode of the 
most critical region in calpastatin, region B, which could only be speculated 
before (Figure 1. 8).  
 
 
Figure	   1.	   8.	   Calcium-­‐dependent	   complex	   between	   m-­‐calpain	   and	   calpastatin	   (PDB	  3DF0).	  DII,	  DIII	  and	  DIV	  of	  the	  calpain	  large	  subunit	  are	  displayed	  in	  white;	  the	  calpain	  small	  subunit	   is	  displayed	  in	  red	  and	  the	  calpastatin	  molecule	  (regions	  A,	  B,	  and	  C)	   is	  displayed	  in	  green.	   	  
 
The mode of calpastatin action found in the crystal structure is consistent 
with what was proposed from previous experimental studies (Figure 1. 8). 
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The regions A and C of calpastatin inhibitory domain adopt α-helical 
structure and bind to DIV and DVI of calpain respectively. Region B which 
is critical for inhibition binds to calpain to block access into the active site. 
Half of the inhibitory region B binds inside the calpain active site cleft, while 
the other half interacts with calpain DIII.  
 
1.4 Part A of this thesis 
 
Part A of this thesis describes computational studies conducted for the 
calpain-calpastatin system. In particular, the dynamic conformational 
preferences of region B of inhibitory domain in calpastatin were examined in 
detail in Chapter 2. The knowledge gained in these studies can be used to 
help in the design of calpain inhibitors constrained to adopt the preferred 
inhibitory conformation and thereby achieve compounds with heightened 
potency and selectivity. 
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Chapter 2: Calpastatin inhibitory domain region B: conformational 
features of the CP1B peptide 
 
2.1 Introduction 
 
In 1989, Maki et al. found that a synthesised 27-mer peptide2, 3 containing 
the central conserved sequence of region B of Domain 1 of human 
calpastatin, possesses potent inhibitory activity against calpain (16). This 
peptide is specific for calpain and shows no inhibition activity against papain 
or trypsin. In 1991, Ishima et al. examined the solution structure of this 
27-mer peptide in DMSO-d6 by two-dimensional 1H NMR spectroscopy and 
found no evidence for any regular α-helix or β-sheet (31). However, they 
reported the possibility for a turn in the region from Glu10 to Lys13, which 
contains a highly conserved residue Gly12, in all calpastatins from different 
species and in the four repetitive inhibitory domains of each calpastatin. 
These findings suggest that although the repetitive domain of calpastatin 
does not have an extensive tertiary structure, it has a well-defined local turn 
structure in the well conserved region which is considered essential for the 
specific interaction with calpain.  
 
In 2003, Anagli et al. used a combination of β-alanine scanning mutagenesis 
and kinetic measurements of the binding of this 27-mer peptide with calpain 
to probe the relative contributions of each of the amino acid side chains and 
the backbones to the overall calpain-inhibitory activity (32). The study 
identified two “hot spots”, Leu11-Gly12 and Thr17-Ile18-Pro19, in the 
peptide which contain residues critical for inhibitory function. Mutation of 
any one of the key residues in either of the two hot spots resulted in a 
dramatic loss of inhibitory activity. The individual contributions of the amino 
acid residues to the overall inhibitory activity were ranked from this study: 
                                                        
2 The amino acid sequence for this 27-mer peptide is: DPMSSTYIEELGKREVTIPPKYRELLA 
3 Amino acid one-letter codes: Gly(G), Ala(A), Ser(S), Thr(T), Cys(C), Val(V), Leu(L), Ile(I), Met(M), 
Pro(P), Phe(F), Tyr(Y), Trp(W), Asp(D), Glu(E), Asn(N), Gln(Q), His(H), Lys(K), and Arg(R). 
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Ile18 > Leu11 > Gly12 > Pro19 > Thr17 > Arg14 > Glu10 > Glu9 >= Pro20 > 
Tyr7 > Tyr22 > Asp1 >= Lys13 > Val16 > Leu26 > Leu25 > Ile8 > Ala27 > 
Thr6 > Lys21 >= Glu15 > Arg23 > Met3 > Pro2 >= Ser5 > Glu24 > Ser4. 
 
In 2004, Anagli et al. analysed the contributions of the side chains of Leu11 
and Ile18 in even more detail (33), by using mutagenesis techniques, and 
found that β- and γ-CH2 of the Leu11 and Ile18 side chains respectively play 
a direct role in calpain inhibition. 
 
A 20-mer peptide with amino acid sequence SSTYIEELGKREVTIPPKYR 
(sequence numbering starts at 4 and finishes at 23, to allow consistency with 
sequence numbering in the 27-mer peptide), identified by systematic 
truncation of the 27-mer peptide of calpastatin region B, has been reported to 
be the core sequence required to maintain affinity and selectivity towards 
calpain (34). This 20-mer peptide was named CP1B to depict the region of 
calpastatin it was derived from.  
 
The importance of the turn-like region between Glu10 and Lys13, that was 
identified earlier from the NMR studies of the 27-mer, has been investigated 
by a study of a series of conformationally constrained macrocyclic variants 
of CP1B (34). These macrocyclic compounds were assayed against calpain, 
and the results showed one of these (Figure 2. 1) was as potent as the ‘linear’ 
CP1B peptide. Modelling showed that this macrocycle contains a loop-like 
conformation in the region from amino acid 10 to 13. The high inhibitory 
activity of this macrocycle suggests that the activity of the linear peptide 
CP1B is a consequence of it adopting a similar loop-like conformation in the 
region between Glu10 and Lys13.  
 
Ac S S T Y I E N
H
O
H
N
O
L G
N
H
O
R E V T I P P K Y R NH2
Figure	   2.	   1.	   Structure	   of	   the	  macrocyclic	   compound	   that	   is	   as	   potent	   as	   linear	  CP1B	  peptide.	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The Pfizer group postulated that with the formation of this loop, the two 
hydrophobic residues Leu11 and Ile18 of the CP1B peptide are positioned to 
interact with their corresponding pockets on calpain (34). The group also 
proposed that it is the presence of oppositely charged residues at positions 10 
and 13 on either side of the loop region that favours the formation of the loop 
conformation, because they can form salt bridges which stabilise the loop 
conformation of the peptide. 
 
Two crystal structures of the calpain-calpastatin complex were released in 
2008 by Moldoveanu et al. and Hanna et al. and showed in detail the 
interactions between region B of calpastatin and calpain (29), (30). The 
section of region B of calpastatin, which corresponds to the 20-mer peptide 
CP1B, is found to bind within the active site cleft of calpain. One of the two 
crystal structures (3DF0) (Figure 2. 2) shows the active site of calpain in 
complex with calpastatin region B (30). 
 
 
 
Figure	   2.	   2.	   Active	   site	   of	   calpain	   in	   complex	  with	   calpastatin	   (shown	   in	   red)	   (PDB	  3DF0).	   The	   key	   residues	   in	   both	   calpain	   active	   site	   and	   region	   B	   of	   calpastatin	   are	  displayed	  with	  tube	  representations.	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The two critical hydrophobic residues, Leu11 and Ile18, on calpastatin 
interact with two corresponding hydrophobic pockets in the calpain active 
site. Ile18 interacts in the prime site of calpain active site (right hand side of 
the active site Cys105S in Figure 2. 2) and Leu11 in the non-prime site (left 
hand side of Cys105S in Figure 2. 2).  The binding pockets in calpain are 
more clearly shown in Figure 2. 3, where Leu11 is shown interacting with the 
S2 binding pocket of calpain and Ile18 is interacting with the S2’ pocket. 
These two hydrophobic interactions together with other non-covalent 
interactions help to keep the calpastatin molecule in the active site and 
exclude other molecules accessing the calpain active site thereby exerting an 
inhibitory action. 
 
 
Figure	  2.	  3.	  Interaction	  between	  calpastatin	  inhibitory	  region	  residues	  Leu11	  and	  Il18	  and	  calpain	  active	  site.	  
 
The loop region first proposed by Pfizer et al. is highlighted in yellow circle 
in Figure 2. 3. To the right of this loop is a second loop adjacent to Leu11 
that had not been predicted. In the crystal structure the peptide adopts an 
overall S-shape in the active site, where the second reverse in direction starts 
with the amino acid Gly12 immediately adjacent to Leu11. The “kink” 
ensures that the peptide bond near the active site cysteine is moved away 
from this thiol nucleophile (Figure 2. 4) thereby preventing proteolysis4 of 
                                                        
4 Proteolysis is the directed degradation (digestion) of proteins by cellular enzymes called proteases or 
by intra-molecular digestion. 
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calpastatin region B by calpain (30). In this way, calpastatin acts to bind in 
the active site of calpain and prevents other molecules from accessing the 
active site, but for the conformational reasons referred to above is not 
digested by calpain. Moldoveanu et al. suggested that calpastatin is not 
digested and can therefore be recycled after being released from calpain.  
 
The second loop region was not detected in the NMR studies (31) of 
calpastatin region B, or in the macrocyclic analogue study (34). The failure 
to observe a second loop in calpastatin region B in the enzyme-free state 
suggests that CP1B is prearranged to form only one loop at Leu11 of region 
B, and we propose that it could be upon binding to calpain that Ile18 residue 
moves to bind in S2’ pocket of the active site and that this forces the second 
“kink” to be formed. 
 
 
Figure	   2.	   4.	  The	  “kink”	  at	  Gly12	  moves	   the	  scissile	  peptide	  bond	   in	  calpastatin	  away	  from	  the	  active	  site	  cysteine.	  Calpastatin	  is	  shown	  in	  red	  and	  calpain	  is	  shown	  in	  blue.	  
 
The aim of the work in this chapter is to identify the essential key structural 
features within CP1B that have a significant influence on the peptide’s 
inhibition activity. This chapter describes a computational study of the 
20-mer peptide CP1B and its various mutants in the absence of calpain, in 
order to establish the dynamic conformational preferences of this peptide and 
the specific contribution of each residue in dictating the pre-formed loop 
region around Leu11 in CP1B. The modelling techniques used for this study 
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include molecular dynamics (MD) simulations conducted with the software 
NAMD and stochastic dynamics simulations combined with Monte Carlo 
sampling method (MCSD). The modelling results were examined and 
compared with measured IC50 data. The results illuminate the importance of 
the prearrangement of this loop region in determining the inhibitory activity 
of CP1B.  
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2.2 Modelling methods 
 
2.2.1 Molecular dynamics simulations 
 
In a molecular dynamics (MD) simulation, the motion of the system in a 
certain time period is simulated according to the Newtonian equation of 
motion:  
 𝑚!𝑎! = 𝐹!            (1) 
 
where 𝑚! is the mass of atom 𝛼, 𝑎! is the acceleration of the atom 𝛼, 
and 𝐹!  is the force in the system that is acting on the atom 𝛼 . The 
acceleration term 𝑎! is calculated by second order differentiation of the 
positional vector of atom 𝛼, i.e.  
 𝑎! = 𝜕! 𝑟! 𝜕𝑡!          (2) 
 
where 𝑟! is the positional vector of atom 𝛼, and 𝑡 is the time from the start 
of the simulation. The force term 𝐹! is calculated as the negative gradient of 
the total potential energy which is dependent on all atomic positions, i.e. 
 𝐹! = −𝜕𝑈!"!#$ 𝜕𝑟!            (3) 
 
where 𝑈!"!#$ is the total potential energy term, and by substituting equations 
(2) and (3) into equation (1), Equation (4) can be obtained: 
 𝑚!𝜕! 𝑟! 𝜕𝑡! = −𝜕𝑈!"!#$ 𝜕𝑟!   (4) 
 
Equation (4) is the Newtonian equation in terms of time and atomic positions 
and this is the form of the equation that is used in a MD simulation. 
 
The most important term in Equation (4) is the total potential energy term, 𝑈!"!#$. This potential energy is represented through the MD force field. A 
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force field includes all types of atomic interactions in a function that is in 
simple mathematical form and therefore can be calculated quickly. The force 
field function used to represent the total potential energy includes the 
following contributions: 
 𝑈!"!#$ = 𝑈!"#$ + 𝑈!"#$% + 𝑈!"!!"#$% + 𝑈!"# + 𝑈!"#$"!"    (5) 
 
The first three terms in Equation (5) describe the bonded interactions such as 
stretching, bending and torsional interactions. The final two terms in 
Equation (5) describe interactions between non-bonded atoms, where 𝑈!"# 
corresponds to van der Waal’s interactions approximated by a Lennard-Jones 
6-12 potential and 𝑈!"#$"%& corresponds to electrostatic interactions. Each 
of the five potential energy terms is written as the function of the positional 
vectors 𝑟! , and  they  are  listed  below: 
 𝑈!"#$ = 𝑘!!"#$ 𝑟! − 𝑟!! !!"#$%  !  𝑈!"#$% = 𝑘!!"#$%!"#$%&  ! 𝜃! − 𝜃!! ! 𝑈!"!!"#$% = 𝑘!!"!! 1+ cos 𝑛!∅! − 𝛾!!"!!"#$%  !  𝑈!"# = 4𝜀!" 𝜎!"𝑟!" !" − 𝜎!"𝑟!" !!!!!  𝑈!"#$"%& = 𝑞!𝑞!4𝜋𝜀!𝑟!"!!!!  
 
In the above equations, 𝑟 in 𝑈!"#$  represents bond length; 𝜃represents 
bond angle term; ∅ represents the dihedral angle term; 𝑟!" terms in 𝑈!"# 
and 𝑈!"#$"%& represent distance between pairs of non-bonded atoms. The 
parameters such as force constants 𝑘! and bond length 𝑟!! etc used in the 
above 5 equations for calculating the five different energy terms are listed in 
the force field parameter files. These parameters are determined through a 
combination of empirical techniques and quantum mechanical calculations 
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and then tested for reliability using small systems that are well characterised.  
 
Periodic boundary conditions (PBC) are used in MD simulations to make 
sure the system does not have an abrupt border with the vacuum. In PBC, the 
modelled system (including solvent surround the biological system) is placed 
in a unit cell. This unit cell is considered to have infinite number of images in 
space. Any atom that leaves the unit cell on one side is replaced by its image 
entering on the other side of the cell.  
 
The van der Waal’s interactions and the Coulomb electrostatic interactions 
exist between all non-bonded atom pairs, even when the atoms are far away 
from each other. Therefore calculating every long range interactions exactly 
is not practical. In MD simulations conducted with the software NAMD, the 
long range van der Waal’s interactions are spatially truncated at a cut-off 
distance of 25Å. The full long range electrostatic interactions are computed 
by making use of the periodicity of the periodic boundary condition and 
combined with the particle-mesh Ewald (PME) method (35). 
 
 
Figure	  2.	  5.	  Distribution	  of	  charge	  q	  over	  the	  grid	  (shown	  in	  2D	  mesh	  here)	  (36).	  
 
In PME, the total electrostatic interaction energy is split into two summations: 
the direct sum of short range electrostatic interactions which converges 
quickly in real space; and the Ewald summation (37) of the long range 
interactions which converges quickly in Fourier space. The Ewald sum of 
long range interactions is basically the sum of the Fourier transforms of 
charge density and potential. In order to evaluate the Fourier transform of the 
charge density, the Fast Fourier Transform (FFT) is used. Since FFT requires 
the charge density to be evaluated on a discrete lattice, the charge is 
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distributed over three dimensional grids (Figure 2. 5), hence the name “mesh” 
in the PME method. 
 
2.2.2 Stochastic dynamics combined with Monte Carlo sampling 
 
In stochastic dynamics simulations the solvent molecules are not modelled 
explicitly as in MD. Instead the effect of the surrounding solvent is modelled 
by introducing a random force combined with a damping force.  
 
The use of Monte Carlo sampling can introduce large changes into a system 
during a simulation, including changes in peptide backbone torsion angle. 
Therefore it is more efficient in sampling conformational space of a molecule 
than MD method, where the molecule can be trapped in a local minimum for 
a long time. 
 
In this chapter, a series of simulations for the overall conformations of both 
CP1B wild type (WT) and its various mutants was carried out using the 
method MCSD, which was the combined method of stochastic dynamics and 
Monte Carlo sampling. The combined method can sample the local minimum 
quite efficiently and also can explore the total conformational space of the 
peptide. 
 
2.2.3 Simulations set up in this chapter 
 
2.2.3.1 Set up of MCSD simulations in this chapter 
 
MCSD simulations for CP1B WT and selected β-Ala mutants were carried 
out with the modelling software package MacroModel using the OPLS2005 
force field with the GB/SA water model to mimic solvent effect (38).  
 
For each mutant and the WT system of CP1B, three repetitive (50 ns each) 
simulations were carried out starting with similar linear conformations. The 
starting linear conformation of the WT peptide CP1B was established using 
the protein builder in the Schrödinger GUI Maestro (39). The analogous 
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starting conformations for the various mutants of CP1B were generated by 
mutating corresponding residues on CP1B WT into β-Ala in silico in line 
with the experimental changes made to the peptide by Betts et al (32).  
 
For CP1B WT, two other MCSD simulations (50 ns each) were carried out 
starting with half-folded and fully-folded conformations respectively. The 
half-folded starting conformation of CP1B WT was the conformation in the 
last frame of a 1 ns MD simulation for CP1B. The starting fully-folded 
conformation used in these calculations was the lowest energy conformer 
obtained from a conformational search for the WT peptide. This 
conformational search was conducted with the MCMM Serial Torsional 
Sampling method and was run with a GB/SA water model, using the 
OPLS2005 force field, with 3000 steps for the conformational search and an 
energy window of 12.0 kJ/mol for collecting appropriate conformers. 
 
For all MCSD simulations conducted in this study, there was no cut-off 
distance applied for electronic and van der Waals interactions. The starting 
structure in each case was first minimised for up to 5000 steps with a 
gradient convergence threshold of 0.05. Stochastic dynamics was then 
carried out for 50 ns with the SHAKE procedure applied to all bonds to 
hydrogen atoms. The simulations were run at a constant temperature of 300K 
and with a time step of 1.5 fs (40). During the dynamics simulation the 
torsions within the peptide were subject to changes by the application of the 
Monte Carlo method. Five hundred structures were sampled in equal time 
intervals for later examination and analysis. 
 
2.2.3.2 Set up of MD simulations in this chapter 
 
To confirm that the conformations obtained from MCSD simulations were 
reasonable, three 100 ns long MD simulations for CP1B WT were carried out 
with the software NAMD running on the BlueFern™ supercomputer at the 
University of Canterbury (36). The starting conformations of these three MD 
simulations were obtained from the final frames in the three MCSD 
simulations for CP1B WT starting from linear, half-folded and folded 
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conformations as described above. The peptides were solvated with explicit 
water molecules in a water box. The water box in each system contains 
approximately 1500~1600 water molecules. The simulations were carried out 
with CHARMM force field parameter specifications at constant temperature 
and pressure at 310 K and 1 atmosphere (41). The cut-off distance for van 
der Waals interactions was set to be 12 Å. In each simulation, the system was 
first minimised for 5000 steps followed by 100 ns of dynamics simulation 
carried out at 2 fs time steps. The trajectory was written out at 100 ps time 
interval, and a total of 1000 frames were obtained from each simulation (100 
ns). These full-atom MD simulations are significantly more computationally 
expensive than the MCSD method. With NAMD using 32 processors running 
on the BlueFernTM supercomputer, each of the three 100 ns MD simulations 
takes 3~5 weeks to complete. A sample of the job setup script for MD 
simulations with NAMD is in appendix I. 
 
2.2.3.3 Cluster analysis of sampled conformations 
 
Cluster analyses were conducted on the sampled structures using XCluster 
(42) in order to examine the conformations explored during the MCSD and 
MD simulations. The clustering was performed in a hierarchical fashion, 
based on the pairwise RMS displacements of selected comparison atoms. In 
this study, the comparison atoms were set to be the backbone heavy atom of 
the loop region Glu10-Lys13 for CP1B WT system, and the region 
Glu9-Glu15 for the β-Ala mutant systems. The clusters with the most 
members were considered to comprise the most stable conformations 
explored during the dynamics simulations, and the representative structures 
of the largest clusters found in these simulations were selected as follows. 
For each cluster, the centroid of each of the comparison atoms was 
determined. Then the structure within the cluster which had the minimum 
RMS inter-atomic distance from these centroids was selected as the most 
representative structure of this cluster. These representative structures were 
then used in further structural comparisons. 
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2.3 Results and Discussions 
 
2.3.1 Dynamics of CP1B WT 
 
To examine the conformational preference of the WT CP1B peptide, 
particularly the proposed loop region (from Glu10 to Lys13), in the absence 
of the calpain enzyme, MCSD simulations were conducted for the WT 
system. 
 
Table 2. 1. Cluster analyses of sampled structures from the MCSD and MD simulations for 
CP1B WT. 
Simulation ID Simulation 
length 
Simulation 
type 
Number of 
clusters 
Cluster sizes 
1 50 ns MCSD 2 270, 230 
2 50 ns MCSD 3 152, 1, 347 
3 50 ns MCSD 2 499, 1 
4 100 ns MD 3 35, 64, 1 
5 100 ns MD 4 9, 8, 8, 75 
6 100 ns MD 4 90, 1, 8, 1 
	  
Table	   2.	   2.	  Overall	   and	   loop	   region	  backbone	  RMSD	  values	   in	   the	   three	  50	  ns	  MCSD	  simulations	  for	  CP1B	  WT	  peptide.	  The	  RMSD	  values	  are	  measured	  between	  the	  starting	  conformation	  and	  the	  average	  structure	  of	  the	  largest	  cluster	  in	  each	  simulation.	  
Simulation 
ID 
Simulation 
length 
Starting 
conformation 
Backbone 
RMSD (Å) 
Loop region 
(Glu10-Lys13) 
backbone RMSD (Å) 
1 50 ns Linear 16.8 2.22 
2 50 ns Half-folded 10.7 1.97 
3 50 ns Folded 2.23 0.30 
 
Three MCSD (50 ns) simulations of the CP1B WT peptide were initiated 
starting from linear, half-folded and fully-folded conformations respectively. 
Cluster analyses were carried out to examine the conformations explored 
during these simulations (Table 2. 1). In the cluster analyses, pairwise RMS 
displacements in backbone atoms of the loop region (Glu10-Lys13) were 
calculated, and the sampled structures were clustered based on these 
displacements. The largest cluster in each simulation was considered to 
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comprise the most stable conformations explored, and the representative 
structure of all members in the largest cluster was obtained to represent the 
cluster and to be used in further structural comparisons. The backbone 
RMSD values for the entire peptide and the loop region (Glu10-Lys13) 
between the representative structures and the starting conformations in these 
simulations are listed in  
Table 2. 2. RMSD measurements for two of the MCSD simulations 
(Simulations 1 and 2,  
Table 2. 2), starting from the linear and half-folded conformations, were 
large, indicating the MCSD method is sampling significant conformational 
space. Simulation 3 which started with folded conformation shows much 
smaller backbone changes. This observation is consistent with the folded 
starting conformation for this calculation representing a low energy 
conformer of the CP1B WT peptide. Therefore, this simulation started from a 
favourable low energy conformation and exhibited limited sampling outside 
this local minimum during the entire simulation.  
 
To ensure efficient sampling over large conformational space, all further 
MCSD simulations for both CP1B WT and its mutants were set to begin with 
the extended linear conformations. The backbone RMSD values for the loop 
region ( 
Table 2. 2) were generally found to be smaller than the overall backbone 
RMSD variation, but still gave the same trend, with Simulations 1 and 2 
producing larger RMSD values than Simulation 3. Importantly all three 
simulations resulted in folded conformations ( 
 
 
 
 
	  
	  
	  
Table 2. 3), demonstrating that the peptide has a strong preference for an 
overall folded loop-like conformation. 
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Table	   2.	   3.	  Table	  of	   starting	  conformations,	   simulation	  ensembles	  of	   the	   loop	   region	  backbone	  for	  CP1B	  WT	  peptide	  in	  the	  three	  50	  ns	  MCSD	  simulations.	  The	  superposition	  of	   the	  representative	  structure	   from	  each	  simulation	  (brown	  carbon)	  and	  the	  binding	  conformation	  in	  the	  crystal	  structure	  (cyan	  carbon)	  is	  also	  displayed.	  
Simulation ID Starting 
conformation 
Simulation Ensemble 
of the loop region 
backbone 
(collected every 1 ns) 
Superposition of the 
loop region between 
the representative 
structures and the 
binding conformation 
1. 
(Fully 
extended 
linear 
conformation) 
   
2 
(Half folded 
conformation) 
   
3 
(Fully folded 
conformation) 
   
 
The MCSD method treats solvent implicitly and combines stochastic 
dynamics with Monte Carlo sampling. To exclude the possibility that folding 
observed in simulations 1 and 2 were artefacts of this particular simulation 
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method, the conformations obtained from the last frames in these three 
MCSD simulations were used as the starting geometries for three more 
rigorous 100 ns MD simulations, in which the solvent was treated explicitly. 
This was done to establish if the loop region between Glu10 and Lys13 
would start to unfold.  
 
	  
	  
Table	   2.	   4.	  Table	  of	   starting	  conformations,	   simulation	  ensembles	  of	   the	   loop	   region	  backbone	   in	   the	   three	   100	   ns	  MD	   simulations	   for	   CP1B	  WT	   started	   from	   last	   frame	  conformations	   obtained	   from	   corresponding	  MCSD	   simulations.	   The	   superposition	   of	  the	   representative	   structures	   from	  each	   simulation	   (brown	   carbon)	  with	   the	   starting	  conformations	  (cyan	  carbon)	  at	  the	  loop	  region	  backbone	  is	  also	  displayed.	  
Simulation 
ID 
Starting 
conformation 
Simulation 
Ensemble of the 
loop region 
backbone 
(collected every 1 
ns) 
Superposition of the 
loop region between 
the representative 
structures and the 
starting conformations 
4    
5    
6    
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Figure	  2.	  6.	  Plots	  of	  backbone	  RMSD	  of	  the	  loop	  region	  (Glu10-­‐Lys13)	  in	  the	  three	  100	  ns	  MD	  simulations	  (Simulations	  4-­‐6).	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Examination of the simulation ensembles showed that the loop region 
(Glu10-Lys13) of WT CP1B remained folded during these three 100 ns MD 
simulations ( 
 
Table 2. 4). The conformation of the loop region was generally observed to 
become stable after 35 ns into the MD simulation (Figure 2. 6). The same 
cluster analyses as described above were carried out to examine the sampled 
structures from these three MD simulations (Table 2. 1), and the 
representative structures of the largest clusters were obtained for structural 
comparison ( 
 
Table 2. 4). The RMSD values of the loop region backbone were reasonably 
small (within 0.8 Å for Simulations 4 and 6, and slightly larger in Simulation 
5, with a RMSD value of 1.84 Å) considering the system under study was a 
small flexible peptide (Table 2. 5). The RMSD values suggest that both the 
full-atom MD and the MCSD simulations are sampling in the same family of 
related loop conformations for the Glu10-Lys13 region. This observation 
validates the use of the less computationally expensive MCSD method for 
the following study, and furthermore confirms that the peptide indeed has an 
inherent propensity to fold. 
 
Table	   2.	   5.	   Backbone	   RMSD	   values	   of	   the	   loop	   region	   in	   the	   three	   100	   ns	   MD	  simulations.	   The	   RMSD	   values	   are	  measured	   between	   the	   starting	   conformation	   and	  the	  average	  structure	  of	  the	  largest	  cluster	  in	  each	  simulation.	  
Simulation ID Simulation 
length 
Starting conformation Loop region 
(Glu10-Lys13) 
backbone RMSD  
4 100 ns Last frame structure of 
Simulation 1 
0.73 
5 100 ns Last frame structure of 
Simulation 2 
1.84 
6 100 ns Last frame structure of 
Simulation 3 
0.74 
 
The modelling results obtained for the WT CP1B can be compared with two 
crystal structures of the calpain-calpastatin complex recently reported by 
Moldoveanu et al. and Hanna et al., which illustrate the interactions between 
region B of calpastatin and the active site of calpain at atomic level (29, 30). 
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In these two crystal structures, the section of region B of calpastatin that 
corresponds to the 20-mer peptide CP1B was found to bind within the active 
site cleft of calpain (Figure 2. 3). 
 
The binding conformation of the loop region of CP1B in the crystal 
structure (3DF0) was used as the reference structure, and the backbone 
RMSD values for the loop region (Glu10-Lys13) were measured for all 
representative structures in the three MCSD simulations for CP1B WT ( 
Table 2. 6,  
 
 
 
 
	  
	  
	  
Table 2. 3). All three simulations showed reasonably small backbone RMSD 
values for the loop region, with Simulation 1 displaying the smallest RMSD 
value (0.75 Å). The comparison between the crystal structure conformation 
and our modelling results suggests that even in the absence of the calpain 
enzyme, the region Glu10-Lys13 of WT CP1B has a propensity to fold into 
loop-like conformations which is very similar to the conformation known to 
bind.  
	  
Table	   2.	   6.	   Backbone	   RMSD	   of	   the	   loop	   region	   (Glu10-­‐Lys13)	   between	   the	   binding	  conformation	   of	   CP1B	   in	   crystal	   structure	   (3DF0)	   and	   the	   average	   structures	   in	   the	  largest	  clusters	  of	  each	  MCSD	  simulation	  for	  CP1B	  WT.	  
Simulation ID Starting conformation Loop region (Glu10-Lys13) 
backbone RMSD compared 
to binding conformation (Å) 
1 Linear 0.75 
2 Half-folded 1.17 
3 Folded 0.79 
 
2.3.2 Dynamics of selected β-Ala mutants of CP1B and analysis 
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Following on from the studies of WT CP1B, studies were undertaken to 
establish the effect of mutations along the peptide on the conformational 
preference of this loop region in the absence of calpain. A prior study 
reported experimental IC50 values of various β-Ala mutants of the CP1B 
peptide (32). Therefore we elected to carry out β-Ala mutation in silico along 
the CP1B peptide in order to provide direct comparison with the reported 
experimental IC50 values. 
 
A series of β-Ala mutants of CP1B was obtained by selective mutation of 
residues Glu9, Glu10, Gly12, Lys13, Arg14 and Glu15, near the proposed 
loop region in silico. The residue Leu11 was omitted from this study because 
it has been shown that the importance of this residue in calpain inhibition lies 
in its side chain functionality (33). The side chain of Leu11 acts to fit in one 
hydrophobic pocket in the calpain active site, and losing this interaction (by 
β-Ala mutation) dramatically decreases the inhibition of calpain by the CP1B 
peptide. Therefore, the effect of Leu11βAla mutation on the measured IC50 
value is mainly contributed by the loss of its side chain functionality, rather 
than its possible effect on the conformation of this loop region. Unlike Leu11, 
the other residues (Glu9-Glu10, Gly12-Glu15) are likely to play a role in 
facilitating the formation of the loop-like conformation (34). The oppositely 
charged residues on either side of the loop region (Glu9, Glu10, Lys13 and 
Arg14) can form salt-bridges which would bring the two ends of the loop 
region into close proximity, and the highly flexible Gly12 can act to promote 
the formation of the loop.  
 
Table	  2.	  7.	  Cluster	  analyses	  of	  sampled	  structures	  from	  MCSD	  simulations	  for	  various	  β-­‐Ala	  mutants	  of	  CP1B.	  
Species Simulations Number of 
Clusters 
Cluster sizes 
Glu9BAla Glu9BAla_1 2 1, 499 
Glu9BAla_2 2 499, 1 
Glu9BAla_3 3 1, 3, 496 
Glu10BAla Glu10BAla_1 5 2, 1, 72, 1, 424 
Glu10BAla_2 2 499, 1 
Glu10BAla_3 2 8, 492 
Gly12BAla Gly12BAla_1 2 1,499 
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Gly12BAla_2 2 498, 2 
Gly12BAla_3 4 496, 2, 1, 1 
Lys13BAla Lys13BAla_1 3 14, 485, 1 
Lys13BAla_2 4 495, 2, 2, 1 
Lys13BAla_3 3 496, 2, 2 
Arg14BAla Arg14BAla_1 2 499, 1 
Arg14BAla_2 4 1, 1, 9, 489 
Arg14BAla_3 2 1, 499 
Glu15BAla Glu15BAla_1 3 2, 22, 476 
Glu15BAla_2 4 34, 464, 1, 1 
Glu15BAla_3 2 499, 1 
 
For each β-Ala mutant, three repetitive MCSD simulations (50 ns) were 
initiated from similar linear conformations in order to enhance the likelihood 
that the conformational space is appropriately traversed. All MCSD 
simulations for all six β-Ala mutants produced folded loop-like 
conformations. A cluster analysis was carried out for each simulation to 
examine the conformations explored (Table 2. 7). In these cluster analyses, 
the pairwise backbone displacements in the region from Glu9 to Glu15 were 
calculated between all sampled structures in each simulation. The largest 
cluster was identified for each simulation and the representative structure 
was obtained to be used in the following structural comparisons. RMSD 
analysis was then used to examine the effect of these β-Ala mutations on the 
conformational preference of the loop region of CP1B. To ensure that the 
effect of any particular mutation was not over-represented, RMSD values are 
measured for the region from Glu9 to Glu15, i.e. all the mutated residues are 
included in RMSD calculations. Backbone heavy atom RMSD values for the 
region Glu9-Glu15 were measured between the binding conformation of 
CP1B in the crystal structure (3DF0) and the representative structures 
obtained from cluster analysis for the simulation ensembles of β-Ala mutants 
of CP1B (Table 2. 8,  
 
 
Table 2. 9).  
 
Table	   2.	   8.	   Backbone	   RMSD	   values	   for	   the	   region	   Glu9-­‐Glu15	   between	   the	   binding	  conformation	   of	   CP1B	   in	   the	   crystal	   structure	   (3DF0)	   and	   the	   average	   structure	  obtained	  from	  each	  MCSD	  simulations	  for	  the	  β-­‐Ala	  mutants	  of	  CP1B.	  “Average	  RMSD”	  is	  the	  average	  RMSD	  values	   in	  the	  three	  repetitive	  MCSD	  simulations	  for	  each	  mutant	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system.	  
Species Simulations Backbone RMSD values between 
average structure and the binding 
conformation 
Average 
RMSD 
Glu9BAla Glu9BAla_1 2.80 3.58 
Glu9BAla_2 3.82 
Glu9BAla_3 4.12 
Glu10BAla Glu10BAla_1 4.76 4.88 
Glu10BAla_2 5.26 
Glu10BAla_3 4.63 
Gly12BAla Gly12BAla_1 5.68 5.43 
Gly12BAla_2 5.83 
Gly12BAla_3 4.78 
Lys13BAla Lys13BAla_1 3.09 3.36 
Lys13BAla_2 3.43 
Lys13BAla_3 3.57 
Arg14BAla Arg14BAla_1 4.08 3.13 
Arg14BAla_2 3.42 
Arg14BAla_3 1.89 
Glu15BAla Glu15BAla_1 3.29 3.10 
Glu15BAla_2 2.17 
Glu15BAla_3 3.85 
	  
	  
	  
Table	   2.	   9.	   Superposition	   of	   the	   loop	   region	   backbone	   between	   the	   representative	  conformation	  (brown	  carbon),	  obtained	   from	  each	  of	   the	  50	  ns	  MCSD	  simulations	   for	  the	  six	  β-­‐Ala	  mutants	  of	  CP1B,	  and	  the	  binding	  conformation	  (cyan	  carbon)	  as	  observed	  in	  the	  crystal	  structure.	  
Mutant 
species 
Simulation  
ID 
Superposition 
of the loop 
region between 
the 
representative 
structures and 
the binding 
conformation 
Mutant 
species 
Simulation 
ID 
Superposition 
of the loop 
region between 
the 
representative 
structures and 
the binding 
conformation 
Glu9BAla 1  Lys13BAla 1  
2  2  
3  3  
Glu10BAla 1  Arg14BAla 1  
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2  2  
3  3  
Gly12BAla 
 
1  Glu15BAla 1  
2  2  
3  3  
 
The RMSD values provide measures of deviation from the binding 
conformation in the loop region for each of the six β-Ala mutants. These in 
turn can give indication of the effect of different β-Ala mutations on the 
conformations and possible prearrangement of the loop region.  
 
The variations in RMSD values (Table 2. 8) for the different mutant systems 
demonstrated that the mutations have indeed altered the conformations of the 
loop region. The largest RMSD deviations were found for the Gly12βAla 
mutant system, indicating that Gly12βAla mutation has the greatest effect on 
conformation of the loop region. This in turn suggests that Gly12 is 
important for adoption of a loop-like conformation in region Glu10-Ly13 
prior to interaction with calpain. In contrast, Glu9βAla, Glu15βAla, and 
Lys13βAla systems showed relatively smaller deviations from the bound 
conformation, suggesting that these residues have a smaller influence on the 
loop conformation. 
 
In order to establish if there is a trend in the effect of the mutations on the 
conformational preference of the loop region, the average of RMSD values 
for each mutant system were compared (Table 2. 8). The deviations from the 
binding conformation in the mutant systems are thereby ranked in the 
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following order: Glu15 < Arg14 < Lys13 < Glu9 < Glu10 < Gly12. The 
larger deviation of the loop region from the binding conformation indicates 
greater influence of the corresponding mutation on conformation of the loop 
region, and in turn indicates the greater contribution the mutated residue 
makes to the conformational preference of the loop region. The rank of 
individual residue contribution to the conformational preference of the loop 
region or loop prearrangement in the absence of calpain (referred to as the 
“conformational rank”) will be in the same order as above.  
 
Previously, Betts et al. have reported a rank of individual residue 
contribution to inhibitory activity based on the experimentally measured IC50 
values for a series β-Ala mutants (32). In this “functional rank”, the 
contributions of the mutated residues near the loop region to the inhibition 
activity were placed in the following order: Glu15 < Lys13 < Glu9 < Glu10 < 
Arg14 < Gly12.  
 
The “conformational rank” was obtained based on only the conformational 
preferences of the CP1B mutants in the absence of calpain, while the 
“functional rank” takes into account not only the conformational factors but 
also other contributing factors such as the interactions between the peptide 
variants and calpain active site. However, comparison between the 
“conformational rank” from our modelling study and the “functional rank” 
from experimental measurements shows that the two ranks are remarkably 
closely correlated, with the only exception being Arg14. This difference in 
ranking for Arg14 may suggest that the effect of Arg14 on calpain inhibition 
is mainly contributed by the side chain functionality and the interactions with 
calpain active site, rather than its effect on the preference of the loop region 
conformation. However, the striking similarity of the general trend in the 
ranking obtained from both experimental and computational methods 
suggests that the differences of conformational preferences of the loop region 
in CP1B mutants may be a significant contributing factor to their ability to 
inhibit calpain.  
 
2.4 Summary 
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In summary, MCSD and MD calculations have been used to demonstrate that 
a series of calpain inhibitors derived from natural regulator calpastatin have a 
preference for a adopting the loop-like conformation that is associated with 
binding in the absence of calpain. Inhibitory activity of these peptides can be 
correlated to the propensity of these peptides to prearrange in a loop-like 
conformation. Therefore the ability to pre-adopt loop-like conformations is 
an important factor for the design of effective inhibitors of calpain. 
 
 
  
36 
 
Part B:  
The 
3-deoxy-D-arabino-heptulosonate 
7-phosphate synthase system 
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Chapter 3: Introduction to 3-deoxy-D-arabino-heptulosonate 
7-phosphate synthase 
 
3.1	  The shikimate pathway 
 
The shikimate pathway is the seven metabolic steps beginning with the 
condensation of phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P) 
and ending with the synthesis of chorismate (Figure 3. 1) (43, 44). The 
shikimate pathway is the biosynthetic route that is responsible for the 
production of essential aromatic compounds (45). These compounds include 
the aromatic amino acids, tryptophan, tyrosine and phenylalanine; folic acid, 
an essential cofactor for many enzymatic processes; and salicylate, used for 
the biosynthesis of the siderophores through which bacteria acquire iron (46). 
The pathway is found in microorganisms and plants, and has more recently 
been discovered in apicomplexan parasites (47, 48). However, the shikimate 
pathway is absent in higher organisms, making the enzymes of this pathway 
attractive as targets for the development of antimicrobial agents. Recent gene 
disruption studies have shown that operation of the shikimate pathway is 
essential for the viability of Mycobacterium tuberculosis (49), the causative 
agent of tuberculosis (TB), a disease that remains a significant world-wide 
health risk (50). Although effective anti-TB drugs exist, the long treatment 
times required, the problems of latent or persistent TB (51) and the 
proliferation of multidrug-resistant strains of M. tuberculosis (52) have all 
created an urgent need for the development of new antimycobacterial agents 
(53). 
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Figure	  3.	  1.	  The	  shikimate	  pathway.	  
 
3.2	  3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase 
 
The first step of the shikimate pathway is the stereospecific aldol reaction 
between PEP and E4P to produce 3-deoxy-D-arabino-heptulosonate 
7-phosphate (DAH7P) and inorganic phosphate. This reaction is catalysed by 
the enzyme 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase 
(DAH7PS). DAH7PSs are classified into two distinct types (54). Type I 
enzymes have molecular masses less than 40 kDa, and this group can be 
further divided into two sequence subfamilies: Iα and Iβ (55, 56). The type Iα 
and Iβ DAH7PSs have been well characterised, both structurally and 
functionally. The crystal structures of the type Iα enzymes from Escherichia 
coli (57-59) and Saccharomyces cerevisiae (60, 61), and the type Iβ enzymes 
from Thermotoga maritima (62) and Pyrococcus furiosus (63), reveal a 
common (β/α)8 TIM barrel fold (Figure 3. 2). Both the E. coli (Phe-sensitive) 
and S. cerevisiae (Phe- and Tyr-sensitive) enzymes have additions to their 
core barrels that have been shown to be associated with the binding of a 
single regulatory aromatic amino acid (60, 64, 65). Regulated type Iβ 
enzymes show one addition to the core barrel that is associated with 
allosteric regulation. This covalently attached regulatory domain appears to 
be either ferredoxin-like (characterised by the enzyme from T. maritima) (62) 
or a functional chorismate mutase fused either to the N- or C-terminus 
39 
 
(DAH7PS from Bacillus subtilis and Porphyromonas gingivalis) (66). 
 
 
Figure	  3.	  2.	  Monomer	  structure	  of	  type	  I	  DAH7PS	  from	  E.	  coli	  (PDB	  1KFL),	  S.	  cerevisiae	  (PDB	   1OFB),	   T.	   maritima	   (PDB	   1RZM)	   and	   P.	   furiosus	   (PDB	   1ZCO).	   The	   additional	  secondary	   structures	   to	   the	   core	  barrel	   are	   coloured	   red	  and	  yellow,	   the	  main	  barrel	  structure	  is	  shown	  in	  blue.	  
 
The M. tuberculosis genome encodes a single DAH7PS (MtuDAH7PS) that 
is a member of the type II family. MtuDAH7PS is the only member of this 
type that has been structurally characterised (67). Type II enzymes were first 
identified in plants (68, 69), however, more recently, an increasing number of 
microbial examples have been identified (54, 70). For some organisms, type 
II enzymes are associated with the biosynthesis of specific secondary 
metabolites, in these organisms type I DAH7PS are also present (71, 72). 
However, the presence of only type II DAH7PS in a number of species 
including Streptomyces species, Corynebacterium diphtheriae, 
Campylobacter jejuni, Agrobacterium tumefaciens, Helicobacter pylori and 
several Mycobacteria species, supports the role of type II DAH7PS enzymes 
in aromatic amino acid biosynthesis. Type II enzymes are larger (>50kDa) 
than their type I counterparts, and the two types share very low sequence 
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identity (<10%). However, the core structure and catalytic machinery of 
MtuDAH7PS is remarkably similar to those of the type I enzymes, revealing 
that despite their low sequence similarity these two DAH7PS types are 
evolutionarily related (67). Along with a distinct quaternary structure, 
MtuDAH7PS displays a distinctly different decoration of the core catalytic 
barrel to the type I enzymes, with two additional independent subdomains, 
which were predicted to be linked to allosteric regulation of this enzyme. 
 
3.3	  Structural features of MtuDAH7PS 
 
The crystal structure of ligand-free wild type DAH7PS from M. tuberculosis 
has been solved previously (67). The monomer structure of MtuDAH7PS 
adopts the (β/α)8 TIM barrel fold, similar to type I DAH7PS family. Two 
major additional structural elements were found to decorate the main barrel 
(Figure 3. 3A). The first addition consists of helices α0a, α0b and α0c 
(residues 1-80) at the N-terminus, and the second addition consists of helices 
α2a and α2b (residues 190-241). The two monomers in the asymmetric unit 
form a tight dimer, and the quaternary structure of MtuDAH7PS is a 
homotetramer (Figure 3. 3B), which is generated by application of a 
crystallographic two-fold symmetry operation. The dimer interface is made 
up mainly by the N-terminal residues 3-10, the long helix α2, and the 
α0b-α0c loop from the N-terminal addition, with a solvent accessible surface 
area of 1885 Å2. The interface between the two dimers to form the tetramer is 
less extensive with solvent accessible surface area of 954 Å2, and is made up 
by the additional α2b helix and α2b-β3 loop, with minor contributions from 
the core α1 helix. 
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Figure	  3.	  3.	  A.	  Monomer	  and	  B.	  tetramer	  structure	  of	  ligand-­‐free	  wild	  type	  MtuDAH7PS	  (PDB	  2B7O).	  The	  main	  barrel	  structure	   is	  shown	  in	  blue,	   the	  additional	  helices	  at	   the	  N-­‐terminus	   are	   coloured	   red	   and	   the	   additional	   helices	   α2a	   and	  α2b	   are	   coloured	   in	  yellow.	   The	   bound	   metal	   ions	   (Mn2+)	   are	   displayed	   in	   (B)	   as	   magenta	   spheres	   to	  indicate	  the	  position	  of	  the	  active	  site.	  
 
The active site of MtuDAH7PS is located at the C-terminal end of the barrel, 
where it is clearly indicated by the presence of the bound metal ion, Mn2+ 
and PEP (Figure 3. 4). The active site residues are contributed by the 
C-terminal ends of the β-strands and α-helices. The metal binding site is 
formed by Cys87, His369, Glu411 and Asp441.  
 
The PEP binding site is defined by a network of hydrogen bonds between the 
protein and the PEP phosphate and carboxylate groups. The phosphate group 
of PEP forms hydrogen bonds with Glu283, Arg284, Lys306, Arg337 and 
two water molecules. The carboxylate group of PEP forms hydrogen bonds 
with Arg126, Lys306 and one additional water molecule. One sulfate ion is 
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also observed to bind in the active site. This sulfate ion interacts with Arg135, 
Arg284 and Ser136 and is likely to indicate the position of the E4P 
phosphate group upon binding of the substrate. 
 
 
Figure	   3.	   4.	   Stereo	   view	   of	   the	   active	   site	   of	  MtuDAH7PS.	   The	   active	   site	  metal	   ion	  (Mn2+)	   is	   shown	   as	  magenta	   sphere,	   the	   substrate	   PEP	   is	   shown	  with	   yellow	   carbon	  atoms,	   and	   the	   sulfate	   ion	  bound	   in	   the	   active	   site	   is	   shown	   in	   green.	  The	   active	   site	  residues	  are	  displayed	  with	  blue	  carbon	  atoms.	  
 
3.4	  Feedback inhibition studies with MtuDAH7PS 
 
Some initial studies on MtuDAH7PS have been conducted by Celia J Webby 
(73). The three aromatic amino acids (Trp, Phe and Tyr) and chorismate were 
tested, individually and in combination, as potential feedback regulators of 
MtuDAH7PS. Results showed that single amino acids do not inhibit the 
activity of MtuDAHP7S, but combinations of Trp+Phe, and Trp+Tyr reduce 
the activity of the enzyme to 54% and 78% respectively. This observation 
indicated that MtuDAH7PS is inhibited synergistically with combination of 
aromatic amino acids. 
 
3.5	  Outline of Part B of this thesis 
 
Part B of this thesis explores the structure and function of MtuDAH7PS 
using various techniques of molecular modelling. Firstly, protein crystal 
structure refinements were conducted and those crystal structures of 
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MtuDAH7PS in complex with various ligand molecules are described in 
Chapter 4. Secondly, the reaction mechanism and roles of active site residues 
were investigated in Chapter 5, through docking calculations (both rigid 
docking and induced fit docking) of a series of designed active site inhibitors. 
Finally, Chapter 6 discusses the molecular basis of the communication 
mechanism of allosteric regulation in MtuDAH7PS. 
 
 
  
44 
 
Chapter 4: Synergistic allostery and series of crystal structures of wild 
type and mutant MtuDAH7PS in complex with different ligands 
 
4.1	  Introduction 
 
4.1.1 Synergistic feedback inhibition of MtuDAH7PS by combinations of 
amino acids 
 
 
Figure	  4.	  1.	  DAH7PS	  reaction	  and	  shikimate	  pathway	  
 
As the first enzyme, DAH7PS is a major control point for shikimate pathway 
flux (Figure 4. 1). Several organisms express two or more isozymes of this 
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enzyme that show different sensitivity to the pathway end products. For 
example, E. coli and Neurospora crassa each produce three isozymes, with 
each enzyme individually inhibited by Phe, Tyr or Trp (74, 75). For S. 
cerevisiae there are two differentially regulated DAH7PS sensitive to either 
Phe or Tyr (60). 
 
M. tuberculosis does not produce any isozyme of DAH7PS, and 
MtuDAH7PS is regulated with a more sophisticated mechanism. Kinetic 
experiments have shown that MtuDAH7PS is not inhibited by any single 
aromatic amino acid (Phe, Tyr or Trp alone), but that combinations of 
aromatic amino acids (Trp and Phe, and to a lesser extend Trp and Tyr) give 
significant enzyme inhibition (76). No inhibition was observed in the 
presence of both Tyr and Phe, a combination that has recently been reported 
to inhibit the activity of the M. tuberculosis chorismate mutase in complex 
with MtuDAH7PS (77). 
 
Steady-state kinetic experiments showed that PEP binding is unaffected by 
the presence of the inhibitory combinations of aromatic amino acids 
(Trp+Phe and Trp+Tyr), however, a dramatic change in cooperativity and a 
significant decrease in affinity was observed for E4P binding (76). 
 
4.1.2 Crystallography and structural refinement 
 
Macromolecular X-ray crystallography has become one of the most critical 
experimental techniques in studies of enzymes and other biological 
macromolecules. X-ray crystal structures not only show quaternary and 
tertiary structures of the protein fold, but can also be used to elucidate details 
of the enzyme active site and ligand binding sites at atomic level, and 
provide valuable insights to the structural-function relationships of the 
enzyme. The crystal structures can be used to guide further studies by either 
experimental or computational means. Structures can be used to inform 
design of drug-like compounds at designated sites on the enzyme and in 
other cases they are usually used as the starting point in computational 
calculations, such as molecular dynamics (MD) simulations and QM/MM 
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calculations. 
 
Once appropriate forms of crystals are formed in the laboratory, the structure 
of an enzyme can be determined by passing X-ray beams through the crystal 
and record the scattering patterns of the X-ray caused by the electrons in the 
enzyme molecule. Because the structures in each unit cells are repeated 
throughout the entire volume of a crystal in a periodic fashion, it can be 
treated as a 3D diffraction grating. The scattering of the X-ray beams is 
governed by the geometry of the unit cell and the wavelength of the X-ray 
beam; and the intensities of the diffracted ray are governed by the atoms that 
constitute the structures in the unit cell. Therefore the entire structure of the 
enzyme is encoded in the diffracted X-ray pattern. The diffracted beams are 
also called “reflections”, and the recorded intensities of the diffracted X-ray 
contain only the amplitude information, but not the phases of the reflections. 
Therefore, a Fourier transformation of the structure factors (F values) is 
calculated that contains both the amplitude and phase information of the 
observed reflections. This usually leads to an initial approximate electron 
density distribution in the crystal, which can be improved in an iterative 
fashion, eventually converging at an appropriate structural model of the 
protein (78).  
 
Up to this point, the data generated (the electron density map) can still be 
considered as experimental results. However, to obtain a 3D model of the 
enzyme structure, the electron density map has to be interpreted by adding 
individual atoms and molecules to the model. The model is then refined 
through a number of rounds to achieve the best possible agreement between 
the atomic model and the electron density map. The process of structural 
refinement can therefore be considered as a “modelling” technique. Because 
the atomic interpretation can be subjective, especially when modelling those 
ambiguous regions of the electron density map, slightly different atomic 
models of the enzyme structure can be obtained with the same electron 
density map. 
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In order to investigate the mechanism of the observed synergistic inhibition 
of MtuDAH7PS by combinations of aromatic amino acids (Trp+Phe and 
Trp+Tyr), crystal structure information is required to identify binding sites 
and binding modes of the ligand molecules, and any structural changes that 
may be caused by ligand binding. In this chapter of the thesis, the technique 
of crystal structure refinement was employed and the physical meanings of 
the final 3D atomic models were discussed. 
 
Prior to the start of the work in this chapter, crystal structures of 
MtuDAH7PS soaked with Trp+Phe, Trp-only and Phe-only had been solved 
and initially refined by Celia J Webby (73). As part of the studies described 
in this thesis, further refinements for these crystal structures were conducted, 
and refinements for a series of other structures of MtuDAH7PS were carried 
out to enable a fuller understanding of the binding of allosteric ligands to 
MtuDAH7PS. 
 
The refinement method used for the crystal structures described in this 
chapter is the same as described in the paper by Webby et al. (76). 
 
4.2	  Crystal structures of wild type MtuDAH7PS	  
 
4.2.1 Crystal structures of MtuDAH7PS in complex with inhibitory 
combinations of aromatic amino acids 
 
4.2.1.1 MtuDAH7PS in complex with Trp+Phe 
 
The crystal structure of MtuDAH7PS in complex with the inhibitory amino 
acid combination Trp+Phe was obtained firstly by soaking Trp and Phe at 
high ligand concentration (2.2 mM Trp and 2.2 mM Phe) (refined at 2.0 Å), 
and then by co-crystallisation at low ligand concentration (100 µM Trp and 
Phe) (refined at 1.95 Å) (Table 4. 1).  
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Table	   4.	   1.	   Refinement	   statistics	   for	   MtuDAH7PS	   in	   complex	   with	   Trp	   and	   Phe	  obtained	  by	  soaking	  and	  co-­‐crystallisation.	  
Structures Trp+Phe 
soaked 
Trp+Phe 
cocrystal 
Space group P3221 P3221 
Unit cell 
dimensions (Å) 
a=b 207.56 204.54 
c 207.56 66.46 
Refinement resolution range (Å) 32.7-2.0 179.8-1.95 
Number of reflections used in 
refinement 
105110 113806 
R factor 0.163 0.153 
Rfree 0.191 0.168 
Number of non-hydrogen atoms 6976 7800 
Mean B value (Å2) 25.42 33.9 
rms deviations 
from ideality 
Bond lengths (Å) 0.016 0.012 
Bond angles (deg.) 1.962 1.318 
Residues in the most favored region 
of Ramachandran plot (%) 
97.6 96.8 
PDB code 3KGF 3RZI 
 
Trp+Phe soaked structure. The final model of Trp+Phe soaked structure 
contains three Phe and two Trp molecules. The asymmetric unit contains two 
molecules with the general (β/α)8 TIM barrel fold. Two major additions 
decorate the basic barrel structure in each monomer. The first addition 
(residues 1-76) is the extended N-terminus and the three additional helices 
(α0a, α0b and α0c) (Figure 4. 2a). The second addition consists of a pair of 
helices (α2a and α2b) and a coil (residues 193-239) that extend the α2-β3 
loop (Figure 4. 2a).  
 
The two molecules in the asymmetric unit form a tight dimer, which further 
associates by application of crystallographic two-fold symmetry to form an 
MtuDAH7PS homotetramer (Figure 4. 2). The dimer interface has a 
solvent-accessible surface area of 1858 Å2, and is formed mainly by elements 
from the N-terminal extension to the core (β/α)8 barrel, specifically residues 
3-10, which form a two-stranded beta sheet across the interface, and the 
α0b-α0c loop, together with the long helix α2. The interface between the two 
dimers, through which the tetramer is generated, is less extensive, with 
solvent accessible surface area of 1065 Å2, and is formed by extra-barrel 
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elements, helix α2b and the loop α2b-β3, with minor contributions from the 
core α1 helix. The ligands Phe and Trp bind at the dimer and tetramer 
interfaces respectively, forming hydrogen bonds as well as hydrophobic 
contacts with the extra-barrel elements. One additional Phe per dimer is 
located between the α0a, α0b and α3 helices and the α-β4 loop of one of the 
monomer units. 
 
 
Figure	   4.	   2.	  a.	   Homotetramer	   and	  b.	  monomer	   structure	   of	  MtuDAH7PS	   in	   complex	  with	  Phe	  and	  Trp	  obtained	  by	  soaking	  (3KGF).	  Ligand	  molecules	  are	  displayed	  in	  green.	  In	   both	   figures,	   the	   N-­‐terminal	   extra-­‐barrel	   elements	   (the	   N-­‐termini	   and	   α0a-­‐α0c	  helices)	   are	   shown	   in	   red,	   and	   the	   additional	   α2a,	   α2b	   helices	   are	   shown	   in	   yellow.	  Active	  site	  metal	  ions	  are	  shown	  as	  purple	  spheres	  and	  the	  ligands	  are	  in	  sphere	  form.	  The	  Phe	  binding	  in	  secondary	  site	  is	  shown	  with	  orange	  carbon	  atoms,	  and	  the	  Phe	  in	  primary	  site	  and	  the	  Trp	  ligand	  are	  shown	  with	  green	  carbons.	  	  
 
Figure	  4.	  3.	  Stereo	  view	  of	  the	  primary	  Phe	  binding	  sites	  in	  the	  tight	  dimer	  interface	  in	  Trp+Phe	  soaked	  structure	  (3KGF).	  Residues	  3-­‐10	  are	  excluded	  for	  clarity.	  
 
The primary Phe binding sites in the Trp+Phe soaked structure (3KGF) are 
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located at the interface of the tight dimer, with binding involving interactions 
with residues from both monomers (Figure 4. 3). There is one primary Phe 
binding site in each subunit. The α-carboxylate group of each Phe ligand 
forms hydrogen bonds with the side chains of Arg171 and Asn175 and the 
α-amino group interacts with the side chain of Asn175 and the main-chain 
carbonyl oxygen of Phe91. The hydrophobic ring of Phe is buried in a pocket 
formed by residues from both subunits including: Ala174, Ala178, Pro56*, 
Val55*, Ala174*, and Tyr173* (where * indicates residues from the other 
subunit of the tight dimer). These binding pockets are “capped” by the 
extended N-termini of both monomers, residues 3-10, with Trp3 from 
subunit B positioned between the two Phe ligands, and contributing to the 
binding pockets for both Phe molecules (Figure 4. 4). 
 
 
Figure	   4.	   4.	   The	   “cap”	   of	   the	   primary	   Phe	   binding	   sites.	   Trp3	   from	   subunit	   B	   is	  positioned	  between	  the	  two	  Phe	  molecules	  bound	  at	  the	  dimer	  interface.	  The	  N-­‐termini	  in	  both	  subunits	  are	  displayed	  in	  ribbon	  form,	  and	  the	  rest	  of	  the	  enzyme	  is	  displayed	  by	  surface.	  
 
A secondary Phe binding site is observable in one monomer in each of the 
tight dimers of the tetrameric complex in this Trp+Phe soaked crystal 
structure (3KGF) (Figure 4. 5). The binding pocket for this site is formed by 
residues from the additional α0a and α0b helices, the α3 helix and the α3-β4 
loop. The α-carboxylate group of the Phe ligand bound here interacts with 
the side chains of Arg23 and Arg256. The α-amino group is hydrogen 
bonded to the backbone carbonyl oxygen of Arg256 and the side chain of 
Glu253. The hydrophobic ring sits in a pocket formed by nearby Leu 
Chain A Chain B 
N-terminus 
of Chain A 
N-terminus 
of Chain B 
Phe 
Phe 
Trp3 
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residues 26, 18, 271, 261 and 259. The helices α0a and α0b, which make up 
the binding pockets of the secondary Phe binding sites, are slightly closer to 
each other in subunit A and there is insufficient space for a Phe ligand to 
bind in this subunit. In subunit B, in contrast, the residues on the α0a helix 
(residues 16-27) have shifted in position so that the bound Phe can be 
accommodated.  
 
 
Figure	   4.	   5.	   Stereo	   view	   of	   the	   secondary	   Phe	   binding	   site	   in	   subunit	   B	   of	   Trp+Phe	  soaked	  structure	  (3KGF).	  
 
The Trp binding sites are located at the interface between the two tight 
dimers that make up the tetramer (Figure 4. 2). Each molecule of Trp is 
bound in a cavity between the extra-barrel pair of helices (α2a and α2b) and 
the core barrel helix α1 in each monomer. The Trp binding site is 
predominately formed by residues of the α2b and α1 helices, and the α2b-β3 
loop, which is also involved in tetramer association. In subunit A (Figure 4. 
6), the α-carboxylate group of Trp forms a salt bridge with the Lys123 side 
chain. The α-amino group interacts with the backbone carbonyl oxygen 
atoms of Asn237 and Thr240. The Nε on the Trp indole ring is hydrogen 
bonded to the backbone carbonyl oxygen of Ala192. The hydrophobic ring 
sits in a relatively deep binding pocket formed by hydrophobic residues, 
Val111, Leu107, Leu194, Ala241 and Val197. Similar interactions are also 
observed for Trp bound in subunit B. 
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Figure	  4.	  6.	  Stereo	  view	  of	  the	  Trp	  binding	  sites	  in	  Trp+Phe	  soaked	  structure	  (3KGF).	  
 
 
Figure	  4.	  7.	  The	  metal	  binding	  site	  and	  the	  phosphate	  ion	  bound	  in	  the	  active	  site	  of	  the	  Trp+Phe	   soaked	   structure	   (3KGF).	   The	   active	   site	   residues	   are	   displayed	  with	   green	  carbons,	  the	  metal	  ion	  is	  shown	  as	  a	  sphere.	  
 
The active site structure of the Trp+Phe soaked MtuDAH7PS is very similar 
to that of the ligand-free structure previously reported (PDB 2B7O), with one 
metal ion Mn2+ bound in the active site of each monomer. The metal binding 
site is formed by four protein ligands, Cys87, His369, Asp441, and both of 
the carboxylate oxygen atoms of Glu411. These residues fill up five positions 
of a pseudo-octahedral metal coordination site. In subunit A (Figure 4. 7), a 
water molecule (HOH278) occupies the sixth coordination site, whereas in 
subunit B, the sixth ligand is absent, but the geometry of the metal binding 
site is the same as that in subunit A.  
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One phosphate ion is bound in the active site of each monomer (Figure 4. 7), 
where it interacts with the side chains of the nearby Lys306, Arg337, the 
backbone NH group of Glu283, and four water molecules. The same 
interactions are observed in both chains. This phosphate ion binds in the 
same position as the phosphate group of PEP when it is bound in the active 
site of ligand-free MtuDAH7PS structure (PDB 2B7O) (Figure 4. 8).  
 
 
Figure	   4.	   8.	   The	   active	   site	   residues	   from	   Trp+Phe	   soaked	   structure	   (3KGF)	  superimposed	  onto	   the	   ligand-­‐free	   structure	  determined	  previously	   (2B7O).	  The	  PEP	  molecule	   bound	   in	   the	   ligand-­‐free	   structure	   (2B7O)	   is	   shown	   in	   yellow	   and	   the	  phosphate	  ion	  found	  in	  the	  Trp+Phe	  soaked	  structure	  is	  coloured	  in	  red.	  
 
Trp+Phe co-crystal structure. Since the Trp+Phe soaked crystal structure 
discussed above showed two distinct Phe binding sites, it is not clear which 
binding site of Phe is critical for inhibition. Therefore, the structure of 
MtuDAH7PS in complex with both Phe and Trp was determined by 
co-crystallisation at concentrations of inhibitors known to result in 
substantial loss of enzymatic activity (100 µM of each ligand). This 
co-crystallised Trp+Phe bound structure (Figure 4. 9) closely resembles the 
Trp+Phe soaked structure (root-mean-square distance of 0.644 Å, matching 
1753 Cα atoms). The solvent accessible surface area of the tight dimer 
interface is 1875 Å2 and that of the tetramer interface is 1024 Å2.  
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Figure	  4.	  9.	  A.	  Homotetramer	  and	  B.	  Monomer	  of	  MtuDAH7PS	  co-­‐crystallised	  with	  Trp	  and	  Phe	  ligands	  (3RZI).	  
 
In the structure determined by co-crystallisation, two Phe molecules bind in 
each of the tight dimer interfaces and two Trp molecules are located in each 
of the tetramer interfaces (Figure 4. 9). Thus one tetrameric biological unit 
binds four Trp and four Phe molecules simultaneously. The interactions 
between the bound ligand molecules and their binding sites at the interfaces 
are consistent with those observed in the soaked crystal structure.  
 
In the Trp+Phe soaked structure (3KGF), an additional Phe binding was 
observed and this site was occupied in one subunit of the asymmetric unit. 
However, in the co-crystallised structure (3RZI), the secondary Phe binding 
site is unoccupied, and its absence in the co-crystallised structure indicates 
that this site is occupied only at the high Phe concentrations (2 mM) used in 
the soaking experiment. This observation confirms that the binding sites at 
the two interfaces as observed in the co-crystal structure are responsible for 
the synergistic inhibition we have observed for the Trp+Phe combination, 
and the occupation of the secondary Phe binding site is not essential for 
inhibition. 
 
4.2.1.2 Crystal structure of MtuDAH7PS in complex with Trp and Tyr 
 
The crystal structure of MtuDAH7PS in complex with the other inhibitory 
combination of aromatic amino acids (Trp+Tyr) was determined and refined 
at 2.8 Å). This crystal was also obtained by soaking ( 
 
	   A	   B	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Table 4. 2). 
	  
	  
Table	  4.	  2.	  Refinement	  statistics	  for	  MtuDAH7PS	  in	  complex	  with	  Trp	  and	  Tyr	  obtained	  by	  soaking.	  
Structure Tyr+Trp 
Space group P3221 
Unit cell 
dimensions (Å) 
a=b 202.777 
c 66.747 
Refinement resolution range (Å) 175.67-2.76 
(2.83-2.76) 
Number of reflections used in refinement (test set) 37979 
(2242) 
R factor 0.183 
Rfree 0.251 
Number of non-hydrogen atoms 7251 
Mean B value (Å2) 32.747 
rms deviations 
from ideality 
Bond lengths (Å) 0.025 
Bond angles (deg.) 3.673 
Residues in the most favored region of 
Ramachandran plot (%) 
89.88 
PDB code Not deposited 
 
The final model of Trp+Tyr soaked structure contains three Tyr and two Trp 
molecules. This structure is very similar to the Trp+Phe soaked crystal 
structure (3KGF) (rms distance of 0.441 Å, matching 806 Cα atoms). The 
solvent accessible surface area of the tight dimer interface is 1761 Å2 and 
that of the tetramer interface is 1022 Å2. 
 
In the Tyr+Trp soaked structure, Tyr molecules are found to bind in the 
primary Phe binding site that is observed in the Trp+Phe soaked structure 
(Figure 4. 10). The interactions between the Tyr ligand and the residues in 
the binding site are the same as those formed when Phe is bound, with the 
α-carboxylate group forming hydrogen bonds with the side chains of Arg171 
and Asn175 and the α-amino group interacting with the side chain of Asn175 
and the main-chain carbonyl oxygen of Phe91. No additional interactions are 
formed between the enzyme residues and the Tyr hydroxyl group. 
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Figure	  4.	  10.	  Tyr	  molecule	  binding	  in	  the	  primary	  Phe	  binding	  sites	  in	  the	  tight	  dimer	  interface.	  Residues	  3-­‐10	  are	  excluded	  for	  clarity.	  
 
Similar to Trp+Phe soaked structure (3KGF), one Tyr molecule is found to 
bind in the secondary Phe binding site (Figure 4. 11). The same interactions 
between Phe molecule and the residues in the secondary Phe binding site are 
also observed when Tyr is bound in this site. In addition, Tyr molecule forms 
one extra hydrogen bond between the hydroxyl group and the backbone 
carbonyl of Pro16. This suggests that the so-called secondary Phe binding 
site may actually have higher affinity for Tyr molecules over Phe molecules. 
 
 
Figure	  4.	  11.	  Tyr	  molecule	  binding	  in	  the	  secondary	  Phe	  binding	  sites.	  
 
Trp molecules still bind in the same binding sites at the tetramer interface in 
the Trp+Tyr soaked structure, and the interactions between Trp molecules 
and the residues in the binding sites are the same as observed in Trp+Phe 
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soaked structure (3KGF). 
 
4.2.2 Crystal structure of ligand-free MtuDAH7PS (Thesit-free) 
 
Previously the ligand-free wild type crystal structure of MtuDAH7PS was 
determined (PDB 2B7O) (67). In this crystal structure, a detergent Thesit 
molecule that was present in the crystallisation condition can be observed to 
bind in the tight dimer interface. After the preliminary refinement of the 
Trp+Phe soaked structure (3KGF) conducted by Celia J Webby, it was found 
that in the presence of Trp and Phe ligand molecules, the detergent Thesit 
molecule was displaced by two Phe molecules binding in the same dimer 
interface (Figure 4. 12). Therefore, to enable direct comparisons of 
ligand-free and various ligand-bound crystal structures, the ligand-free 
structure of MtuDAH7PS that is also free of bound Thesit molecules was 
determined and refined at 2.3 Å (Table 4. 3). 
 
 
Figure	  4.	  12.	  The	  Thesit	  molecule	  (yellow)	  in	  the	  original	   ligand-­‐free	  structure	  2B7O	  (green)	   is	   displaced	   by	   two	   Phe	   molecules	   (cyan)	   in	   the	   Trp+Phe	   soaked	   structure	  3KGF	  (magenta).	   	  
 
In the final model of the Thesit-free structure, both molecules in the 
asymmetric unit contain the full polypeptide chain (Residues 1 to 462). The 
final model contains one PEP molecule, one phosphate ion, two manganese 
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ions, three sulfate ions, one chloride ion, and six glycerol molecules. The 
solvent accessible surface area of the tight dimer is 1885 Å2 and that of the 
tetramer interface is 954 Å2. 
 
The new ligand-free Thesit-free structure of MtuDAH7PS (3NV8) is 
essentially identical to the original Thesit-bound ligand-free structure (2B7O), 
with the α-carbons in both chains in the two structures match with RMSD of 
0.3 Å. The major differences only occur in structurally disordered regions 
including the α3-β4 loop (residues 265-268), β7-α7 loop (residues 375-381), 
and α2b-β3 loop (residues 234-241). In the tight dimer interface where the 
Thesit molecule was bound in the original crystal structure (2B7O), only 
slight changes are observed for the N-terminal residues 10 to 16 in Chain B. 
All other residues within 5 Å of the Thesit molecule still adopt the same 
conformation in the Thesit-free structure. 
 
Table 4. 3. Refinement statistics for ligand-free MtuDAH7PS (Thesit-free). 
Structure Thesit-free 
Space group P3221 
Unit cell 
dimensions (Å) 
a=b 203.54 
c 66.42 
Refinement resolution range (Å) 39.37-2.25 
(2.31-2.25) 
Number of reflections used in 
refinement (test set) 
69535 
(3648) 
R factor 0.180 
Rfree 0.208 
Number of non-hydrogen atoms 7098 
Mean B value (Å2) 36.9 
rms deviations 
from ideality 
Bond lengths (Å) 0.008 
Bond angles (deg.) 2.157 
Residues in the most favored region of 
Ramachandran plot (%) 
95.1 
PDB code 3NV8 	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4.2.3 Comparison of Trp+Phe soaked structure with Theist-free structure 
 
Since the Trp+Phe cocrystal structure (3RZI) and Trp+Tyr soaked structure 
are both very similar to the Trp+Phe soaked structure (3KGF), only one of 
these is used to compare with ligand-free structure (3NV8) to inform any 
major structural changes that occur upon simultaneous binding of the 
inhibitory combinations of aromatic amino acids to MtuDAH7PS. The 
crystal structure of the Trp+Phe soaked MtuDAH7PS complex (3KGF) was 
superimposed on to the new Thesit-free ligand-free structure (3NV8), in 
order to identify any structural differences caused by ligand binding and to 
identify a possible mechanism for inhibition. Ligand binding was found to 
cause no significant change in the overall structure of the MtuDAH7PS 
enzyme (Figure 4. 13).  
 
 
Figure	   4.	   13.	   Superposition	   of	   the	   Thesit-­‐free	   structure	   3NV8	   (magenta)	   and	   the	  Trp+Phe	  soaked	  structure	  3KGF	  (green)	  of	  MtuDAH7PS.	  The	  Phe	  and	  Trp	  ligands	  are	  in	  yellow	  sphere	   form.	  The	  backbones	  of	  residues	   in	  regions	  with	  minor	  conformational	  changes	  are	  displayed	  in	  stick	  form.	  
 
The two structures match with an RMSD in Cα atomic positions of only 0.7 
Å over the entire dimer. The greatest displacements were in the Phe and Trp 
binding sites, the N-termini, and the disordered α3-β4 loop (residues 
263-268). Upon binding of the Trp and Phe ligands, residues from β4 to α8 in 
both monomers (residues 273-462) show very little change in Cα positions, 
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indicating these secondary structures are not affected significantly.  
 
Binding of both Trp and Phe ligands causes the extended β2-α2 loop 
(residues 135-144) in the active site, which contains the highly conserved 
KPRS motif for type II DAH7PS enzymes, to become more disordered.  
These residues have been shown to be associated with the binding of 
substrate E4P in other DAH7PS enzymes (61, 62). This change is more 
clearly observed in subunit A, in which the loop shows alternative positions 
for residues 135-139 (Figure 4. 14). This change in the active site loop is not 
observed in the Trp-only and Phe-only structures. 
 
 
Figure	   4.	   14.	   Superposition	   of	   chain	   A	   and	   zoom	   in	   view	   of	   the	   active	   site	   loop	  containing	  the	  KPRS	  motif	  in	  the	  Trp+Phe	  soaked	  structure	  (3KGF,	  shown	  in	  magenta),	  and	   the	   ligand-­‐free	   Thesit-­‐free	   structure	   (3NV8,	   shown	   in	   cyan)	   of	  MtuDAH7PS.	   The	  backbone	   of	   residues	   133-­‐136	   is	   displayed	   in	   stick	   form,	   and	   the	   alternative	  conformation	  found	  in	  Trp+Phe	  soaked	  structure	  is	  shown	  in	  pink.	  
 
In the tight dimer interface, the binding of Trp and Phe simultaneously 
results in a subtle movement of residues of the α2 helix. This allows Ser189 
on the α2 helix to form new interactions with Ser62 on the α0c helix of the 
other monomer (Figure 4. 15). Another interaction gained at the dimer 
interface upon ligand binding is the hydrogen bond between Arg236 and 
Asn237 of the other monomer, with Asn237 also contributing to the tetramer 
interface (Figure 4. 16). In spite of Phe binding into the tight dimer interface, 
  
loop β2-α2 
residues 133-136 
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the backbone Cα atom positions are not affected for most amino acids near 
the Phe binding sites except for those on the N-termini. For both monomers, 
the N-terminal residues (1-10) have shifted in position (Table 4. 4), with 
displacements up to 6.2 Å in chain B and 3.1 Å in chain A. The displacement 
is greater in chain B because in the ligand-bound structure Trp3 sits in 
between the two bound Phe molecules, near where Val5 was found in the 
ligand-free structure.  
 
 
Figure	   4.	   15.	   The	   flip	   of	   peptide	   bond	   at	   Ser189	   upon	   binding	   of	   Trp	   and	   Phe.	  Ligand-­‐free	  structure	  (3NV8)	  is	  shown	  in	  cyan	  and	  Trp+Phe	  soaked	  structure	  is	  shown	  in	  magenta	  (3KGF).	  
 
 
Figure	   4.	   16.	   The	   new	   interaction	   at	   dimer	   interface	   between	   Arg236	   and	   Asn237	  upon	  Trp	  and	  Phe	  binding.	  Ligand-­‐free	  structure	  (3NV8)	  is	  shown	  in	  cyan	  and	  Trp+Phe	  soaked	  structure	  is	  shown	  in	  magenta	  (3KGF).	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Table	   4.	   4.	   Displacement	   of	   Cα	   atoms	   upon	   ligand	   binding.	   Only	   residues	   with	   Cα	  displacement	  greater	  than	  1	  Å	  in	  either	  subunit	  are	  listed.	   	  
Residue Cα Displacements (Å) upon Trp and Phe Binding 
Subunit A Subunit B 
Met1  4.97 
Asn2  4.96 
Trp3 1.50 6.19 
Thr4 1.52 5.37 
Val5 1.33 5.71 
Asp6 1.35 6.13 
Ile7 1.51 5.56 
Pro8 1.42 6.14 
Ile9 2.10 4.80 
Asp10 3.07  
Leu15  2.88 
Pro16 0.40 2.20 
Asp138 1.59 0.56 
Ser189 1.60 1.84 
Gly190 1.46 1.75 
Leu191 1.09 1.30 
Ser193 1.00 1.10 
Leu196 0.87 1.09 
Asp199 1.00 1.14 
Arg202 0.83 1.20 
Arg206 1.05 1.23 
Ser208 0.85 1.12 
Pro209 0.89 1.03 
Gly211 1.05 1.03 
Met228 0.89 1.12 
Ser229 1.06 1.21 
Ala230 1.02 0.99 
Gly232 1.04 0.94 
Val233 2.56 2.19 
Ala234 5.38 4.89 
Asp235 3.35 3.36 
Arg236 1.32 1.27 
Asn237 4.47 4.53 
Leu238 4.07 4.20 
Gln239 6.84 6.98 
Thr240 3.18 2.62 
Gly264 0.34 1.18 
Asp265  1.99 
Asp266  1.87 
Gly267  1.45 
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Upon binding of Phe in the Trp+Phe soaked structure, the side chain of 
Arg171 in chain B becomes disordered and shows one alternative 
conformation that interacts with the carboxylate group the Phe molecule. 
This displaces the side chain of Asp10 in chain A which was previously 
occupying the same site in the ligand-free structure, and results in the loss of 
the salt bridge between Arg171 of chain B and the Asp10 of chain A (Figure 
4. 17). Due to the shifts of N-terminal residues in subunit B, Arg171 in chain 
A gained a salt bridge with Asp6 and does not show any alternative 
conformation. 
 
 
Figure	  4.	   17.	  Alternative	  conformation	  of	  Arg171	  in	  chain	  B	  upon	  Phe	  binding	  in	  the	  dimer	   interface.	   Ligand-­‐free	   structure	   (3NV8)	   is	   shown	   in	   cyan	   and	   Trp+Phe	   soaked	  structure	  is	  shown	  in	  magenta	  (3KGF).	  
 
The residues contributing to the tetramer interface remain the same upon 
ligand binding although they undergo considerable structural changes. 
Considerable structural changes of the tetramer interface occur in the α2b-β3 
loop, while the α2a and α2b helices display slight movements near the Trp 
binding sites. Upon binding of the Trp ligands, residues 232-241 (in the 
α2b-β3 loop) show the most significant displacements in Cα atoms (Table 4. 
4). As a result the backbone carbonyl groups of Gln237 and Thr240 both 
interact with the amino group of Trp molecule. The side chain conformations 
of residues Leu194 and Val111 are changed in order to form the hydrophobic 
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pocket for Trp binding. The side chains of Lys123 in both monomers also 
moved slightly to interact with the carboxylate groups of the bound Trp 
molecules (Figure 4. 18). 
 
 
Figure	   4.	   18.	   Changes	   in	   residue	   conformations	   around	   tetramer	   interface	   upon	  binding	  of	  Trp.	  
 
4.2.4 Crystal structure of MtuDAH7PS in complex with single amino acids 
 
4.2.4.1 Phe-only soaked structure 
 
The crystal structure of MtuDAH7PS in complex with Phe alone obtained by 
soaking was refined at 3.0 Å ( 
 
Table 4. 5). The final model contains five phosphate ions and five Phe 
molecules in the asymmetric unit. Three of the Phe molecules occupy the 
same primary and secondary binding sites as in the Trp+Phe soaked structure 
(3KGF), with two bound in the tight dimer interface and one bound in 
subunit B near helices α0a, α0b and α3. The remaining two Phe molecules 
are observed to bind in the Trp binding sites in the tetramer interface. The 
solvent accessible surface area of the tight dimer is 1746 Å2 and that of the 
tetramer interface is 1030 Å2. 
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Table	  4.	  5.	  Refinement	  statistics	  for	  MtuDAH7PS	  in	  complex	  with	  Phe	  alone	  obtained	  by	  soaking.	  
Structure Phe-only 
Space group P3221 
Unit cell dimensions (Å) a=b 204.65 
c 66.61 
Refinement resolution range (Å) 39.6-3.0 
(3.08-3.0) 
Number of reflections used in refinement (test set) 29566 
(1574) 
R factor 0.212 
Rfree 0.269 
Number of non-hydrogen atoms 6756 
Mean B value (Å2) 32.7 
rms deviations from 
ideality 
Bond lengths (Å) 0.012 
Bond angles (deg.) 1.160 
Residues in the most favored region of 
Ramachandran plot (%) 
92.1 
PDB code 3NUD 
 
 
 
Figure	   4.	   19.	   Stereo	   views	   of	   Phe	   in	   the	   Trp	   site	   at	   the	   tetramer	   interface	   in	   the	  Phe-­‐only	   structure	   (3NUD).	   The	   alternative	   positions	   for	   residues	   237-­‐239	   are	  displayed	  with	  orange	  carbons.	   	  
 
In the Phe-only structure (3NUD) the primary and secondary Phe binding 
sites are essentially the same as in the Trp+Phe soaked structure (3KGF), 
with minor changes in side chain conformations of Arg171, and small shifts 
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in the positions of the N-terminal residues. The interactions between the 
bound Phe ligands and the enzyme are retained.  
 
Interestingly, in the Phe-only structure obtained by soaking in high 
concentration of Phe ligand (2 mM), Phe molecules are observed to also 
occupy the Trp binding sites at the tetramer interface and show similar 
interactions (Figure 4. 19). The α-carboxylate group of the Phe interacts with 
the side chain of Lys123, and the hydrophobic ring sits in the same pocket as 
that of the Trp ligand when it is bound. Unlike Trp, the α-amino groups of 
the bound Phe ligands only show interaction with the backbone carbonyl 
oxygen of Asn237, but not Thr240. The loop comprising residues 237-242 is 
more disordered than in the Trp+Phe soaked structure, and shows at half 
occupancy an alternative position similar to that observed in the ligand-free 
structure (3NV8).  
 
4.2.4.2 Tyr-only soaked structure 
	  
Table	  4.	  6.	  Refinement	  statistics	  for	  MtuDAH7PS	  in	  complex	  with	  only	  Tyr	  obtained	  by	  soaking.	  
Structure Tyr-only 
Space group P3221 
Unit cell dimensions (Å) a=b 202.777 
c 66.747 
Refinement resolution range (Å) 175.67-2.69 
(2.76-2.69) 
Number of reflections used in refinement (test set) 41510 
(2959) 
R factor 0.156 
Rfree 0.190 
Number of non-hydrogen atoms 7168 
Mean B value (Å2) 47.9 
rms deviations from 
ideality 
Bond lengths (Å) 0.028 
Bond angles (deg.) 2.349 
Residues in the most favored region of 
Ramachandran plot (%) 
92.08 
PDB code Not deposited 
 
The structure of MtuDAH7PS in complex with only Tyr was obtained by 
soaking in high concentration of Tyr ligand (2 Mm) and refined at 2.7 Å ( 
Table 4. 6). The final structure contains three Tyr ligands in the asymmetric 
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unit. The solvent accessible surface area of the tight dimer is 1736 Å2 and 
that of the tetramer is 973 Å2. 
 
The Tyr molecules in the Tyr-only structure are observed to bind in the 
primary and secondary Phe sites in the same way as observed in the Tyr+Trp 
soaked structure.  
 
With the absence of Trp molecules, Tyr molecules are not found in the Trp 
binding sites as was observed for Phe molecules in the Phe-only structure 
(3NUD), despite Tyr being similar in structure with Phe. This may suggest 
that the Trp binding pocket does not efficiently accommodate the additional 
hydroxyl group of Tyr molecule. 
 
4.2.4.3 Trp-only structure 
 
The crystal structures of MtuDAH7PS in complex with only Trp molecules 
were obtained by soaking in 2mM Trp (refined at 2.5 Å) and by 
co-crystallisation at very high Trp concentrations (1 mM) (refined at 2.3 Å) 
(Table 4. 7). 
 
Table	  4.	  7.	  Refinement	  statistics	  for	  MtuDAH7PS	  in	  complex	  with	  Trp	  alone	  obtained	  by	  soaking	  and	  co-­‐crystallisation.	  
Structures Trp-only 
soaked 
Trp-only 
cocrystal 
Space group P3221 P3221 
Unit cell 
dimensions (Å) 
a=b 204.68 204.71 
c 204.68 66.26 
Refinement resolution range (Å) 38.7-2.5 
(2.57-2.5) 
44.24-2.25 
Number of reflections used in 
refinement (test set) 
52324 
(2815) 
72258 
R factor 0.189 0.143 
Rfree 0.228 0.169 
Number of non-hydrogen atoms 6871 8150 
Mean B value (Å2) 28.2 23.97 
rms deviations 
from ideality 
Bond lengths (Å) 0.016 0.018 
Bond angles (deg.) 1.485 1.67 
Residues in the most favored region of 
Ramachandran plot (%) 
95.6 97.2 
PDB code 3NUE Not deposited 
68 
 
 
  
69 
 
Trp-only soaked structure. The final model of Trp-only soaked structure 
(3NUE) contains two phosphate ions, two manganese ions, four sulfate ions, 
one chloride ion, one Thesit molecule and two Trp molecules. The Trp 
binding sites in the Trp-only structure are essentially identical to that in the 
Trp+Phe soaked structure (3KGF), with Trp molecules forming the same 
interactions with the enzyme. The solvent accessible surface area of the tight 
dimer interface is 2125 Å2 and that of the tetramer interface is 1047 Å2. 
 
One Thesit molecule is bound in the Phe binding sites in the tight dimer 
interface. The N-terminal residues has shifted in position in comparison with 
the Trp+Phe soaked structure, however the positions of these residues are 
essentially identical to those found in the previously reported ligand-free 
wild type structure, which also has a Thesit molecule bound at the same site 
(PDB 2B7O). This suggests that the shift in N-terminal residues only occurs 
upon Phe binding in the tight dimer interface. This shift in position may be 
caused by the positioning of Trp3 of subunit B between the two bound Phe 
molecules. 
 
Trp-only co-crystallised structure. The crystal structure of MtuDAH7PS in 
complex with Trp alone was determined by co-crystallisation at high ligand 
concentration (1 mM of Trp). This co-crystallised Trp-only bound structure 
closely resembles the Trp+Phe co-crystal and soaked structures determined 
above, with rms distance of 0.270 Å matching 849 Cα atoms, and rms 
distance of 0.149 Å matching 867 Cα atoms, respectively. The solvent 
accessible surface area of the tight dimer interface is 2034 Å2 and that of the 
tetramer interface is 1189 Å2. 
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Figure	   4.	   20.	   The	   dimer	   in	   the	   asymmetric	   unit	   of	  MtuDAH7PS	   co-­‐crystallised	  with	  only	  Trp	  at	  high	  ligand	  concentration.	  The	  basic	  barrel	  structure	  is	  shown	  in	  blue;	  the	  N-­‐terminal	  additions	  are	  coloured	  red,	  and	  the	  additional	  helices	  at	  tetramer	  interfaces	  are	  coloured	  yellow.	  The	  Trp	  molecules	  bound	  in	  the	  interfaces	  are	  shown	  in	  green,	  and	  the	  Trp	  molecule	  bound	  in	  the	  secondary	  Phe	  site	  is	  coloured	  in	  orange.	  
 
 
Figure	  4.	  21.	  Trp	  molecule	  bound	  in	  primary	  Phe	  site.	  Trp	  molecule	  binding	  in	  chain	  A	  is	  shown	  on	  top,	  and	  Trp	  molecule	  binding	  in	  chain	  B	  is	  shown	  on	  the	  bottom,	  both	  of	  the	  alternative	  conformations	  of	  Trp	  molecules	  binding	   in	   chain	  B	  are	  displayed.	  The	  glycerol	  molecule	  positioned	  in	  between	  the	  two	  Trp	  molecules	  is	  shown	  in	  magenta.	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There are five Trp molecules in the asymmetric unit (Figure 4. 20), two Trp 
molecules bind in the normal Trp site with the same binding mode as 
observed in all other crystal structures with Trp bound, and surprisingly, two 
Trp molecules are found to bind in the primary Phe binding sites, and one 
Trp molecule is found in the secondary Phe binding site. In other words, Trp 
molecule is observed to bind in all possible ligand binding sites in this 
co-crystal structure. This suggests that these ligand binding sites can be 
accommodative enough to fit Trp molecule at very high concentration.  
 
The carboxylate and amino groups of Trp molecules bound in the primary 
Phe site form the same hydrogen bond interactions with the enzyme residues 
as when Phe is bound (Figure 4. 21). The Trp molecule bound in chain A 
forms an additional hydrogen bond with a glycerol molecule that is 
positioned between the two Trp molecules in the dimer interface, and this 
glycerol molecule also forms an additional hydrogen bond with the Trp 
molecule bound in chain B (Figure 4. 21). This glycerol molecule is in the 
same position as the Trp3 residue of chain B in the Trp+Phe soaked and 
co-crystal structures. As a result, the N-terminal shift upon Phe binding is not 
observed in the Trp-only co-crystal structure. The N-terminal residues 
(residues 1-10) in the Trp-only co-crystal structure adopts the same 
conformations and positions as in the ligand-free wild type structure 
(Thesit-free). The Trp molecule bound in chain B is disordered and two 
alternative conformations can be modelled into the electron density map. 
This suggests that although the primary Phe binding sites at the dimer 
interface can accommodate the bigger Trp molecules, they are not as tight 
binding as Phe molecules, and only occupy the primary Phe binding sites at 
such high ligand concentration (1 mM). 
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Figure	  4.	  22.	  Trp	  molecule	  bound	  in	  the	  secondary	  Phe	  site.	  
 
In the Trp-only co-crystal structure, one Trp molecule is observed to bind in 
the secondary Phe binding site with the same binding mode as when Phe is 
bound (Figure 4. 22). The interactions between the enzyme residues and the 
backbone carboxylate and amino groups of the Trp molecule are the same as 
those observed in the Phe-only and Trp+Phe soaked structure. Interestingly, 
Trp molecule is also capable of forming one extra hydrogen bond with the 
backbone carbonyl group of Pro16, in a manner similar to when Tyr is bound 
in this site in the Tyr-only and Tyr+Trp structure.  
 
4.3	   Implications on molecular mechanism of feedback allosteric 
regulation of MtuDAH7PS 
 
Seven crystal structures of MtuDAH7PS in complex with various ligands 
(Trp+Phe soaked, Trp-only soaked, Phe-only soaked, Tyr+Trp soaked, 
Tyr-only soaked, Trp-only cocrystal, Trp+Phe cocrystal) was determined and 
one ligand-free wild type structure without the Thesit molecule bound was 
also obtained. Comparison of these wild type structures shows clearly that 
there is no gross conformational change within MtuDAH7PS associated with 
any ligand binding event ( 
Table 4. 8).  
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Table	   4.	   8.	   RMSD	   values	   between	   various	   ligand-­‐bound	   crystal	   structures	   of	  
MtuDAH7PS	  and	  the	  ligand-­‐free	  structure	  (3NV8).	  
Structures rms distance compare to 
Thesit-free ligand-free 
structure (Å) 
number of matching Cα 
atoms 
Trp+Phe soaked 0.334 808 
Trp-only soaked 0.354 798 
Phe-only soaked 0.328 778 
Tyr+Trp soaked 0.652 846 
Tyr-only soaked 0.255 841 
Trp-only cocrystallised 0.355 823 
Trp+Phe cocrystallised 0.489 806 
 
The synergistic nature of allosteric regulation of MtuDAH7PS by only 
combinations of amino acids is quite unusual. The fact that there is no gross 
conformational change associated with ligand binding is even more 
intriguing. Experimental kinetic measurements have shown that the binding 
of both Trp and Phe affects the binding of the substrate E4P by reducing the 
enzyme’s affinity for this substrate. From comparison of crystal structures, it 
can be observed that the loop responsible for E4P binding (loop β2-α2) 
shows an alternative conformation in the Trp+Phe soaked structure (3KGF), 
suggesting increased flexibility in this region may be associated with ligand 
binding. These observations suggest that mechanism of allosteric regulation 
and the communication among distant binding sites of MtuDAH7PS may 
arise from an alteration of protein dynamics upon ligand binding. Therefore, 
MD simulations can be employed to study the change in dynamics within the 
enzyme structure in detail, and may help to elucidate the molecular basis of 
this unusual synergistic allostery in MtuDAH7PS. 
 
4.4	  Crystal structures of mutant MtuDAH7PS 
 
Crystal structures of two mutants of MtuDAH7PS were obtained ( 
Table 4. 9). Both mutations (R23A, R256A) are located in the secondary Phe 
binding site, and both of the mutated Arg residues participate in interactions 
with the carboxylate group of the bound ligand at this site (Phe, Tyr or Trp).  
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Table	  4.	  9.	  Refinement	  statistics	  for	  mutant	  crystal	  structures	  of	  MtuDAH7PS.	  
Structures  R23A R256A 
Space group P3221 P3221 
Unit cell 
dimensions 
a (Å) 203.479 203.77 
b (Å) 203.479 203.77 
c (Å) 66.34 66.22 
Resolution range (Å) 40.37-2.41 62.23-2.37 
Number of reflections 112702 60903 
R factor 0.164 0.168 
Rfree 0.183 0.199 
Number of non-hydrogen 
atoms 
7643 7211 
Average B factors (Å2) 19.12 23.63 
Rms 
deviations 
from 
ideality 
Bond 
lengths (Å) 
0.014 0.006 
Bond angles 
(deg.) 
2.849 1.502 
Residues in most favored 
region of Ramachandran 
plot (%) 
95.23 96.10 
PDB code Not deposited Not deposited 
 
4.4.1 R23A 
 
The crystal structure of MtuDAH7PS R23A mutant was refined at 2.41 Å to 
a final R factor of 0.164 (Rfree=0.183). This mutant structure is very similar to 
the ligand-free Thesit-free wild type crystal structure (3NV8), with RMSD of 
0.253 Å matching 870 Cα atoms (Figure 4. 23). The solvent accessible 
surface area of the tight dimer is 1918 Å2 and that of the tetramer interface is 
967 Å2. 
 
The overall conformation of MtuDAH7PS was not altered by the R23A 
mutation, apart from the residues on loop α2-α2a and α2b-β3 (residues 
188-195 and 233-244) which showed a slightly different conformation to that 
of the ligand-free wild type structure, indicating the flexible nature of these 
loops. Inspection of the mutant structure at position 23 indicated clearly that 
the mutation was successful (Figure 4. 24). In chain B of the ligand-free wild 
type structure (3NV8), one sulfate ion is observed to interact with the side 
chain of Arg23. However in the mutant structure, the sulfate ion is not 
observed to bind in this site due to loss of the side chain functionality of 
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Arg23 (Figure 4. 24). 
 
 
Figure	  4.	  23.	  Superposition	  of	  crystal	  structure	  of	  R23A	  mutant	  (red)	  with	  ligand-­‐free	  Thesit-­‐free	   wild	   type	   structure	   3NV8	   (green).	   The	   positions	   with	   slightly	   different	  conformations	   are	   highlighted	   by	   displaying	   the	   residues	   in	   stick	   form	   (residues	  188-­‐195,	  233-­‐244).	  
 
 
Figure	  4.	  24.	  Superposition	  of	  R23A	  mutant	  crystal	  structure	  (red)	  with	  the	  ligand-­‐free	  wild	  type	  crystal	  structure	  (green)	  at	  the	  mutation	  site	  (R23).	  
 
  
76 
 
4.4.2 R256A 
 
The crystal structure of R256A mutant of MtuDAH7PS was refined at 2.37 Å 
to a final R factor of 0.168 (Rfree=0.199). This mutant structure is also very 
close to the ligand-free wild type crystal structure (3NV8), with rms distance 
of 0.228 Å matching 873 Cα atoms (Figure 4. 25). The solvent accessible 
surface area of the tight dimer interface is 1878 Å2 and that of the tetramer 
interface is 975 Å2. 
 
Similar to R23A mutant, the mutation site of R256A crystal structure (Figure 
4. 26) has lost the ability to bind the sulfate ion that is observed in the wild 
type structure.  
 
 
Figure	   4.	   25.	   Superposition	   of	   crystal	   structure	   of	   R256A	   mutant	   (magenta)	   with	  ligand-­‐free	   wild	   type	   structure	   3NV8	   (green).	   The	   positions	   with	   slightly	   different	  conformations	   are	   highlighted	   by	   displaying	   the	   residues	   in	   stick	   form	   (residues	  188-­‐195,	  233-­‐244).	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Figure	   4.	   26.	   Superposition	   of	   R256A	   mutant	   crystal	   structure	   (magenta)	   with	   the	  ligand-­‐free	  wild	  type	  crystal	  structure	  3NV8	  (green)	  at	  the	  mutation	  site	  (R256).	  
 
4.5 Summary 
 
MtuDAH7PS is synergistically inhibited by combinations of Trp+Phe and to 
a lesser extent by Trp+Tyr, but not by any single aromatic amino acids. In 
order to understand this unique mechanism of allosteric regulation of 
MtuDAH7PS, crystal structures of wild type MtuDAHP7S in complex with 
different aromatic amino acids and two mutants of MtuDAH7PS were 
refined and examined in this chapter. 
 
Crystal structures of MtuDAH7PS in complex with Trp+Phe obtained by 
soaking (3KGF) showed that upon simultaneous binding of Trp and Phe, 
there are two Phe molecules bound in the tight dimer interface and two Trp 
molecules bound in the tetramer interface. A secondary Phe site can also be 
observed, however structure of Trp+Phe co-crystallised with MtuDAH7PS 
(3RZI) suggested that this secondary Phe binding site is not important for 
inhibition of MtuDAH7PS by the Trp+Phe combination. Tyr molecules are 
shown to bind in the same binding sites as Phe molecules (as observed in 
Tyr+Trp and Tyr-only structures). One extra hydrogen bond is formed 
between Tyr molecule and residues in the secondary Phe binding site, 
indicating that the “secondary Phe binding site” may have higher affinity for 
Tyr molecules. 
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Crystal structure of MtuDAH7PS in complex with single aromatic amino 
acids showed that the allosteric ligand binding sites can be quite flexible, at 
high ligand concentrations, Phe molecules are observed to bind in the Trp 
binding sites at the tetramer interface, and Trp molecules are observed to 
bind in both the primary Phe binding sites in the dimer interface and the 
secondary Phe binding sites. 
 
Comparison of the structures of MtuDAH7PS in complex with different 
aromatic amino acids shows clearly that there is no gross conformational 
change within MtuDAH7PS associated with any ligand binding event. This 
suggests that mechanism of allosteric regulation and the communication 
among distant binding sites of MtuDAH7PS is mainly contributed by 
alteration of protein dynamics upon ligand binding. Therefore, MD 
simulations can be employed to study the molecular basis of this usual 
synergistic allosteric regulation of MtuDAH7PS (discussed in Chapter 6). 
 
  
79 
 
Chapter 5. Investigating the active site: molecular modelling of active 
site inhibitors into MtuDAH7PS 
 
5.1 Introduction to mechanism of reaction catalysed by DAH7PS 
 
DAH7PS catalyses the first reaction in the shikimate pathway, which is an 
aldol condensation between PEP and E4P to form the seven carbon sugar 
DAH7P (Figure 5. 1).  
 
 
Figure	   5.	   1.	   Overall	   reaction	   catalysed	   by	   DAH7PS	   and	   proposed	   mechanism	   of	  condensation	  of	  PEP	  with	  E4P.	  
 
Many of the details of the reaction mechanism catalysed by DAH7PS are 
known, and crystal structures of the enzymes from several sources have been 
solved, revealing several features of the reaction intermediates that could be 
targeted in inhibitor design (57, 59, 61-63, 67). The reaction occurs 
stereospecifically with respect to both substrates, with the si face of PEP 
attacking the re face of E4P (79-81). A divalent metal ion present in the 
active site is essential for activity. The initial attack of PEP on E4P is 
believed to be promoted via Lewis acid activation of the E4P aldehyde group 
by a divalent metal ion, followed by attack of PEP to give an oxocarbenium 
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intermediate 4 with trigonal planar geometry at the former C2 of PEP (Figure 
5. 1) (61, 82). Attack of water on the electrophilic oxocarbenium ion gives 
rise to tetrahedral phosphohemiketal intermediate 5, and elimination of 
phosphate leads to the open chain form 6 of the product DAH7P. For the step 
of water attack, the water molecule can potentially attack from either face of 
4, giving rise to two possible diastereoisomers of tetrahedral intermediate 5, 
differing in their absolute configuration at C2. Although this stereogenic 
centre is transient, and the stereochemical information is lost by elimination 
of phosphate in the final step to generate the product DAH7P, the geometry 
of the enzyme active site is likely to favour stereoselective attack of water to 
form one diastereoisomer of 5. The DAH7P is formed in its acyclic form, and 
cyclises into the cyclic pyranose form following release from the enzyme.   
 
In this chapter, the substrates (PEP and E4P) and the intermediate molecule 
(5) were modelled into the active site of MtuDAH7PS, to understand the 
roles the active site residues of DAH7PS play in substrates binding and 
catalysis, and to help identify the preferred side of water attack on the 
oxocarbenium species (4) during the reaction. This chapter also describes the 
modelling studies conducted on a series of intermediate mimicking inhibitors, 
in order to support existing results from synthetic work, and to guide future 
design of inhibitor molecules for MtuDAH7PS.  
 
5.2 Docking studies for MtuDAH7PS 
 
5.2.1 Docking E4P into MtuDAH7PS active site 
 
To understand the binding mode of the two reaction substrates, and to 
identify the active site residues involved, the substrate E4P was docked into 
the active site of MtuDAH7PS. The crystal structure of the ligand-free 
MtuDAH7PS (PDB ID 2B7O) was used as the starting coordinates to 
develop the model of the active site receptor for the docking of E4P. One of 
the two substrates, PEP, was already bound in the active site of this crystal 
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structure. A grid file of the receptor was generated for each docking 
calculation to increase computation efficiency. The shape and properties of 
the receptor are represented on the grid file. In order to generate the grid file 
for docking E4P, the structure of the active site was first prepared by adding 
the missing side chains of residues that were not modelled in the original 
crystal structure due to disorder. Hydrogen atoms were also added because 
they were not present in the crystal structures. The structure was then 
minimised in MacroModel using OPLS_2005 force field and the PRCG 
method, with water as the solvent (38), and residues within 5 Å of the active 
site Mn2+ ion were “frozen” during the minimisation. The receptor grid was 
generated based on the minimised structure using Glide (83), with the grid 
centre defined as the centroid of residues 284, 133, 134, 135, 440, 441 and 
the active site PEP, the size of the grid was defined with the option “docking 
ligands shorter than 20 Å”. The substrate E4P was then docked in to this 
rigid receptor model using Glide (83). 
 
5.2.1.1 Docking E4P into MtuDAH7PS active site in which one water 
molecule is bound to Mn2+ 
 
In the original crystal structure of MtuDAH7PS (PDB 2B7O), one water 
molecule (HOH2024) is coordinated to the active site metal ion. In the first 
docking attempt, this water molecule was retained for the generation of the 
grid file, and the position of the water molecule was kept rigid during the 
docking calculation The docking produced six poses of E4P in the active site. 
The pose with the best docking score is shown in Figure 5. 2. The E4P 
molecule is held in the active site by forming hydrogen bonds with Pro134 
backbone carbonyl and the side chain of Lys133. The aldehyde of E4P forms 
hydrogen bond with Arg248 which is bridging between the two substrates 
PEP and E4P. As a result of this hydrogen bonding, the aldehyde exposes its 
si face to the attacking PEP carbon in this pose. None of the poses obtained 
contain E4P aldehyde with an orientation consistent to the known 
experimental results which require re face attack of PEP (all poses have si 
face facing PEP C3). Furthermore, the distances between the two reacting 
atoms in all six poses are greater than 3.5 Å, which places the two substrates 
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too far away for reaction to occur. 
 
 
Figure	  5.	  2.	  Best	  scored	  pose	  of	  E4P	  in	  MtuDAH7PS	  active	  site	  with	  one	  water	  molecule	  bound	   to	   Mn2+.	   The	   active	   site	   residues	   and	   the	   bound	   PEP	   are	   shown	   with	   green	  carbon	  atoms	  and	  the	  docked	  E4P	  is	  shown	  with	  magenta	  carbon	  atoms.	  The	  active	  site	  metal	   ion	   (Mn2+)	   is	   shown	   as	   a	   cyan	   sphere.	   Hydrogen	   bonds	   are	   displayed	   as	   black	  dashed	  lines.	  
 
5.2.1.2 Docking E4P into MtuDAH7PS active site with no water molecule 
bound to Mn2+ 
 
The reason why docking results are inconsistent with experimental results 
could be due to the water molecule (HOH2024) that was left in the active site 
during docking. This water molecule occupies the space near the active site 
metal ion, and as a result, the E4P molecule cannot get closer to either the 
PEP molecule or the Mn2+ ion. Therefore, the water molecule was removed 
from the active site, and the receptor grid regenerated. The E4P molecule 
was then docked into the new grid file. 
 
The best pose from this second attempt of docking was selected to be the best 
scored pose that has the re face of E4P aldehyde facing the PEP molecule. In 
this best pose (Figure 5. 3), PEP forms a network of hydrogen bonds with the 
active site residues, including Arg126, Lys306, Arg337, Glu283, and Arg284. 
These hydrogen bonds formed are retained from the original crystal structure 
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(2B7O). The two hydroxyl groups on the E4P molecule form hydrogen 
bonds with the backbone carbonyl of Pro134, and the phosphate group on 
E4P forms hydrogen bonds with Lys133 and Lys380. The E4P molecule is 
held in such a way that the re face of the aldehyde is facing C3 of PEP, 
which is consistent with the experimental finding that attack occurs on the re 
face of the aldehyde. However, the distance between C3 of PEP and the 
aldehyde carbon on E4P in this model is still quite long at 3.5 Å. 
 
 
Figure	   5.	   3.	   Best	   pose	   from	   rigid	   docking	   of	   E4P	   in	   the	   active	   site	   of	   ligand-­‐free	  
MtuDAH7PS	  (PDB	  2B7O)	  with	  no	  water	  bound	  to	  Mn2+	  ion.	  Hydrogen	  bonds	  are	  shown	  as	  black	  dashed	  lines.	  
 
The position of the phosphate group in E4P in the model is different from 
that of the sulfate ion found in the active site of the original crystal structure 
of the ligand-free MtuDAH7PS (PDB 2B7O). A superposition between the 
original crystal structure and the modelled structure reveals this difference 
(Figure 5. 4). The distance between the sulfur atom in the sulfate ion and the 
phosphorus atom in the phosphate group on E4P is 4.8 Å. It was proposed 
that the position of the sulfate ion in the crystal structure indicates the likely 
position of the phosphate group of E4P in the active site (67). In the crystal 
structure, the sulfate ion forms a salt bridge with the nearby Arg135 residue, 
and a hydrogen bond with side chain of Ser136. However, the best pose of 
E4P predicts the phosphate group to be positioned between positively 
charged side chains of residues Lys133 and Arg135 and Lys380. The 
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negative charge on the phosphate is stabilised in the positively charged 
environment.  
 
 
Figure	  5.	  4.	  Superposition	  of	  the	  active	  site	  of	  ligand-­‐free	  MtuDAH7PS	  from	  the	  crystal	  structure	  2B7O	  and	  the	  modelled	  structure	  from	  rigid	  docking.	  The	  crystal	  structure	  is	  displayed	   with	   pink	   carbon	   atoms,	   and	   the	   modelled	   structure	   with	   yellow	   carbon	  atoms.	   The	   two	   circles	   highlight	   the	   sulfate	   ion	   in	   the	   crystal	   structure	   and	   the	  phosphate	  group	  of	  E4P	  in	  the	  modelled	  structure.	  
 
5.2.2 The induced fit docking protocol 
 
In standard virtual docking studies, ligands are docked into the binding site 
of a receptor where the receptor is held rigid and the ligand is free to move. 
However, the assumption of a rigid receptor can give misleading results, 
since in reality many proteins undergo side chain or backbone movements, or 
both, upon ligand binding. These changes allow the receptor to alter its 
binding site so that it more closely conforms to the shape and binding mode 
of the ligand. To allow for a change in receptor conformation upon ligand 
binding an “induced fit” protocol has been incorporated into the modelling 
software (84).  
 
The induced fit docking protocol (84) surmounts the shortcoming of rigid 
docking, by allowing movement of active site residues close to the docked 
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ligand, thereby accounting for the “induced fit” effect on the receptor upon 
ligand binding. In this procedure, the ligand molecule is initially docked into 
the receptor with scaled atomic van der Waals radii, then the side chain 
conformations of the active site residues close to the docked ligand (within 5 
Å) are optimised to form the best interactions with the ligand molecule. The 
optimised side chain conformations of residues represent the “induced fit” of 
the active site to the docked ligand. In the final step, the ligand molecule is 
re-docked into the “induced-fit” conformation of the active site and the 
docked pose is evaluated and examined. The induced fit docking therefore 
can produce more accurate prediction of ligand binding mode, especially for 
large ligand molecules that usually do not model well with rigid docking.  
 
5.2.3 Induced fit docking of reaction intermediate 
 
The problem resulting from rigid docking of E4P into the active site receptor 
with PEP already bound is that in all the docked poses the distance between 
the two reacting atoms are too great for reaction to occur. This is because the 
van der Waals interaction becomes unfavourable when any two atoms get too 
close to each other. However, for the reaction to occur, C3 of PEP and C1 of 
E4P have to approach each other, as a result, the rigid docking procedure is 
not predicting the position of E4P before reaction happens. 
 
To overcome the distance problem, the predicted tetrahedral intermediate 5 
(Figure 5. 1) of the reaction between PEP and E4P was docked into the active 
site of the ligand-free MtuDAH7PS. The position of the aldehyde of E4P and 
C3 of PEP could then be predicted based on how the intermediate is held in 
the active site. Since it is unclear which side of the oxocarbenium species (4) 
the water attacks from, both possible diastereoisomers of this tetrahedral 
intermediate (5) were docked into the active site receptor. 
 
The structures of both possible diastereoisomers of the tetrahedral 
intermediate were built using the protein builder in Maestro (39) of the 
Schrödinger Suite 2006 and then minimised with MacroModel (38). The 
Polak-Ribiere Conjugate Gradient (PRCG) minimisation method was used 
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with up to 5000 iterations and a gradient convergence threshold of δ=0.05 
kJ/(mol*Å). A conformational search was then carried out for each isomer in 
order to generate an ensemble of low-energy conformers to find a suitable 
starting conformation for the later docking calculation. Conformational 
searches were conducted with the MCMM Serial Torsional Sampling method 
and were run with a GB/SA water model, using the OPLS2005 force field, 
with 3000 steps for the conformational search and an energy window of 12.0 
kJ/mol for collecting appropriate conformers. All the conformers from the 
conformational search were clustered by consideration of torsional RMS of 
the backbones, and the representative conformations from the clustering 
analysis were selected based on the clustering statistics, which were then 
used in the docking calculations as the starting conformations for each 
diasteroisomer of the tetrahedral intermediate.  
 
The modelling of the tetrahedral intermediate into the active site of 
MtuDAH7PS was carried out with the Schrödinger Suite 2006 Induced Fit 
Docking protocol (84). The active site in chain A of the ligand-free crystal 
structure of MtuDAH7PS (2B7O) was used as the receptor. The centre of the 
receptor grid was defined as the centroid of residues 87, 126, 133, 134, 135, 
136, 137, 248, 250, 280, 282, 283, 284, 306, 337, 366, 369, 380, 382, 409, 
411, 440, and 441. For the initial docking, the van der Waals radii of the 
linear intermediate atoms were scaled to 0.8. The 20 best solutions of initial 
docking were kept. All residues of the protein within a 5 Å distance of the 
respective linear molecule solution were refined. The ligands were re-docked, 
with a van der Waals radii scale of 0.8, to the top 20 newly generated protein 
structures if the energy was within 30 kcal/mol of the best protein structure. 
 
This docking study produced a total of 30 poses for both diastereoisomers 
and out of which 17 poses showed retained PEP binding interactions. All of 
the 17 poses with the retained PEP orientation are from the S-isomer of the 
tetrahedral intermediate. This suggests that the R-isomer does not fit in the 
active site of MtuDAH7PS as well as the S-isomer. The S-isomer 
corresponds to the tetrahedral intermediate molecule if the water attacks 
obxocarbenium species from the opposite side of the active site Mn2+ ion (i.e. 
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the re face), therefore, the modelling results suggest the direction of the 
incoming water molecule is from the re face of the oxocarbenium 
intermediate (4).  
 
 
Figure	  5.	  5.	  Stereo	  view	  of	  the	  best	  scored	  pose	  of	  linear	  intermediate	  (S-­‐isomer)	  from	  induced	   fit	   docking.	   The	   active	   site	   carbons	   are	   displayed	   in	   green,	   and	   the	   docked	  intermediate	   is	   shown	   with	   magenta	   carbon	   atoms,	   and	   the	   active	   site	   metal	   ion	   is	  displayed	  as	  the	  cyan	  sphere.	  Hydrogen	  bonds	  are	  represented	  by	  black	  dashed	  lines.	  
 
The best pose from this induced fit docking (Figure 5. 5) shows a network of 
hydrogen bonds between the tetrahedral intermediate and the enzyme active 
site. The PEP part of the intermediate forms hydrogen bonds between the 
carboxylic acid group and Arg126, this interaction is also observed in the 
ligand-free crystal structure of MtuDAH7PS (PDB 2B7O). Lys306 also 
interacts with the negative carboxylic acid on PEP. The phosphate group on 
PEP is forming hydrogen bonds and salt bridges with the nearby Arg337 and 
Arg284 and one hydrogen bond with the backbone NH group of Glu283. In 
this pose, bridging between the PEP part and the E4P part of the intermediate 
is observed. This bridging occurs via Arg284 by forming salt bridges and 
hydrogen bonds with the two phosphate groups on PEP and E4P. The E4P 
phosphate group is held by side chains of both Arg284 and Arg135, and the 
backbone NH group of Ser136. This indicates that Arg135 can play a role in 
positioning of the E4P phosphate group. The previous E4P aldehyde, now the 
newly formed OH group on the linear intermediate, is at a close distance (2.2 
Å) to the active site Mn2+ ion, and this suggests metal coordination to the 
Mn2+ ion via the oxygen atom may occur. This indicates that the aldehyde of 
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E4P may be held in place by coordination to the metal ion before reaction 
occurs. The OH group that corresponds to the incoming water molecule is 
forming hydrogen bonds with Trp280, Glu248, and Lys133. This suggests 
that the incoming water molecule may be held in place in the active site 
before reaction occurs by the above residues. Two of these residues, Glu248 
and Lys133, are conserved across the entire DAH7PS family, whereas 
Trp280 is only conserved in the type II enzymes.  
 
One of the problems of the results from rigid docking of E4P into the active 
site (section 5.2.1) is that the position of the E4P phosphate was never 
predicted to be close to the sulfate ion that was found in the active site of the 
original crystal structure (2B7O). In order to check whether the induced fit 
docking of the linear intermediate can predict such a position for the 
phosphate moiety, the best pose from induced fit docking was superimposed 
with the ligand-free crystal structure (2B7O) with the sulfate ion bound 
(Figure 5. 6). The distance between the predicted position of E4P phosphate 
and the bound sulfate ion is 1.8 Å, which is a significant improvement, 
compared to the best pose from rigid docking of E4P (4.8 Å, Figure 5. 4). 
 
 
Figure	  5.	  6.	  Stereo	  view	  of	  the	  superposition	  between	  the	  best	  pose	  from	  the	  induced	  fit	  docking	  of	  the	  linear	  intermediate	  molecule	  (green	  carbon	  atoms	  for	  residues	  at	  the	  active	   site)	   and	   the	   original	   crystal	   structure	   (2B7O,	   grey	   carbon	   atoms).	   The	   sulfate	  ion	   present	   in	   the	   original	   crystal	   structure	   is	   highlighted	   in	   black	   circle,	   and	   the	  docked	  linear	  intermediate	  is	  shown	  with	  purple	  carbon.	  
 
The best pose was then superimposed on the crystal structure of SceDAH7PS 
(Figure 5. 7), and showed that the position of the E4P phosphate group in the 
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modelling pose is also quite close to the position of the G3P phosphate group 
in the crystal structure, which was considered to be the best indication of the 
position of E4P phosphate. The distance between the predicted E4P 
phosphate and the G3P phosphate is 1.6 Å. 
 
 
Figure	  5.	  7.	  Stereo	  view	  of	  the	  superposition	  of	  the	  best	  pose	  of	  the	  linear	  intermediate	  from	  induced	  fit	  docking	  (green	  carbons)	  with	  the	  crystal	  structure	  of	  SceDAH7PS	  (PDB	  ID	  1OF8)	  (cyan	  carbons)	  with	  G3P	  bound	  in	  the	  active	  site.	  PEP	  and	  G3P	  in	  SceDAH7PS	  are	  shown	  with	  yellow	  carbon	  atoms.	  
 
One of the interesting features in the modelling result is the position of the 
Lys133 side chain. The Lys133 residue in the original MtuDAH7PS crystal 
structure (2B7O) is found in a completely different conformation (Figure 5. 
8B) from the docking pose. A different Lys133 conformation is also 
observed in the crystal structure of SceDAH7PS (Figure 5. 8A). This large 
difference in side chain conformations for the absolutely conserved Lys133 
shows the extent of flexibility of this residue. In the modelled pose for the 
tetrahedral intermediate, the Lys133 residue forms a hydrogen bond with the 
oxygen atom on the incoming water molecule. This suggests that the Lys133 
side chain may help position the incoming water molecular and play a role in 
facilitating proton transfer during the reaction. 
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Figure	  5.	  8.	  Superposition	  between	  active	  site	  residues	  of	  MtuDAH7PS	  in	  the	  best	  pose	  from	  induced	  fit	  docking	  (displayed	  in	  green	  carbons)	  and	  (A)	  the	  crystal	  structure	  of	  
SceDAH7PS	  (PDB	  ID	  1OF8,	  displayed	  in	  cyan	  carbons);	  (B)	  the	  original	  crystal	  structure	  (PDB	  ID	  2B7O,	  displayed	  in	  grey	  carbons).	  The	  active	  site	  metal	   ions	  are	  displayed	  as	  yellow	  spheres.	  
 
5.2.4 Docking of intermediate mimicking inhibitors 
 
Based on the results from induced fit modelling of the tetrahedral 
intermediate molecule 5, a series of inhibitors mimicking the structure of the 
linear intermediate was designed by Sebastian Reichau from our research 
group, and here molecular modelling technique was used to predict the 
binding mode and potency of these structures as potential inhibitors. In order 
to carefully evaluate results from docking calculations, two different receptor 
grids were generated.  
 
The first grid was based on the wild type crystal structure of MtuDAH7PS 
(PDB ID 2B7O). The grid file was generated with Glide. The centre of the 
grid was defined as the centroid of residues 87, 126, 133, 134, 135, 136, 137, 
248, 250, 280, 282, 283, 284, 306, 337, 366, 369, 380, 382, 409, 411, 440, 
and 441.  
 
A second grid was generated based on the best pose from induced fit 
modelling of the tetrahedral intermediate above. The active site conformation, 
especially the residues in close proximity to the modelled intermediate 
molecule (within 5 Å), adopted different conformations from the original 
crystal structure (2B7O), to optimise interactions with the modelled 
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tetrahedral intermediate. The active site conformation can be considered as 
“intermediate-adapted”. This particular active site conformation may be 
useful in modelling of the following compounds, since these molecules were 
designed to mimic the intermediate molecule. The centre of the grid was 
defined as the centroid of the modelled intermediate molecule. 
 
The series of intermediate mimicking structures ( 
Table 5. 1) were treated the same way as that in the modelling of the 
tetrahedral intermediate. The structures were first minimised in MacroModel, 
and then a conformational search was conducted to search for low energy 
conformers. The low energy conformations of each structure were then 
clustered and the selected representative conformations for each structure 
obtained from this clustering analysis were modelled into both receptor grids 
with rigid docking procedure and XP (extra precision) mode with Glide. In 
general each structure had a better docking score in the receptor with 
intermediate adapted conformation ( 
Table 5. 1), suggesting that this receptor is better suited for this series of 
designed structures. Therefore, docking poses from the intermediate adapted 
receptor were mainly considered for evaluation below.  
	  
Table	   5.	   1.	   Table	   of	   structures	   and	   docking	   scores	   for	   the	   series	   of	   designed	  intermediate-­‐mimicking	  structures	  modelled	  in	  two	  different	  receptor	  grids.	  
Number Structure Docking scores in 
the wild type 
receptor grid 
(based on crystal 
structure 2B7O) 
Docking scores in 
the intermediate 
adapted receptor 
grid 
S-5.1 
O-
O
OPO32-
2-O3PO
 
-5.11 
 
-5.81 
R-5.1 
O-
O
OPO32-
2-O3PO
 
-4.84 
 
-5.96 
S-5.3 
R-5.3 O O-
O
OPO32-
2-O3PO
 
-4.95 
-4.69 
-5.91 
-5.94 
S-5.4 
R-5.4 O-
O
OPO32-
2-O3PO
 
-5.07 
-5.01 
-6.60 
-8.26 
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5.5 
O-
O
Br
P
OHO
-O
 
-4.74 
 
-5.76 
5.6 
O-
O
2-O3PO
P
O
OH-O  
-5.29 
 
-6.37 
5.7 
O-
O
2-O3PO
P
OHO
-O
 
-5.33 
 
-6.53 
5.11 
O-
O
F
P
OHO
-O
 
-4.44 
 
-5.51 
5.12 
O-
O
F
P
OHO
-O
F
F
 
-4.33 
 
-5.44 
S-5.13 
R-5.13 O-
O
2-O3PO
P
O
OH-O
Me
 
-5.27 
-5.75 
-5.11 
-6.27 
5.14 
O-
O
P
O
OH-O
Me
P
O
-O OH
 
-5.51 -5.66 
5.15 
O-
O
P
O
OH-O
Me
P O
O-
HO
 
-5.64 -6.04 
S-5.16 
R-5.16 O-
O
2-O3PO
P
OHO
-O
Me
 
-5.69 
-5.79 
-6.54 
-5.77 
5.17 
O-
O
P
OHO
-O
P
MeOH-O
O
 
-6.18 -6.36 
5.18 
O-
O
P
OHO
-O
Me
PHO
O-
O
 
-7.21 
 
-6.68 
S-5.19 
R-5.19 
CO2-
OPO32-
CO2-
OPO32-
 
-3.55 
-3.63 
-4.98 
-5.37 
R-5.30 
2-O3PO
2-O3PO
CO2-
Me
 
-5.35 -7.62 
S-5.30 
2-O3PO
Me
CO2-
OPO32-
 
-5.14 -7.58 
R-5.31 
2-O3PO
HO
CO2-
PO32-
 
-5.12 -7.77 
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S-5.31 
2-O3PO
HO
CO2-
PO32-
 
-6.77 -6.50 
R-5.32 
2-O3PO
OPO32-
CO2-
OH
 
-4.82 -6.63 
S-5.32 
2-O3PO CO2-
OPO32-OH
 
-4.97 -7.33 
 
Compound 5.1 (Figure 5. 9) is the simplified analogue of the intermediate 
molecule with the hydroxyl groups removed. Both stereoisomers of 5.1 were 
modelled and the results showed that the R-isomer of 5.1 has slightly better 
docking scores than the S-isomer. However, both isomers adopt similar 
binding modes, which are also very similar to those of the linear intermediate 
in the active site (Figure 5. 5). The phosphate moieties in the PEP mimicking 
portion of both isomers of compound 5.1 form interactions with Arg337, 
Lys306, Arg126 and Arg284. The phosphate moieties of the E4P mimicking 
portion of both isomers form interactions with Arg135 and the backbone of 
Ser136. Unlike the selectivity observed in the docking of the actual 
tetrahedral intermediate, where only the S-isomer can fit in the active site, 
here both the S- and R- isomers of 5.1 can fit in the active site with similar 
binding mode. This is probably due to the absence of a hydroxyl group at the 
C2 centre. 
 
	  
Figure	   5.	   9.	   Best	   pose	   from	   docking	   compounds	   S-­‐isomer	   (A)	   and	   R-­‐isomer	   (B)	   of	  compound	  5.1	  into	  intermediate	  adapted	  receptor	  of	  MtuDAH7PS.	  
 
	  
 
O-
O
OPO32-
2-O3PO
	   	   	   	   	   	   	   	   	   	   	   	  
O-
O
OPO32-
2-O3PO
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   B	  
S-5.1 R-5.1 
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Figure	   5.	   10.	   Superposition	   between	   structure	   of	   MtuDAH7PS	   co-­‐crystallised	   with	  racemic	  mixture	  of	  compound	  5.1	  (PDB	  3PFP)	  and	  the	  modelling	  poses	  for	  compound	  5.1s	  (A)	  and	  5.1r	  (B).	  The	  crystal	  structure	  is	  displayed	  with	  yellow	  carbon	  atoms	  and	  the	  modelling	  poses	  are	  displayed	  with	  green	  carbon	  atoms.	  
 
A structure of MtuDAH7PS co-crystallised with the racemic mixture of 
compound 5.1 was obtained and refined at 2.35 Å (PDB 3PFP) by Sebastian 
Reichau (85). In this crystal structure, based on the electron density maps 
obtained, it could not be concluded whether there is preferential binding of 
one of the diastereroisomers of 5.1 from the racemic mixture, therefore both 
R- and S-isomers of 5.1 were included in the structure. Inhibition studies 
(also carried out by Sebastian Reichau) conducted with pure S- and 
R-isomers of compound 5.1 showed that both isomers have a high affinity to 
the enzyme active site, with the R-isomer have slightly higher affinity, 
consistent with the R-isomer having slightly better docking score in the 
modelling study. The interactions formed between 5.1 and the enzyme active 
site in the crystal structure are the same as those predicted in the modelling 
results for 5.1 (Figure 5. 10), and the inhibitors adopt binding modes nearly 
identical to the modelled pose. Interestingly the movement of Lys133 side 
chain that was predicted in the induced fit docking of the linear intermediate 
is also observed in this crystal structure. This validates that the modelling 
approach used here is effective for predictions of enzyme-inhibitor 
interactions for MtuDAH7PS, and the intermediate adapted receptor 
conformation is more suitable for predicting the potency of the series of 
intermediate-mimicking inhibitors.  
 
	   A	   B	  
95 
 
5.2.5.1 Docking of intermediate mimicking structures that have not been 
synthesised 
 
The structures discussed below have not yet been synthesised at the time of 
writing this thesis. All modelling results and the predictions of the potencies 
of the designed molecules should be considered as a guide to improving 
inhibitor design, and for filtering out the unnecessary synthesis of 
compounds that likely will prove to be weak inhibitors (tables showing 
number of contacts made in each of the modelled pose are in Appendix 2 and 
3, and a plot of different components of the docking scores for each modelled 
structure is in Appendix 4).  
 
	  
Figure	  5.	  11.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	  5.3	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structure 5.3 was designed with an oxygen atom inserted in the chain to 
coordinate to the active site metal ion (Mn2+) and hence to increase binding 
affinity. However, docking both isomers of this compound into the 
intermediate adapted receptor suggests that the binding affinity may not be 
greatly improved by the presence of the inserted oxygen (Figure 5. 11). The 
docking scores of 5.3 are very close to the simple intermediate mimic 5.1. 
The insertion of oxygen atom seems to reduce the number of hydrophobic 
contacts with the binding pocket of the active site and no extra hydrogen 
bonding interactions are formed. The distance between the inserted oxygen 
	  
	   A	   B	  
	  
O O-
O
OPO32-
2-O3PO
S-5.3 R-5.3 
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atom and the active site metal ion is 3.4 Å and 3.0 Å for the S-isomer and 
R-isomer of 5.3 respectively, which is slightly long for coordination to the 
metal ion.  
 
Although modelling did not predict metal coordination between the inserted 
oxygen atom in compound 5.3 and the active site metal ion, it may still occur 
in reality, due to the limitation of the docking method. In the docking 
procedure used here, the metal ion in the active site was treated as a point 
charge with a defined atomic radius and interactions with the electron 
orbitals of the metal ion that are essential for predicting coordination were 
not considered during the docking calculation. Therefore, metal coordination 
cannot be predicted with any accuracy in the current docking method. 
Whether this inhibitor is potent, and whether it forms coordination to active 
site metal ion as intended should be verified by experiments.  
 
	  
Figure	  5.	  12.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	  5.4	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structure 5.4 contains a double bond between C4 and C5 of the carbon chain 
(Figure 5. 12). Both isomers of this structure are less bulky around the double 
bond in comparison to compound 5.1, which could give both isomers fewer 
close contacts and better van der Waals score. The carboxylate group in the 
PEP-mimicking portion of the R-isomer is twisted slightly so instead of 
forming two hydrogen bonds with the side chain of Arg126 as is observed for 
	  
	   A	   B	  
	  
O-
O
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the other inhibitors above, one hydrogen bond is formed with the side chain 
of Lys133.  
 
	  
Figure	  5.	  13.	  Best	  poses	  from	  docking	  the	  structure	  5.5	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structure 5.5 (Figure 5. 13) is slightly different from the above inhibitors, as 
it contains a Br atom, which replaces the phosphate group at the E4P end of 
the molecule. As expected this compound does not form hydrogen bonds and 
salt bridges between the E4P end of the inhibitor and the enzyme active site. 
However, this molecule is predicted to fit well with the shape of the binding 
pocket, with very good hydrophobic contacts to the active site. This suggests 
that despite the lack of hydrogen bonding interactions with the enzyme active 
site, structure 5.5 may still be a potent inhibitor for MtuDAH7PS. 
 
Structures 5.6 and 5.7 are geometric isomers at the PEP-mimicking portion 
(Figure 5. 14). Structure 5.6 (the cis-isomer) has better van der Waals scores 
than 5.7 (the trans-isomer). However, this is only due to the model predicting 
that the PEP-mimicking portion of 5.6 is not binding as deep in the pocket as 
in structure 5.7. Structure 5.7 can also pick up more hydrogen bonds at the 
PEP-mimicking portion of the structure, indicating it may be more potent 
than 5.6. 
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Figure	   5.	   14.	   Best	   poses	   from	   docking	   structure	   5.6	   (A)	   and	   5.7	   (B)	   into	   the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
	  
Figure	   5.	   15.	   Best	   poses	   from	   docking	   structure	   5.11	   (A)	   and	   5.12	   (B)	   into	   the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structures 5.11 and 5.12 are analogues of 5.5 (with the Br atom at the E4P 
end) (Figure 5. 15). The PEP-mimicking portions of both 5.11 and 5.12 adopt 
the same binding mode as in 5.5. However, the favourable hydrophobic score 
that is in 5.5 is disrupted by replacing Br with the more electronegative F. 
The van der Waals interactions in 5.11 and 5.12 in the model show no 
improvement compare to 5.5. 
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Figure	  5.	  16.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	  5.13	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structure 5.13 has cis geometry in the PEP-mimicking portion. Modelling 
shows that both isomers of this structure can bind in the active site of 
MtuDAH7PS (Figure 5. 16). Results suggest that this structure has fewer 
close contacts with the active site residues but this is only due to the 
PEP-mimicking portions of the isomers not binding as deep in the active site 
pocket as the intermediate molecule (or compound 5.1). The E4P-mimicking 
parts of 5.13 isomers possess an added methyl group to probe any 
hydrophobic space in the active site. However, modelling suggests that the 
added methyl group will not add many extra hydrophobic contacts. 
 
Structures 5.14 and 5.15 both have the same PEP-mimicking portion as 5.13, 
with the cis geometry, and as expected the PEP-portions of these two 
compounds bind in the same way as in 5.13 (Figure 5. 17). The 
E4P-mimicking portions of 5.14 and 5.15 are modified based on 5.13 with a 
double bond introduced to restrict the orientation of the added methyl group. 
Modelling results suggest that the double bond will not increase potency of 
the inhibitor, especially in compound 5.14, where the methyl group is forced 
to point outside the active site pocket, to the solvent exposed space. 
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Figure	   5.	   17.	   Best	   poses	   from	   docking	   structure	   5.14	   (A)	   and	   5.15	   (B)	   into	   the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
	  
Figure	  5.	  18.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	  5.16	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structure 5.16 is a geometric isomer of 5.13 (Figure 5. 18), with the trans 
geometry at the PEP-mimicking portion. Due to the trans geometry being a 
better mimic of the PEP molecule, this structure is predicted to bind deep in 
the active site pocket, as a result, the added methyl group at the E4P end is 
positioned in the hydrophobic environment of the active site. Unlike in 
structures 5.13, 5.14 and 5.15, where the methyl group is predicted to point 
towards solvent exposed space, here in 5.16, the added methyl group 
provides extra hydrophobic contacts. This suggests that 5.16 may have 
higher binding affinity than its cis geometry analogues.  
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Figure	   5.	   19.	   Best	   poses	   from	   docking	   structure	   5.17	   (A)	   and	   5.18	   (B)	   into	   the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structures 5.17 and 5.18 contain the same moiety at the PEP-mimicking 
portion as in 5.16, but the E4P-mimicking end contains a double bond to 
restrict the positioning of the added methyl group (Figure 5. 19). Modelling 
suggests that by adding the double bond at the E4P-mimicking end, the steric 
clashes are reduced in 5.17 compared to 5.16. In 5.18, the added methyl 
group is forced to point inwards to the active site pocket and results in very 
favourable hydrophobic interactions in the modelling result. However, the 
buried methyl group also resulted in close contacts with the active site 
residues, and produces unfavourable van der Waals interactions. 
 
	  
Figure	   5.	   20.	   Best	   poses	   from	   docking	   the	   S-­‐isomer	   (A)	   of	   structure	   5.19	   into	   the	  intermediate-­‐adapted	   receptor	   and	   the	   R-­‐isomer	   in	   the	   original	   active	   site	  conformation	  (PDB	  2B7O)	  of	  MtuDAH7PS.	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Structure 5.19 is a PEP mimic but with the tetrahedral geometry at C2 as in 
the intermediate. Modelling results show that in the intermediate adapted 
receptor grid, only the S-isomer of 5.19 can fit in the active site with retained 
orientation of phosphate and carboxylate groups as that of PEP found in the 
crystal structure. The R-isomer can fit with the retained orientation in only 
the receptor grid generated from the original crystal structure (2B7O). When 
both isomers retain the PEP orientations of phosphate and carboxylate 
moieties upon binding to the active site, due to the difference of absolute 
configurations at C2, the C3 methyl group will point to different directions. 
In the intermediate adapted receptor, due to the movement of the Lys133 side 
chain, the space behind the metal ion is more crowded than the original 
conformation in the crystal structure, in which Lys133 side chain is pointing 
away from the active site metal ion (Figure 5. 20). Therefore, the 
intermediate adapted receptor would select for binding poses with the methyl 
group pointing away from the Lys133 side chain, as observed for the 
S-isomer. While the receptor generated from the original crystal structure is 
more “open” and can accommodate both isomers with the same orientation. 
This selectivity does not predict that the S-isomer is preferred than the 
R-isomer, since the active site of MtuDAH7PS is flexible and dynamic in 
reality, and may interconvert between the two or more conformations. 
Therefore, both isomers of 5.19 are predicted to be capable of binding to 
MtuDAH7PS and may do so with similar affinity. 
 
	  
Figure	  5.	  21.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	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5.30	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
Structure 5.30 is an analogue to 5.1, but with an added methyl group at the 
C2 centre. The R-isomer of 5.30 does not model in the active site with the 
same orientation of the PEP-mimicking portion as that observed in the 
modelling of the tetrahedral intermediate (Figure 5. 21). This is because that 
if the PEP-mimicking portion is held in the correct orientation, the methyl 
group at C2 would point towards the metal ion in the active site, which may 
cause steric clashes and form unfavourable interactions. However, the 
S-isomer of 5.30 can bind in the same fashion as the intermediate molecule, 
with the methyl group at C2 positioned in the same binding pocket as the 
hydroxyl group in the linear intermediate. Consequently this monomer does 
not have a favourable hydrophobic score from modelling, due to the methyl 
group occupying the pocket surrounded by hydrophilic residues (e.g. Trp 280 
and Glu248). 
 
	  
Figure	  5.	  22.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	  5.31	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
The R-isomer of 5.31 is predicted to bind in similar mode as the linear 
intermediate (Figure 5. 22). Due to replacement of the oxygen atom with a 
methylene group in the phosphate moiety of the PEP-mimicking portion, the 
stereochemical configuration at C2 is reversed. This R-isomer of 5.31 has the 
same geometry as the S-isomer of the intermediate molecule. The S-isomer 
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of 5.31 can also fit in the active site in the retained PEP orientation, but does 
not have many favourable van der Waals interactions, due to steric clashes 
between the hydroxyl group at C2 carbon and residue His269 of the active 
site.  
 
	  
Figure	  5.	  23.	  Best	  poses	  from	  docking	  the	  S-­‐isomer	  (A)	  and	  R-­‐isomer	  (B)	  of	  structure	  5.32	  into	  the	  intermediate-­‐adapted	  receptor	  conformation	  of	  MtuDAH7PS.	  
 
The R-isomer of 5.32 binds with the retained orientation of the 
PEP-mimicking portion and in similar fashion to the intermediate molecule 
(Figure 5. 23). The hydroxyl group on C4 of R-isomer of 5.32 is 2.7 Å away 
from metal ion, suggests that it may be able to form coordination with the 
active site metal ion upon binding. The binding mode of the S-isomer is 
predicted to be quite similar to the R-isomer, with an extra hydrogen bond 
forming between the hydroxyl group at C4 and side chain of residue Asp441. 
 
5.3 Docking studies for E. coli DAH7PS 
 
During the course of the aldol reaction between PEP and E4P catalysed by 
DAH7PS, there are two intermediate species, the phosphohemiketal 
intermediate (5) with the tetrahedral geometry, and the oxocarbenium 
intermediate (4) with the trigonal planar geometry at the C2 carbon centre 
(Figure 5. 1). Whereas all intermediate inhibitors discussed above are 
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mimicking the tetrahedral intermediate 5, another series of inhibitors based 
on the oxocarbenium intermediate 4 was designed and synthesised, and 
tested in E. coli DAH7PS (all experimental work mentioned in this section 
was conducted by Dr. Scott R. Walker). A molecular modelling study was 
therefore conducted for this series of inhibitors to explain the observed 
potencies . 
 
E. coli DAH7PS is a member of the Type I family, and the crystal structures 
of both E. coli DAH7PS and MtuDAH7PS show that although both enzymes 
adopt basic TIM barrel fold, the additional structural features responsible for 
allosteric regulation of the enzyme are quite different. However, the active 
site residues are well conserved due to the same catalytic function, and the 
interactions between bound substrates and the active site residues are 
retained in DAH7PS from both species (Figure 5. 24). 
 
 
Figure	   5.	   24.	   The	   active	   site	   of	   phenylalanine-­‐regulated	   DAH7PS	   from	   E.	   coli	   (PDB	  1N8F)	  (59).	  A	  sulfate	  ion	  bound	  the	  active	  site	  interacts	  with	  Thr100	  and	  Arg99,	  which	  is	   indicative	   of	   the	   E4P	   phosphate	   position	   when	   it	   is	   bound	   in	   the	   active	   site.	   The	  enzyme	  is	  displayed	  with	  white	  carbons	  and	  the	  active	  site	  bound	  PEP	  is	  shown	  with	  green	  carbon	  atoms.	  Hydrogen	  bonds	  are	  displayed	  as	  black	  dashed	  lines.	  
 
Previously, a series of PEP analogues was synthesised and investigated as 
inhibitors to examine the ability of inhibitors to target the PEP site of the 
DAH7PS from E. coli (86). Compounds bearing both carboxylate and 
phosphonate or phosphate groups separated by a similar distance to those 
found in PEP were found to be effective competitive inhibitors with respect 
to PEP. The best inhibitors of the enzyme were compounds that included a 
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trigonal centre adjacent to the carboxylate moiety, such as allylic 
phosphonate 7 and vinyl phosphonate 8 (Figure 5. 25). These compounds 
were considered to be mimicking the intermediate oxocarbenium ion 4. 
 
Previous single site inhibitors were then elaborated to include an 
appropriately spaced distal phosphate moiety, positioned to be capable of 
interacting with the binding pocket for the corresponding phosphate moiety 
of co-substrate E4P (Figure 5. 24).  This alteration was made in order to 
allow the inhibitors to bind to both PEP and E4P binding sites 
simultaneously, utilising the principle of multivalency (87).  
 
 
Figure	   5.	   25.	   Parent	   PEP-­‐competitive	   inhibitors	   allylic	   phosphonte	   7	   and	   vinyl	  phosphonate	  8,	  and	  their	  corresponding	  extended	  inhibitors	  9	  and	  10.	  
 
In order to understand the binding modes and contributions from active site 
residues for ligand binding, and hence explain the trends observed from 
experimental measurements, the designed extended compounds were 
modelled into the active site of E. coli DAH7PS using induced fit docking 
protocol. Similar to the induced fit docking set up used in MtuDAH7PS 
(discussed above), here the active site in chain A of the E. coli DAH7PS 
crystal structure (1NF8) was used as the receptor. The centre of the grid was 
defined as the centroid of residues 92, 97, 98, 99, 165, 186, 268 and 234. For 
the initial docking, side chains of residues 268, 186, and 97 were removed 
because they were blocking access to the active site, and the van der Waals 
radii of the docked inhibitors were scaled to 0.8. The 20 best poses of initial 
docking were kept. All residues of the enzyme within 5 Å of the docked 
inhibitor poses were refined to optimise interactions. At this stage the side 
chains of residues 268, 186, 97 and 99 were also included. The inhibitors 
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were then re-docked, to the top 20 newly generated protein structures if the 
energy was within 30 kcal/mol of the best protein structure. 
 
The ability of the extended compounds to inhibit E. coli DAH7PS was 
determined by kinetic assay ( 
Table 5. 2). The diastereomeric mixture of extended allylic phosphonate 9 
was found to give competitive inhibition with respect to PEP, with an 
inhibition constant Ki of 154±20 µM. The inhibition constant is an 
improvement over that found for the parent PEP-like inhibitor 7, 
demonstrating the advantages of a dual-site approach for DAH7PS inhibition. 
To understand the binding modes and contributions of each isomer in the 
mixture to the inhibition, the two isomers were modelled into the E. coli 
DAH7PS active site separately using induced fit docking (Figure 5. 26). The 
(Z)-isomer of allylic phosphonate 9 showed a reversed binding mode, with 
the PEP portion of the molecule binding in the E4P site and the E4P 
phosphate group binding in the PEP site. This suggests that the (Z)-geometry 
of this compound at the double bond does not fit well with the shape of the 
active site binding pocket. As a result, the PEP portion of the compound was 
placed in the more accommodating E4P site. However, the (E)-isomer of 
phosphonate 9 showed the expected binding mode, with the PEP-like and 
E4P-phosphate like portions placed in the designated binding site. The 
carboxylate group on the PEP side of the (E)-isomer shows interactions with 
Arg92 and Lys186; the phosphonate group on the PEP side interacts with 
Lys186, Arg234 and Arg165. These interactions are equivalent to those 
observed in the original crystal structure between the bound PEP molecule 
and the DAH7PS active site (Figure 5. 24). The E4P-like phosphate group of 
the (E)-9 forms interactions with residues Arg165, Lys273, Arg99 and 
Thr100. The (E)-isomer of allylic phosphonate 9 is a better mimic of the 
reaction intermediate 4 and therefore is likely to largely account for the 
inhibition of E. coli DAH7PS observed for the isomeric mixture. 
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Table	   5.	   2.	   Inhibition	   constants	   of	   the	   parent	   compounds	   and	   the	   extended	  compounds.	  
Parent 
Compound 
Ki (µM) 
Parent 
compound 
Extended compounds Ki (µM) 
Extended 
compound 
 
 
270±50 
 
 
154±20 
 
 
 
 
4.7±0.7 
 
 
5.3±0.6 
 
3.6±0.4 
 
 
Figure	   5.	   26.	   Poses	   (in	   stereoview)	   from	   induced	   fit	   docking	   calculations	   for	  compounds	  (a)	  (E)-­‐9	  and	  (b)	  (Z)-­‐9.	  Atoms	  on	  the	  enzyme	  active	  site	  are	  displayed	  with	  white	  carbons	  and	  the	  inhibitor	  molecules	  are	  displayed	  with	  green	  carbons.	  Hydrogen	  bonds	  are	  showed	  as	  black	  dashed	  lines.	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The vinyl phosphonate 10 was obtained as a 1:1 mixture of (Z)- and 
(E)-isomers. This mixture was determined to competitively inhibit E. coli 
DAH7PS with respect to PEP. The vinyl phosphate 10 was a potent inhibitor 
of DAH7PS, with an inhibition constant Ki of 5.3±0.6 µM. This inhibition 
constant is similar to the unelaborated parent compound 8, however this 
compound consisted solely of the desired (E)-isomer, and the corresponding 
(Z)-isomer is a much weaker inhibitor of DAH7PS (86). The inseparable 
mixture of isomers in 10 may obscure the anticipated increase in binding 
strength expected for the originally designed (E)-isomer of the vinyl 
phosphonate 10. To understand the binding mode and potency of each isomer 
in the compound 10 mixture, the (E)- and (Z)-isomers of compound 10 were 
modelled into the active site of E. coli DAH7PS separately (Figure 5. 27A 
and B). Both isomers showed the expected binding mode with the PEP and 
E4P portions positioned in the desired sites. The (E)-isomer fits well in the 
active site (Figure 5. 27A), with the PEP phosphate-like phosphonate group 
interacting with Arg234 and Arg165. The side chains of Lys186 and Arg92 
interact with the carboxylate group. The E4P-like phosphate group forms 
interactions with Arg165, Arg99 and Thr100. In the (Z)-isomer model, the 
PEP-like portion does not fit deep in the PEP site, presumably due to the 
change in relative geometry of the phosphonate and carboxylate groups 
(Figure 5. 27B). As a result, interactions between the inhibitor carboxylate 
group and Arg92 are lost in compound (Z)-10; a carboxylate-Arg92 binding 
interaction is observed for PEP in the original crystal structure (Figure 5. 24) 
(59). Therefore, the modelling results suggest that the (E)-isomer of 
compound 10 binds to the enzyme active site better than the corresponding 
(Z)-isomer.  
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Figure	   5.	   27.	   Poses	   (in	   stereoview)	   from	   induced	   fit	   docking	   calculations	   for	  compounds	   (a)	   (E)-­‐10,	   (b)	   (Z)-­‐10,	   and	   (c)	   26.	   Atoms	   on	   the	   enzyme	   active	   site	   are	  displayed	   with	   white	   carbons	   and	   the	   inhibitor	   molecules	   are	   displayed	   with	   green	  carbons.	  The	  Hydrogen	  bonds	  are	  showed	  as	  black	  dashed	  lines.	  
 
The bromide 26, a side product from synthesis of compound 10, was also 
evaluated as an inhibitor of E. coli DAH7PS. It too proved to be an inhibitor 
of E. coli DAH7PS, with a Ki of 3.6±0.4 µM. The potency of bromide 26 was 
initially surprising, since it lacks the terminal phosphate group designed to 
enhance the binding of these compounds to DAH7PS. Modelling of this 
compound showed that the PEP portion of bromide 26 (Figure 5. 27C) is in 
the same position as the PEP molecule found in the crystal structure (Figure 
5. 24). As expected, the bromide compound 26 is not picking up distal 
interactions at the E4P-phosphate binding site. However, the Ki value for this 
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compound is not significantly different from that of the extended vinyl 
phosphonate compound 10, or the parent compound 8. The similar Ki values 
may be due to the bromide compound 26 consisting of only the PEP-like 
(E)-isomer of the vinyl phosphonate group, whereas compound 10 also 
contains the interfering (Z)-isomer.  The presence of the hydrocarbon tail 
therefore does not appear to impede the ability of the PEP-mimicking portion 
of bromide 26 to occupy the PEP binding site of E. coli DAH7PS. From the 
modelling results, the side chain of Lys97 moved away from the PEP site 
which creates a binding pocket for the bromide. This added hydrophobic 
interaction between the hydrocarbon linker of bromide 26 and the enzyme 
active site may also contribute to the potency of this inhibitor.  
 
5.4 Summary 
 
In this chapter, the technique of molecular modelling was employed to 
validate the methodology and to explain observations from existing 
experimental data. Having validated the methodology it was used to predict 
potency of proposed structures and hence guide the future design of potential 
drug-like compounds for DAH7PS.  
 
Although many aspects of the reaction mechanism catalysed by DAH7PS are 
known to date, the stereochemistry for the water attack remains unclear 
(Figure 5. 1). Induced fit docking was conducted for both diastereoisomers of 
the tetrahedral intermediate molecule (5), in order to identify preferred 
stereochemistry for the water attack. The results showed the active site of 
MtuDAH7PS exhibits a preference for the S-isomer of the linear intermediate, 
which suggests that it is preferred that water attacks from the re face of the 
oxocarbenium species (4). Important active site residues involved in 
substrate binding were also identified from the modelling results, and they 
include Arg126, Lys306, Arg284, Arg337, Arg135, Ser136, Trp280, Glu284 
and Lys133. 
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Induced fit docking of the intermediate mimicking compound 5.1 predicted 
very similar binding modes to that of the linear intermediate molecule (5), 
and interestingly the predicted binding mode closely resembles the binding 
mode observed in the crystal structure of MtuDAH7PS co-crystallised with 
racemic mixture of 5.1. This demonstrates that the method of induced fit 
docking is suitable for predicting binding modes and potencies of the series 
of intermediate mimicking inhibitors. The predicted binding modes and 
potencies of the series of intermediate mimicking compounds (discussed in 
section 5.2.5.1) that have not yet been synthesised will need to be verified by 
experiments. 
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Chapter 6. Investigating the molecular basis of synergistic allostery of 
MtuDAH7PS 
 
6.1 Introduction 
 
6.1.1 Allosteric regulation 
 
Allosteric regulation of protein function is critical for the control of 
metabolism. Allostery is the process by which remote sites of system are 
energetically coupled to give functional change. This mechanism of 
regulation is widely observed in biological systems and has been recognised 
for many years (88-94). The most prominent examples of allostery have 
featured proteins where ligand binding was associated with significant 
conformational changes, such as haemoglobin and aspartate 
transcarbamoylase (89, 90). More recently, this view of allostery has been 
refined, and allosteric mechanisms including far more subtle changes in 
protein conformational states have been recognised, contributing to the 
growing understanding of the importance of protein dynamic motion to the 
catalytic function of enzymes (95-106). The current understanding of 
allostery is based on the concept of “population shift” of the protein 
ensembles, which is mediated by alteration of the two thermodynamic 
components, enthalpy (gross conformational change) and entropy (change in 
protein dynamics), and systems at both extremes have been examined. For 
example, MD simulations have been used to study the synergistic regulation 
of tryptophan synthase complex, which is a bifunctional tetrameric αββα 
enzyme complex (107). This complex illustrates cooperative motions and 
conformational changes of α- and β- subunits by tightly controlled allosteric 
interactions. Studies using MD simulations reveal that, in the ligand-free 
state, both α- and β- subunits of the enzyme samples a range of 
conformations including open and partially closed conformations, and that 
binding of ligands shifts the conformational ensemble towards the fully 
closed conformations. In contrast, the binding of two cAMP ligands to the 
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catabolite activator protein (CAP) system results in negative cooperativity 
with no average conformational changes (108). Experimental studies have 
shown that binding of the first cAMP ligand to CAP does not result in any 
conformational changes of the ligand binding site in the other subunit; 
however, the dynamics of the system is altered so that the binding of the 
second cAMP ligand is associated with a higher entropic penalty, thus 
reducing the binding affinity of the second cAMP ligand by two orders of 
magnitude (108).  
 
Allosteric regulation of MtuDAH7PS is proposed to be mainly entropy 
driven, as structural changes on binding the allosteric regulators are subtle 
(see Chapter 4) (76). Unlike other DAH7PSs, single amino acids do not alter 
enzymic activity, yet binary combinations of aromatic amino acids give rise 
to a synergistic response. Combinations of Trp and Phe, and to a lesser extent 
Trp and Tyr, result in significant inhibition of the enzyme, providing a 
sophisticated mechanism for the control of a branched biosynthetic pathway. 
Moreover, in the presence of inhibitory concentrations of Trp and Phe or Trp 
and Tyr, significant homotropic cooperativity was observed in enzyme 
activity with respect to the concentration of substrate E4P, providing another 
level of sophistication to the communication between inhibitor and substrate 
binding sites. 
 
In this chapter, the communication among the allosteric binding sites and the 
active sites of MtuDAH7PS will be investigated using a combination of MD 
simulations and bioinformatics techniques (statistical coupling analysis). 
These studies illuminate the central role that subtle changes in protein 
dynamics play in the unusual synergistic inhibition of this enzyme. 
 
6.1.2 Application of the statistical coupling analysis 
 
One of the computational methods used to study allostery is the sequence 
based statistical coupling analysis (SCA) (109). This analysis has been used 
to identify amino acid networks that are responsible for communication 
within proteins. It uses the evolutionary data of a protein family to measure 
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energetic coupling between positions on a multiple sequence alignment 
(MSA). This analysis is based on the view that evolution of a protein fold is 
the result of a large scale random mutagenesis, with selection constraints 
imposed by function. 
 
The SCA method is based on two hypotheses. First is that lack of 
evolutionary constraint at one position should cause the distribution of 
observed amino acid at that position in the MSA to approach their mean 
abundance in all proteins, and deviance from the mean values should 
quantitatively represent conservation. The second hypothesis is that, the 
functional coupling of two residues, even when they are distantly located in 
the structure, should mutually constrain evolution at the two positions, and 
these should be represented in the statistical coupling of the underlying 
amino acid distributions.  
 
The capability of the SCA method to predict coupled amino acids distant 
from the active site has attracted huge attention in the research community 
since its introduction (the original paper introducing the SCA method (109) 
published in 1999 has been cited 424 times so far according to data on Web 
of Science SM), because residues involved in catalysis or allostery but not in 
the near vicinity to the active site are generally hard to predict by other 
means of experimental methods. The SCA method has been used to study 
co-evolved amino acids in various protein families, including PDZ domains, 
G-protein coupled receptors, M.Hhal, iLBPs, aspartic proteinases, (β/α)8 
barrel proteins, and superoxide dismutases (110-116). 
 
New techniques have been developed which combine the SCA with other 
computation methods, such as MD simulations. The SCA method was used 
in combination with MD simulations to identify amino acid pairs essential 
for catalysis in the M.Hal family (111). In this work, a hybrid method, 
denoted SCA·MD, which weights the correlated motion from MD 
simulations with evolutionary conservation from SCA, was developed. The 
hybrid SCA·MD matrix was obtained by multiplying elements in the SCA 
correlation matrix with the ones in the MD correlated motion matrix. In the 
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SCA part, the correlation values were not calculated for all positions on the 
MSA. Positions on the termini were omitted. In the MD part, the backbone α 
carbon movement was considered. The hybrid matrix predicted several pairs 
of amino acids with high correlated or anti-correlated motions. Some of the 
predictions were tested by mutagenesis experiments, in which one of the 
amino acids in the pair were mutated into Ala, and the changes in kcat were 
measured as indication of the mutation effect. Experimental results showed 
that mutation of amino acids predicted from the SCA·MD method produced 
large effect on rate of catalysis, while mutation of residues adjacent to the 
predicted residues did not produce the same effect. The SCA technique is 
more powerful when combined with MD simulations, for identification of 
subset of co-evolved residues which show coupled motions within the 
protein. The results from SCA and MD simulations are generally visualised 
with crystallography and tested by mutagenesis experiments. 
 
In this chapter, the molecular basis of the communication mechanism of 
synergistic allostery in MtuDAH7PS was examined. MD simulations were 
conducted for ligand-free and ligand-bound MtuDAH7PS complexes, in 
order to examine the changes in dynamic fluctuations of individual residues 
caused by allosteric ligand binding. The SCA method was applied for type II 
DAH7PS family, of which MtuDAH7PS is a member, in order to identify the 
co-evolved residues within this protein family. Finally the SCA method was 
combined with results from the MD simulations using the hybrid SCA·MD 
approach, to identify residues that are critical for the communication between 
the allosteric sites and the active site in MtuDAH7PS. 
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6.2 MD simulations for MtuDAH7PS in complex with different ligands 
 
6.2.1 ITC measurements of ligand binding affinity.  
 
The unusual synergistic inhibition of MtuDAH7PS is only observable in the 
presence of both Trp and Phe. In order to probe the binding of single ligands, 
isothermal titration calorimetry (ITC) was employed (ITC experiments were 
conducted by Dr. Richard Hutton in our research group). These results are 
reported here as they are important to the interpretation of the computational 
studies described in this chapter. Titrations of the allosteric inhibitor Phe 
yielded a dissociation constant (Kd) of 21.2 µM. Binding experiments with 
the alternative allosteric inhibitor, Trp, yielded a Kd value of 4.7 µM, 
indicating clearly that Trp binds to MtuDAH7PS with higher affinity than 
Phe ( 
Table 6. 1). 
	  
Table	  6.	  1.	  Results	  from	  ITC	  binding	  experiments.	   	  
 Binding experiment (298 K) Kd (µM) Stoichiometry 
Phe titration 21.2 ± 1.0 - 
Phe titration (20 µM Trp background)  5.0 ± 0.1 3.98 ± 0.02 
Trp titration 4.7 ± 0.1 4.02 ± 0.03 
Trp titration (20 µM Phe background)  1.08 ± 0.03 3.96 ± 0.01 
 
To examine the influence that the presence of one ligand has on the affinity 
of the protein for the other ligand, ITC experiments were performed using a 
background of one of the allosteric inhibitors in the sample cell whilst 
titrating in the other. Titration of Phe onto a Trp background yielded a 
reduced Kd of 5.0 µM. Inversely, titrating in Trp to a Phe background yields 
a reduced Kd of 1.08 µM. These experiments clearly show that both binding 
sites do not just communicate their occupancy to the active site to influence 
catalysis, but that the Phe and Trp sites exchange information on their 
occupancy directly. 
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6.2.2 MD simulations for MtuDAH7PS complexes 
 
MD simulations were conducted to examine the change of dynamic 
properties of the MtuDAH7PS tetramer upon binding of different ligands. 
MD simulations (20 ns) were set up for four systems of the MtuDAH7PS 
tetramer: ligand-free, Trp+Phe, Trp-only, and Phe-only bound.  
 
The MD simulations were carried out with NAMD running on the BlueFern 
supercomputer at the University of Canterbury (36). Four crystal structures 
of MtuDAH7PS, including ligand-free (PDB 3NV8), Trp+Phe co-crystallised 
(PDB 3RZI), Trp-only (PDB 3NUE) and Phe-only (PDB 3NUD) bound, 
were used in the MD simulations. Missing residues in the three ligand-bound 
structures of MtuDAH7PS were built in with COOT in accordance with the 
electron density map before MD simulations (117), so that the dynamic 
properties of the disordered loops can also be examined. The Phe-only 
soaked structure (3NUD) (76) contains Phe molecules in primary and 
secondary Phe sites and Trp binding sites. For MD simulations, only Phe 
molecules in primary Phe binding sites were kept, in order to investigate the 
dynamic behaviour of the enzyme when the ligand molecules were only at 
their preferred sites (the preferred binding sites for Phe molecules are at the 
dimer interface, this has been validated by both the co-crystallised Trp+Phe 
structure (Chapter 4) and mutagenesis experiments (76)). The tetrameric 
form of each complex was generated from the dimer in the asymmetric unit 
based on the 2-fold crystallographic symmetry operation. Each of the four 
complete tetramer structures was solvated with explicit TIP3 water molecules 
in a box in VMD (118) ionised by adding Na+ and Cl- ions to balance the net 
charge of the water box. The ions were added with a minimum distance of 5 
Å from the molecule and each other. MD simulations were conducted with 
the CHARMM force field parameter specifications at a constant temperature 
and pressure (310 K, 1 atm) (41). The cut-off distance for van der Waals 
interactions was set to 12 Å. In each simulation, the system was first 
minimised for 1000 steps followed by 20 ns of dynamics simulation 
conducted with 2 fs time steps. The trajectory was written out at 100 ps time 
intervals, and a total of 200 frames were obtained from each simulation (20 
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ns). 
 
 
Figure	  6.	  1.	  Backbone	  RMSD	  of	  MtuDAH7PS	  in	  complex	  with	  different	   ligands	  during	  20	  ns	  MD	   simulations.	   The	  RMSD	  values	  were	   calculated	  using	   the	   first	   frame	  of	   the	  trajectory	  as	  the	  reference	  structure.	  
 
Protein backbone RMSD values (Figure 6. 1) indicate that the backbone 
RMSD values of the protein molecule in all four simulations become stable 
after ~2.3 ns, indicating that all for simulations equilibrated after ~2.3 ns. 
Within the equilibrated time period (2.3 ns to 20 ns), all four complexes 
showed small fluctuations in backbone conformation. The average 
conformations of the Trp+Phe bound, Trp-only and Phe-only bound systems 
during equilibrated time period match to that of the ligand-free system with 
RMSD values of 1.562 Å (matching 1751 Cα atoms), 1.375 Å (matching 
1714 Cα atoms) and 1.326 Å (matching 1659 Cα atoms), respectively. 
Considering the extent of movement within each system (~1.5 – 3 Å) during 
the MD simulations, these RMSD values are relatively small, and average 
conformations of the four systems differ only slightly, consistent with the 
absence of major conformational change in MtuDAH7PS upon allosteric 
ligand binding observed crystallographically. 
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Figure	  6.	  2.	  Chain-­‐averaged	  RMSF	  values	  residue-­‐by-­‐residue	  for	  the	  four	  MtuDAH7PS	  complexes.	   The	   RMSF	   values	   were	   calculated	   using	   the	   trajectory	   frames	   collected	  during	  the	  equilibrated	  simulation	  period,	  and	  all	  non-­‐hydrogen	  atoms	  in	  each	  residue	  are	  included	  in	  the	  calculation	  (including	  backbone	  and	  side	  chain).	  
 
In order to examine the changes in flexibility of specific regions of the 
structure upon ligand binding, the RMSF (root mean square fluctuation) 
values of individual residues of MtuDAH7PS were calculated. The RMSF 
values were calculated for each amino acid using its average conformation 
during the MD simulation as the reference structure, and therefore these 
values provided an indication of individual residue conformational 
fluctuation during the MD simulations. For this calculation, trajectory frames 
collected from the equilibrated simulation period were used (after 2.3 ns), 
and all non-hydrogen atoms of each amino acid (backbone and side chain 
atoms) were included. During the MD simulations, the four identical 
monomers of the tetrameric MtuDAH7PS can be considered as sampling 
slightly different regions of the same conformational space. Therefore, 
instead of comparing residue RMSF values of individual monomers, 
comparison of the RMSF values averaged over the four monomers was 
conducted to give a better indication of regions of flexibility (Figure 6. 2). As 
expected, for all four systems, the residues on the loop regions gave greater 
RMSF values (more flexible) and the residues on secondary structures such 
as helices and sheets showed relatively smaller RMSF values (less flexible). 
The differences in residue RMSF values (ΔRMSF) between the ligand-bound 
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systems and the ligand-free system were then calculated so that positive 
ΔRMSF values indicate greater flexibility and negative values indicate less 
flexibility in the corresponding region upon ligand binding (Figure 6. 3).  
 
 
Figure	   6.	   3.	   Percentage	   changes	   in	   flexibility	   (ΔRMSF)	   with	   respect	   to	   wild	   type	  
MtuDAH7PS	  upon	  binding	  of	  different	  ligands	  to	  MtuDAH7PS;	  positive	  values	  indicate	  increased	  flexibility	  in	  the	  corresponding	  region	  and	  negative	  values	  indicate	  reduced	  flexibility	  upon	  binding	  of	  (A)	  Trp+Phe,	  (B)	  Trp-­‐only,	  and	  (C)	  Phe-­‐only,	  as	  revealed	  by	  molecular	   dynamics	   simulations.	   Residues	   involved	   in	   Trp	   and	   Phe	   binding	   sites	   are	  coloured	  in	  cyan	  and	  red,	  respectively.	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6.2.2.1 Change in flexibility upon binding of both Trp and Phe 
 
Upon binding of both Trp and Phe in the allosteric sites (Figure 6. 5A), the 
tetramer interface becomes more rigid and the N-termini and part of the 
dimer interface become more flexible. Notably, the loop (β2-α2) containing 
residues 133-135 of the active site, becomes more flexible when both Trp 
and Phe are bound (ΔRMSF values are ~0.840 Å on average for residues 
133-135). The alteration in regional flexibility is also confirmed by an 
analysis of the B-values (temperature factors) between the Trp+Phe 
co-crystal and ligand-free structure of MtuDAH7PS (Error! Reference source 
not found.). The β2-α2 loop is responsible for the binding of the substrate E4P 
(61), (62) and has recently been shown to bind to the E4P-mimicking portion 
of an MtuDAH7PS inhibitor designed to resemble the reaction intermediate 
between PEP and E4P (85). The increased flexibility of loop β2-α2 increases 
the entropy penalty upon binding of the substrate E4P, and thus disfavours 
E4P binding. The MD result is entirely consistent with experimental 
observations: kinetic analysis has earlier revealed that the strongly inhibitory 
effect of the combination of Trp and Phe is focused on a dramatically 
reduced affinity of the enzyme for E4P (76). 
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Figure	   6.	   4.	   Plot	   of	   percentage	   differences	   in	   B-­‐value	   of	   CA	   and	   CB	   atoms	   in	   each	  residue	   between	   wild-­‐type	  MtuDAH7PS	   with	   and	   without	   Trp+Phe	   (where	   Trp+Phe	  was	  co-­‐crystallised),	  comparison	  of	  B-­‐value	  in	  Chain	  A	  is	  plotted	  in	  top	  frame,	  and	  that	  of	   Chain	   B	   is	   plotted	   in	   bottom	   frame.	   Positive	   values	   indicate	   increased	   B-­‐values	  (flexibility)	   on	   binding	   Trp+Phe;	   Negative	   values	   indicate	   decreased	   B-­‐values	  (flexibility	  on	  binding	  Trp+Phe,	  and	  -­‐100%	  indicates	  residues	  missing	  in	  the	  Trp+Phe	  structure.	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Figure	  6.	  5.	  Changes	  in	  residue	  flexibility	  (ΔRMSF)	  in	  MtuDAH7PS	  upon	  binding	  of	  (A)	  both	  Trp	  and	  Phe,	   (B)	  Trp-­‐only	  and	  (C)	  Phe-­‐only,	  as	   revealed	  by	  molecular	  dynamics	  simulations.	  The	  changes	  in	  flexibility	  are	  displayed	  both	  by	  colour	  and	  tube	  width.	  The	  regions	   with	   increased	   flexibility	   are	   coloured	   with	   changing	   gradient	   of	   red,	   and	  thicker	   tube	   width;	   regions	   with	   decreased	   flexibility	   are	   coloured	   with	   changing	  gradient	  of	  blue,	  and	  thinner	  tube	  width.	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6.2.2.2 Change in flexibility upon binding of single amino acids 
 
One of the intriguing aspects of the unusual synergistic response to Trp and 
Phe binding in MtuDAH7PS is that no alteration in catalytic activity of the 
enzyme on binding of a single ligand is observed, yet ITC results show 
clearly that the two sites are in mutual communication. Therefore, MD 
trajectories of Trp-only and Phe-only systems were analysed to investigate 
dynamic changes in the active site and the allosteric binding sites associated 
with single ligand binding.  
 
Upon binding of Trp alone (Figure 6. 5B), the tetramer interface and Trp 
binding sites become more rigid, in a manner similar to that observed for the 
Trp+Phe system. However, surprisingly, the binding of Trp alone was 
associated with an increase in flexibility of the distant N-terminal region 
(residue 1-4, 9-10), which caps the Phe binding pocket. Other residues 
constituting the Phe binding sites, namely the β1-α1 loop (residues 91-94) 
and the α2 helices (residues 170-178) in the dimer interface become slightly 
less flexible upon Trp binding. These observations suggest that in the 
presence of Trp, the binding of Phe will be enhanced as most residues in the 
Phe binding sites become less flexible, decreasing the entropic cost of Phe 
binding. The more flexible capping N-terminal residues facilitate access to 
the Phe binding sites. The active site loop β2-α2 (residues 133-135) also 
showed a slight increase in flexibility (ΔRMSF is ~0.359 Å for residues 
133-135 on average), but this increase is much smaller than that calculated 
when both Trp and Phe are bound (0.840 Å), indicating the most prominent 
effect on active site loop dynamics (hence inhibitory effect) is only achieved 
by binding of both Trp and Phe. 
 
The binding of Phe alone (Figure 6. 5C) also resulted in slight increases in 
flexibility of the dimer interface and the N-terminal region. Loops β7-α7 and 
β8-α8 showed unusually large increases in flexibility in the Phe-only system, 
in conjunction with the fact that these loops were also missing in the original 
crystal structure due to disorder, it indicates that the highly mobile loops 
β7-α7, β8-α8 are intrinsic to the structure upon only Phe binding. 
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Interestingly the dynamic properties of the distant Trp binding sites seem to 
be also affected by the binding of Phe. The residues on helix α1 and sheet β2 
(residues 107-123) and helix α2a (residues 192-197) which constitute parts of 
the Trp binding pockets become less flexible. The residues on loop α2b-β3 
(residues 237-242) which enclose the Trp binding sites become more flexible. 
This suggests that upon binding of Phe, part of the Trp binding site becomes 
more ordered favouring subsequent binding of Trp. In parallel to the 
behaviour of the N-terminal region in the Trp-only system, here in the 
presence of only Phe, the loop α2b-β3, which encloses the Trp binding sites, 
becomes more flexible to open up and facilitate entrance of the Trp 
molecules to the binding sites.  
 
In summary, the simulations reveal that whereas ligand binding does not 
significantly alter the average conformations adopted by the MtuDAH7PS 
tetramer, as also observed by the structural studies, it has a significant effect 
on the conformational fluctuations and the regional flexibilities of the protein, 
which may reflect the changes in the conformational energy landscape. For 
some regions of the enzyme, the relative energies of conformations around 
the average conformation become more similar, and the energy landscape 
around this average conformation can be considered to become somewhat 
flattened upon ligand binding. This alteration means that more conformations 
become energetically accessible, and as a result those corresponding regions 
of the enzyme become more flexible. It is proposed that this increased 
flexibility of the β2-α2 loop results in reduced affinity of the protein for 
substrate E4P, accounting for the inhibition of the enzyme by dual inhibitor 
binding. However, for other regions that become less flexible upon ligand 
binding, this suggests that the local minima on the conformational energy 
landscape become more pronounced, so that fewer conformations are 
energetically accessible. We observe this effect on the second 
inhibitor-binding site, when a single ligand is in place.  
 
To date the majority of the known cases of allostery described involve gross 
conformational changes of the enzyme structure upon ligand binding. 
Computational and experimental techniques are now beginning to allow the 
127 
 
analysis of systems minimal average conformational changes are observed on 
ligand binding:  MtuDAH7PS with its complicated synergistic allostery 
appears to belong to this less studied group. The absence of distinct 
conformational states of the protein with altered functionality poses greater 
challenges for detecting the underlying molecular basis of the allosteric 
mechanism. A combination of computational and experimental techniques 
have been used to illustrate that the dynamic interplay between ligand 
binding sites is responsible for communication between allosteric sites and 
the synergistic allosteric regulation of MtuDAH7PS. This study contributes 
to our increasing understanding of the allostery associated with limited 
conformational changes, and may help in elucidating a more general 
molecular understanding of the mechanisms for allosteric control. 
 
6.3 SCA for type II DAH7PS family 
 
The SCA method was conducted for type II DAH7PS family, in order to 
identify the co-evolved residues within this protein family that may be 
important for the observed synergistic allostery in MtuDAH7PS. By applying 
this method to type II DAH7PS family, an assumption is made that allosteric 
regulation observed in MtuDAH7PS is conserved between all members of 
this protein family. The SCA for type II DAH7PS family was conducted with 
MATLAB. All calculation algorithms, theories and program scripts used in 
the following analysis were developed by the Ranganathan lab (109). The 
SCA method was distributed by the original developers as a toolbox in the 
MATLAB station.  
 
Step 1: obtaining and loading multiple sequence alignment and 
conditioning. All available amino acid sequences for the type II DAH7PS 
family were obtained from the KEGG encyclopaedia (119-121). A multiple 
sequence alignment (MSA) for all identified amino acid sequences of type II 
DAH7PS was carried out with CLUSTAL W (122). The produced MSA 
contains 262 sequences. This was imported into MATLAB for the SCA 
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method (109). To prevent trivial over-representation of gaps in the MSA and 
ensure that the calculations were only made at the largely non-gapped 
sequence positions, the sequence positions with gap frequencies greater than 
20% were truncated from the full MSA. The truncated MSA contained 262 
sequences with 433 positions in each amino acid sequence.  
 
Step 2: sequence correlations. Ideally, the sequences in the MSA should 
represent a uniform sampling of the sequence space, in order to exclude the 
effect of biased sampling in the SCA. This could be examined from the 
structure of the correlations between sequences, through the computation of 
the matrix S of similarity between pairs of sequences, such that S(s1, s2) gave 
the fraction of amino acids that were common between the sequences s1 and 
s2 in the truncated MSA. 
 
Figure	  6.	   6.	  Distribution	  of	  pairwise	  sequence	  similarities	   in	  the	  full	  set	  of	  MSA	  (262	  amino	  acid	  sequences).	  
 
The distribution of sequence similarities computed in matrix S was visualised 
by a histogram (Figure 6. 6). The distribution showed the mean sequence 
similarity to be around 50%; however a number of sequences were shown to 
be highly similar (pairwise similarity above 90%). This high similarity was 
likely to cause sampling bias which will later affect the statistical analysis 
results. Therefore, those sequences with high similarities (above 80%) were 
removed from the full set MSA. This was carried out by inspection of the 
similarity matrix S, and the removal of groups of sequences with high 
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similarity score. 
 
After the removal of a subgroup of high similarity sequences, the resultant 
MSA contains 69 amino acid sequences with 433 positions (the amino acid 
sequences used can be found in Appendix 5). To examine the sequence 
correlations in the refined MSA, the pairwise similarities between amino acid 
sequences in the refined MSA were calculated again by means of similarity 
matrix S. It is clear from this distribution of sequence similarities (Figure 6. 7) 
that all sequences with similarity above 80% were removed. The mean 
similarity is about 50%, and the similarity distribution ranges from 25% to 80% 
due to the small sequence divergence of this family. This distribution is not 
as ideal as the example system (the PDZ domain system) studied by the 
original developers of SCA (116), in which the MSA contains 240 sequences 
with mean similarity about 20% and similarity distribution from 5% to 50%. 
However, one of the most important requirements on the MSA used for the 
SCA method is the uniform distribution. After the removal of those highly 
similar sequences from the MSA of type II DAH7PS, the distribution of the 
amino acid sequences is considered reasonably uniform in the refined MSA 
and therefore suitable for the SCA method (Figure 6. 7). Another 
requirement on the MSA to be used in the SCA method is that the size of the 
sequence alignment should be large enough (~100 sequences). The refined 
MSA of type II DAH7PS family contains 69 sequences which is smaller than 
the required number. This means that there may be false positives identified 
in the final clusters of co-evolved residues due to statistical noise. Therefore, 
the interpretations of the final outcome from the SCA method should be 
considered carefully keeping in mind this limitation of MSA size. 
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Figure	  6.	  7.	  Distribution	  of	  pairwise	  sequence	  similarities	  in	  the	  refined	  set	  of	  MSA	  (69	  amino	  acid	  sequences).	  
 
Step 3: positional conservations. The degree of conservation of the 
different positions on the MSA was measured in SCA by an information 
theoretic quantity called the relative entropy, 𝐷!(!). If 𝑓!(!) represented the 
frequency of amino acid 𝑎 at position 𝑖, and the probability of observing 𝑓!(!)  in an alignment of M sequences was represented by the binomial 
probability 𝑃! 𝑓!(!)  with a given background probability of 𝑞(!), then 
the relative entropy 𝐷!(!) was defined as: 𝐷!(!) = − 1𝑀 ln 𝑃! 𝑓!(!)  
 
This quantity indicated how unlikely the observed frequency of amino acid 𝑎 at position 𝑖 would be if it occurred randomly with probability 𝑞(!), and 
could capture the divergence of the observed frequencies of amino acids at 
each position from their background frequencies in the non-redundant 
database of proteins (109). 
 
The positional conservation values (Figure 6. 8, top) of type II DAH7PS 
family show a mean value around 1.5 and the majority of the positions show 
conservations at a lower range from 0.5 to 3.5. Only a few positions show 
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high conservation values above 3.5. This pattern suggests that only the few 
functionally important residues are highly conserved in this protein family 
(109, 123). 
 
 
Figure	  6.	  8.	  Top:	  Distribution	  of	  positional	  conservation	  values	  of	  amino	  acids	  from	  the	  refined	  MSA	  of	  type	  II	  DAH7PS	  family.	  Bottom:	  Positional	  conservations	  plotted	  along	  the	   primary	   sequence	   of	   type	   II	   DAH7PS,	   the	   positions	   are	   numbered	   as	   in	   the	  MtuDAH7PS	  structure.	  
 
Plotting the positional conservation values along the primary amino acid 
sequence shows a dispersed pattern (Figure 6. 8, bottom). However, mapping 
the conservation values on to three dimensional crystal structure of 
MtuDAH7PS (Figure 6. 9B) shows that most of the positions with high 
conservation values are located at the centre of the barrel structure. They 
constitute part of the active site and are important for maintaining the 
catalytic function of the enzyme. Some of them are located on the β-strands 
of the core barrel structure, which are important for maintaining the basic 
fold of this protein family. Several other positions with high conservation 
values were found at the dimer interface (Figure 6. 9A), e.g. Pro56, Arg181 
and Arg184, and tetramer interfaces, e.g. Phe227. 
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Figure	  6.	  9.	  Positional	  conservation	  values	  mapped	  on	  crystal	  structure	  of	  MtuDAH7PS.	  The	   conservation	   values	   are	   represented	   using	   a	   colour	   scale,	   blue	   indicates	   low	  conservation	   and	   red	   indicates	   high	   conservation.	   A.	   Positional	   conservation	   values	  mapped	  on	  the	  tetramer	  of	  MtuDAH7PS,	  the	  tetramer	  structure	  in	  the	  same	  orientation	  with	   cartoon	   representation	   is	   shown	  on	   the	   right	   to	   indicate	  positions	  of	   active	   site	  and	   interfaces.	   B.	   Positional	   conservation	   values	   mapped	   on	   the	   monomer	   of	  
MtuDAH7PS	  shown	  in	  three	  different	  orientations	  (highlighted	  in	  three	  boxes),	  and	  the	  monomer	   structure	   in	   each	   orientation	   is	   displayed	  by	   both	   sphere	   form	   and	   ribbon	  form,	  to	  indicate	  the	  position	  of	  the	  active	  site.	  
 
Step 4: positional correlations. The co-evolved residues within a protein 
family were identified in the SCA by calculating the correlation of positional 
conservations between each pair of positions on the truncated refined set of 
MSA. The correlation values were represented in a correlation matrix (𝐶!"(!")) 
which is defined as:  𝐶!"(!") = 𝑓!"(!") − 𝑓!(!)𝑓!(!) 
Where 𝑓!"(!") represented the joint frequency of having amino acid 𝑎 at 
position 𝑖 and amino acid 𝑏 at position 𝑗. Here, the correlation matrix for 
type II DAH7PS family was calculated with the “binary approximation” 
applied. In the “binary approximation”, only the most frequent amino acid 𝑎! 
at position 𝑖 was considered. The alignment was then represented by a 
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binary array 𝑥!,! where 𝑥!,! = 1 if sequence 𝑠 contained the most frequent 
amino acid at position 𝑖, and 0 otherwise. After application of the binary 
approximation, the correlation matrix 𝐶!"(!") was reduced to: 𝐶!" = 𝑓!"(!!!!) − 𝑓!(!!)𝑓!(!!) 
This reduction was proved to be useful by the original developers of the SCA 
method (109), since the positional conservation in the full alignment was 
well-approximated by the positional conservation in the binary alignment. 
 
The full correlation matrix for type II DAH7PS family was plotted using a 
colour scale (Figure 6. 10, top), where blue indicated low correlations and 
red indicated high correlations between pairs of positions on the MSA, and 
the x and y axes represented the positions on the MSA. Most of the pairs of 
positions showed low correlations (blue) to each other. However, a few 
non-adjacent pairs of positions (off-diagonal) with medium or high 
correlations can still be observed. This was clear from the distribution of 
correlation values (Figure 6. 10, bottom), which was skewed with a long tail 
into the high correlation range. Due to a large number of positions in the 
MSA, it is difficult to identify exactly which positions were showing high 
correlations by inspection of the correlation matrix. Therefore, a clustering 
analysis was carried out to reveal more clearly the statistically coupled 
positions. 
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Figure	   6.	   10.	   Top:	   Full	   SCA	  matrix	   for	   type	   II	  DAH7PS	   family,	   correlation	  values	   are	  shown	   using	   a	   colour	   scale,	   blue	   indicates	   low	   correlation	   and	   red	   indicates	   high	  correlation.	  Bottom:	  Distribution	  of	  the	  positional	  correlation	  values.	  
 
Step 5: clustering analysis. In this clustering analysis, positions in the 
correlation matrix were grouped into clusters according to their correlation 
values. The clusters were defined so that the most closely related positions 
are placed next to each other. The correlation values were plotted onto a new 
matrix in which the positions on the x and y axes were “scrambled” 
according to the clustering order. The cluster regions of high correlation 
values were identified from the new, sorted correlation matrix, based on 
visual inspection of the sorted correlated matrix and the clustering tree, and 
further iterations of clustering analysis were carried out until the positions in 
the identified clusters converged. 
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Figure	   6.	   11.	   Sorted	  correlation	  matrix	  after	   the	   first	   iteration	  of	   clustering	  analysis.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  x	  and	  y	  axes	  represent	  positions	  on	  the	  MSA,	  but	  the	  order	  of	  these	  positions	  are	  sorted	  according	  to	  the	   clustering.	   The	   region	   identified	   for	   further	   iterations	   of	   clustering	   analysis	   was	  highlighted	  in	  black	  box	  
 
l Iteration 1 
After the first iteration of clustering analysis on the correlation matrix, the 
correlations were sorted into clusters and the matrix was reordered 
accordingly (Figure 6. 11). 
 
From this, a region of high correlation values was identified (Figure 6. 11). 
This region was selected to go through a second iteration of the clustering 
analysis, and it included the following positions (with MtuDAH7PS 
numbering): 
 
289+26+202+386+45+350+90+446+102+388+401+49+220+64+237+187+428+98+364+236+352+37
4+241+274+279+105++160+191+30+251+151+169+244+122+225+361+172+213+385+273+276+45
2+457+286+440+438+394+29+132+307+389+437+393+387+68+357+152+93+183+334+36+37+95+
316+174+342+418+353+408+195+324+327+329+449+222+283+344+405+115+224+333+403+33+7
9+303+34+156+104+238+295+55+203+159+392+373+377+70+170+317+320+211+427+148+254+2
91+368+331+74+272+168+83+308+246+281+96+137+217+138+258+332+416+52+314+400+319+3
23+81+124+82+413+109+455++154+180+299+318+345+142+340+176+321+38+417+111+209+379
+214+395+41+293+48+205+343+431+287+365+72+354+165+397+410+458+201+338+58+432+179
+146+164+63+260+177+107+194+259+99+192+193+143+158+378+384+243+25+28+298+40+245+
294+297+271+103+131+65+94+175+101+412+100+262+278+57+108+84+144+162+145+112+451+
147+185+157+60+186+61+62+189+204+110+218+114+435+123+232+182+197+230+231+391+198
+200+228+454+59+423+406+71+275+372+450+67+184+128+381+414+422+348+121+221+249+30
9+120+453+181+190+227+173+358+402+363+398 
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A subset of the full SCA correlation matrix was made to include only 
positions identified above. This smaller correlation matrix was subjected to 
the second round of clustering analysis. 
 
l Iteration 2 
After the second iteration of clustering analysis on the subset of the 
correlation matrix, the correlations were sorted into clusters again and the 
matrix was reordered accordingly (Figure 6. 12). From this sorted correlation 
matrix, two regions of high correlation values were observed (Figure 6. 12). 
These two regions contained the following positions (MtuDAH7PS 
numbering): 
 
67+184+128+381+348+414+422+121+58+432+179+99+192+63+260+177+107+158+384+243+160+
191+452+457+30+251+273+276+231+391+52+81+124+59+423+406+372+71+275+450+72+354+16
5+397+410+458+194+259+193+221+249+309+289+26+202+297+324+90+446+105+271+386+102+
388+401+45+350+49+220+428+374+151+64+237+187+55+98+364+236+352+241+274+279+103+1
31+146+164+245+294+25+28+298+40+65+94+175+101+412+100+262+278+143+378+358+402+39
8+120+453+181+190+227+173+363+57+108+84+144+145+162+112+451+147+157+185+230+189+
204+198+60+186+61+62+110+218+435+114+123+232+182+197+200+228+454 
 
 
Figure	  6.	  12.	  Sorted	  correlation	  matrix	  after	  the	  second	  iteration	  of	  clustering	  analysis.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  x	  and	  y	  axes	  represent	  positions	  on	  the	  MSA,	  but	  the	  order	  of	  these	  positions	  are	  sorted	  according	  to	  the	  clustering.	  The	  regions	  identified	  for	  further	  iterations	  of	  clustering	  analysis	  were	  highlighted	  in	  black	  boxes.	  
 
The same procedure was applied as before, that a subset of the correlation 
matrix was generated with only positions identified from the above two 
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regions in the second iteration. This subset of the correlation matrix was 
subjected to the third round of clustering analysis. 
 
l Iteration 3 
After the third iteration, three regions of high correlation values were 
observed (Figure 6. 13), these regions contained the following residues 
(MtuDAH7PS numbering): 
 
94+175+101+412+241+274+279+103+131+164+294+245+298+146+40+25+28+65+100+262+173+1
43+453+378+120+181+402+398+363+57+108+157+185+189+204+198+230+60+182+26+202+162+
112+147+110+446+324++388+186+84+451+144+145+271+102+386+401+278+358+227+61+62+10
5+218+435+114+123+232+197+200+228+454+128+381+422+348+414+121+251+64+428+374+151
+350+49+220+45+55+98+364+236+352 
 
A subset of the correlation matrix containing only the above positions was 
generated and subjected to the fourth iteration of clustering analysis. 
 
 
Figure	  6.	  13.	  Sorted	  correlation	  matrix	  after	  the	  third	  iteration	  of	  clustering	  analysis.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  x	  and	  y	  axes	  represent	  positions	  on	  the	  MSA,	  but	  the	  order	  of	  these	  positions	  are	  sorted	  according	  to	  the	  clustering.	  The	  regions	  identified	  for	  further	  iterations	  of	  clustering	  analysis	  were	  highlighted	  in	  black	  boxes.	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l Iteration 4 
 
Figure	  6.	  14.	  Sorted	  correlation	  matrix	  after	  the	  fourth	  iteration	  of	  clustering	  analysis.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  x	  and	  y	  axes	  represent	  positions	  on	  the	  MSA,	  but	  the	  order	  of	  these	  positions	  are	  sorted	  according	  to	  the	  clustering.	  The	  regions	  identified	  for	  further	  iterations	  of	  clustering	  analysis	  were	  highlighted	  in	  black	  boxes.	  
 
The fourth iteration of clustering analysis identified two regions of high 
correlation values (Figure 6. 14). These two regions contained the following 
positions (MtuDAH7PS numbering): 
 
94+175+101+412+100+262+173+143+453+378+120+181+402+398+103+131+164+294+245+298+6
5+146+40+358+25+28+271+102+197+200+218+435+114+123+232+228+363+57+108+241+279+27
4+352+55+236+98+364+128+381+151+428+374+422+121+348+414+251+64+350+49+220+45 
 
After the fourth iteration, the position numbers identified from high 
correlation clusters started to converge, therefore, a final iteration of 
clustering analysis was carried out to finalise the definition of clusters for the 
type II DAH7PS family. A subset of the correlation matrix was generated 
containing only the positions identified above, and this matrix was subjected 
to the final round of clustering analysis. 
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l Iteration 5 (final iteration) 
 
 
Figure	  6.	   15.	  Sorted	  correlation	  matrix	  after	   the	   final	   iteration	  of	  clustering	  analysis.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  x	  and	  y	  axes	  represent	  positions	  on	  the	  MSA,	  but	  the	  order	  of	  these	  positions	  are	  sorted	  according	  to	  the	  clustering.	  The	  clustering	  tree	  was	  displayed	  on	  the	  top	  and	  left	  of	  the	  correlation	  matrix.	  The	  final	  clusters	  identified	  for	  type	  II	  DAH7PS	  family	  were	  highlighted	  in	  black	  boxes.	  
 
The final iteration of clustering analysis identified two clusters of positions 
with high correlation values (Figure 6. 15). These two clusters were 
consistent with the two clusters found after iteration 4, indicated that the 
clustering analysis had converged. A total of 62 positions were identified as 
co-evolved residues within the type II DAH7PS family. The two clusters 
contained the following positions (MtuDAH7PS numbering): 
 
Cluster 1: 
94+175+101+412+402+100+262+173+363+57+108+143+453+398+378+12
0+181+358+103+164+294+245+131+298+65+146+40+28+25+197+218+43
5+114+123+232+271+102+200+228 
 
Cluster 2: 
241+279+274+352+55+236+98+364+128+381+422+121+348+414+251+64
+428+374+151+350+49+220+45 
	  
	  
	  
140 
 
 
These two clusters of co-evolved residues were mapped onto the crystal 
structure of MtuDAH7PS, to examine the locations of these residues on the 
tertiary structure of the enzyme, and to investigate the possible physical 
meaning of these clusters. 
 
The first cluster contains 39 co-evolved residues with high correlation values 
(Figure 6. 16). Most of these co-evolved residues are found on the α-helices 
which are on the exterior of the barrel structure. This is consistent with the 
results about the conservation values discussed above that the centre of the 
barrel contains most of the highly conserved positions in the type II DAH7PS 
family (Figure 6. 9), since the highly conserved residues usually have very 
low correlation values and do not show up in the correlation analysis. The 
first cluster of co-evolved residues can be found at the Phe binding sites (e.g. 
residues 94 and 175), at the Trp binding sites (e.g. residues 123, 114 and 
197), and on the loops in the active site (e.g. residues 143, 146, and 378). The 
other co-evolved residues in cluster 1 are found to mediate physical 
connectivity through van der Waals interactions between these three distant 
sites. The communication signal between the Phe and Trp binding sites 
within the same monomer could propagate along those co-evolved residues 
on helices α1 and α2 (Figure 6. 16c). The ligand binding signals could 
potentially propagate across different monomers through those co-evolved 
residues at the dimer and tetramer interfaces (e.g. residues 228, 181). 
 
Therefore, the first cluster of co-evolved residues within the type II DAH7PS 
family may represent the communication pathway between the allosteric 
ligand binding sites and the active site, throughout the quaternary (tetrameric) 
structure. Ligand binding at the distant allosteric sites at the dimer and 
tetramer interfaces may first disrupt the movement of those residues in their 
binding sites, and this disruption signal can then propagate along the pathway 
formed by these co-evolved residues in the first cluster, and eventually reach 
the active sites in order to achieve inhibition of the enzyme. 
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Figure	  6.	  16.	  Co-­‐evolved	  residue	  in	  the	  first	  cluster	  identified	  from	  the	  SCA	  for	  type	  II	  DAH7PS	  family,	  mapped	  onto	  the	  ligand-­‐bound	  (Trp+Phe)	  crystal	  structure	  (PDB	  3KGF)	  of	  MtuDAH7PS,	   shown	   with	   white	   cartoon	   representation.	   The	   tetramer,	   dimer	   and	  monomer	  structures	  are	  shown	  in	  a,	  b,	  and	  c	  respectively.	  The	  co-­‐evolved	  residues	  are	  displayed	   as	   blue	   spheres;	   the	   bound	   Trp	   and	   Phe	   ligands	   are	   displayed	  with	   green	  carbon	   atoms.	   The	   active	   site	  metal	   ions,	  Mn2+,	   are	   displayed	   as	  magenta	   spheres	   to	  indicate	  the	  position	  of	  the	  active	  site.	  
 
The second cluster contains 23 co-evolved residues (Figure 6. 17). Similar to 
cluster 1, most of these co-evolved residues are found on the outside of the 
core barrel structure. These co-evolved residues are found between helices 
and sheets within the same monomer (e.g. residues 151, 251, 64 and 274) and 
between different monomers at the dimer and tetramer interfaces (e.g. 
residues 220, 236). Since these co-evolved residues are not located at the 
ligand binding sites, they may represent the communications between 
secondary structural elements in the enzyme in the absence of the inhibitors. 
 
	  
a.	  
b.	  
c.	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These residues may have co-evolved due to their importance in maintaining 
the basic barrel fold of the enzyme, and/or maintaining the functional 
quaternary structures within the type II DAH7PS family. 
 
 
Figure	  6.	  17.	  Co-­‐evolved	  residues	  in	  the	  second	  cluster	  identified	  from	  the	  SCA	  for	  type	  II	   DAH7PS	   family,	   mapped	   onto	   the	   crystal	   structure	   (PDB	   3KGF)	   of	   MtuDAH7PS,	  shown	   with	   white	   cartoon	   representation.	   The	   tetramer,	   and	   dimer	   structures	   are	  shown	   on	   the	   left	   and	   right	   respectively.	   The	   co-­‐evolved	   residues	   are	   displayed	   as	  yellow	  spheres.	  The	  active	  site	  metal	   ions,	  Mn2+,	  are	  displayed	  as	  magenta	  spheres	   to	  indicate	  the	  position	  of	  the	  active	  site.	  
 
In summary, SCA was carried out for type II DAH7PS family, in order to 
identify important co-evolved residues and possible communication 
pathways between distant allosteric inhibitor binding sites and the active sites. 
The analysis identified 62 co-evolved residues in two clusters. The first 
cluster of co-evolved residues can be found to mediate propagation pathway 
between the allosteric sites and active sites throughout the quaternary 
structure. This cluster is considered to represent the communication pathway 
between the three distant sites, and is of potential interest in deciphering the 
allosteric communication mechanism. The second cluster of co-evolved 
residues may be important for structural reasons. 
 
6.4 SCA·MD analysis for MtuDAH7PS 
 
The SCA method identified two clusters of residues (total of 62 residues) that 
co-evolved within the type II DAH7PS family, of which MtuDAH7PS is a 
member. The SCA proposed a large number of potentially interesting targets 
for further investigation by experiments. In order to narrow down the range 
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of potential targets, MD simulations for wild type MtuDAH7PS at the 
ligand-free state, and in combination with different allosteric inhibitors were 
carried out. The movements of the residues were analysed and combined 
with the results in SCA to filter out those co-evolved residues that were 
important for structural reasons, and to propose reasonable numbers of 
candidates for further experimental investigations. 
 
6.4.1 Residue movement correlations from MD simulations 
 
The atomic fluctuations of each amino acid of the tetramer of MtuDAH7PS 
during the MD simulations are represented by the average displacement 
vectors (∆𝑟). The displacement vectors were measured using the first frame 
of the equilibrated part of the trajectory (2.3 ns to 20 ns) as the reference, and 
all non-hydrogen atoms of each residue (both backbone and side chain), were 
included for the calculation. Then the correlations of movement between a 
pair of residues 𝑖 and 𝑗 is represented by the correlation coefficient (𝑅!,!) 
of the covariance matrix (𝐶𝑂𝑉 ∆!!,∆!! ) between ∆𝑟!  and ∆𝑟! , where the 
covariance matrix is defined as: 𝐶𝑂𝑉 ∆!!,∆!! = 𝐶(!,!) = 𝐸 ∆𝑟! − 𝜇!! ∆𝑟! − 𝜇!!  
in which 𝐸  is the mathematical expectation and 𝜇!! = 𝐸!! . Then the 
correlation coefficient (𝑅!,!) (i.e. the correlation of motion between pair of 
residues 𝑖 and 𝑗) is calculated by: 𝑅!,! =    𝐶(!,!)𝐶(!,!)𝐶(!,!) 
The correlation coefficient values (𝑅!,! ) range from -1 to 1. Positive 
correlation values indicate that the pair of residues moves in the same 
direction, whereas the negative correlation values indicate the residues move 
in the opposite direction. A completely correlated ( 𝑅!,! = 1 ) or 
anti-correlated (𝑅!,! = −1) motion means that the motions have the same 
phase and period. 
 
The matrix of the correlation coefficients (𝑅) was determined based on MD 
trajectories from each of the four systems of MtuDAH7PS (ligand-free, 
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Trp+Phe, Trp-only, and Phe-only bound), in order to detect any difference in 
correlations of motion upon ligand binding. 
 
Ligand-free MtuDAH7PS. The correlation coefficient matrix (𝑅) for the 
ligand-free MtuDAH7PS was plotted using a colour scale (Figure 6. 18) 
where blue indicates complete anti-correlations and red indicates complete 
correlations between the corresponding pair of residues.  
 
 
Figure	   6.	   18.	   Correlation	   matrix	   (𝑅)	   of	   residue	   motions	   during	   MD	   simulations	   of	  ligand-­‐free	  MtuDAH7PS	   tetramer.	   The	   correlation	   values	  were	  plotted	  using	   a	   colour	  scale,	  with	  red	  indicating	  complete	  correlation	  in	  motion,	  and	  blue	  indicating	  complete	  anti-­‐correlation	  in	  motion.	  
 
From the tetramer correlation matrix, two sets of information can be obtained, 
including the correlations of motion between residues on the same monomer 
(highlighted in black boxes in Figure 6. 18), and correlations of motion 
between different monomers. The same-monomer-correlations can provide 
an indication of the relative movement between specific loops and helices 
within the same monomer, whereas the different-monomer-correlations can 
provide an indication of which monomer is moving in correlation (or 
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anti-correlation) with the other monomers, thus provide a picture of overall 
domain movements on the tetramer of MtuDAH7PS.  
 
The four monomers in the ligand-free tetramer complex show different 
same-monomer-correlation patterns, indicating that the relative movements 
of the secondary structure elements are different in each monomer. Chains A 
and B show similar regions of correlation and anti-correlation. Chains C and 
D show larger regions of correlated motion, especially for chain C, in which 
almost all the regions on the monomer are moving in correlation, with the 
exception of the N-terminus, and several loop structures.  
 
The different-monomer-correlations show that chain D was mostly moving in 
correlation with chain A and in anti-correlation with chain C.  
 
 
Figure	   6.	   19.	   Correlation	   matrix	   (𝑅)	   of	   residue	   motions	   during	   MD	   simulations	   of	  A)Trp+Phe	   bound,	   B)	   Trp-­‐only	   bound	   and	   C)	   Phe-­‐only	   bound	  MtuDAH7PS	   tetramer.	  The	  correlation	  values	  were	  plotted	  using	  a	  colour	  scale,	  with	  red	  indicating	  complete	  correlation	  in	  motion,	  and	  blue	  indicating	  complete	  anti-­‐correlation	  in	  motion.	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Ligand-bound MtuDAH7PS. The same correlation matrix was calculated 
for the three ligand-bound systems of MtuDAH7PS tetramer (Trp+Phe, 
Trp-only and Phe-only bound), and plotted using the same colour scale 
(Figure 6. 19). 
 
The three ligand-bound systems of MtuDAH7PS tetramers show different 
correlations of motion during the MD simulations (Figure 6. 19). When both 
Trp and Phe are bound, the relative domain movement is altered compared to 
the ligand-free system, but the regions of correlation and anti-correlation are 
still clearly defined from the matrix. On the other hand, in the two single 
ligand-bound systems (Trp-only and Phe-only), the patterns of correlation 
and anti-correlation are completely disrupted, and the regions are not as 
clearly defined as in the ligand-free system. These differences suggest that 
binding of single or double ligands can alter the relative movements between 
secondary structure elements within the same monomer, as well as the 
relative movements between different monomers on the tetramer of 
MtuDAH7PS. These differences in correlations may be induced by ligand 
binding to the MtuDAH7PS tetramer, and may contribute to the mechanism 
of the propagation of ligand binding signals throughout the tetramer 
structure.  
 
6.4.2 SCA·MD hybrid analysis for MtuDAH7PS 
 
As mentioned previously, the SCA was used to identify groups of residues 
that have evolved in correlation with each other within the type II DAH7PS 
family. The identified co-evolved residues were important for either 
functional or structural reasons. Here, MD simulations were conducted, and 
residues on the MtuDAH7PS tetramer that have moved in correlation (or 
anti-correlation) were identified by computing the MD correlation matrix.  
 
Then a hybrid matrix (SCA·MD) can be computed by multiplying the 
individual elements of the SCA matrix with the corresponding elements of 
the MD matrix. The resultant hybrid matrix contains information from both 
the MD simulation and the SCA. In this calculation, the elements from the 
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MD matrix can be considered to act as a “weighting” term for the SCA 
matrix, so that those co-evolved residues from the SCA that are only 
important for maintaining basic fold of the enzyme will be down-weighted. 
As a result, the elements with high correlation values from the hybrid matrix 
belong to a subset of the co-evolved residues, which contains the ones that 
are important for the dynamics fluctuations within this enzyme.  
 
From analysis of the crystal structures of MtuDAH7PS in complex with 
different ligands (Chapter 4), it can be observed that there is no major 
conformational change upon ligand binding. Therefore, the synergistic 
allosteric inhibition of MtuDAH7PS by binding of ligands (Trp and Phe) was 
predicted to be contributed mainly by altering the dynamics within the 
structure upon ligand binding. Dynamic pathways between the allosteric 
ligand binding sites and the active sites must exist for the ligand binding 
signal to be transmitted to achieve inhibition. Therefore, residues with high 
correlation values in the hybrid matrix (SCA·MD) were identified in order to 
find the dynamic pathways. 
 
SCA·MD analysis for ligand-free MtuDAH7PS. The MD correlation 
matrix contains both positive and negative values, indicating correlation and 
anti-correlation in motion respectively. In this hybrid analysis however, the 
phase of the correlation is not important, since what is of interest is the 
magnitude of the correlation values between pairs of residues. 
Anti-correlation can also be considered as a special case of correlation, i.e. 
pairs of residues with large anti-correlation values are the same as pairs of 
residues with large correlation values but in the opposite direction. The SCA 
matrix does not contain phase information either. Therefore, the absolute 
values of the elements in the MD matrix were obtained and this absolute MD 
matrix with all positive values was used to compute the hybrid matrix. The 
MD matrix has dimension 1848 by 1848, because each monomer on the 
structure was observed to behave differently during the dynamics simulations, 
and in order to discover the dynamic pathway within the tetramer complex, 
all of the four monomers must therefore be considered. The SCA matrix 
however only has dimension 462 by 462, since it is solely based on the 
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amino acid sequence of the enzyme, and this enzyme is a homo-tetramer, i.e. 
all of the four monomers share the same amino acid sequence. To make the 
MD matrix and the SCA matrix consistent in dimension, a “tetrameric” form 
of the SCA matrix (1848 by 1848) was generated. The tetrameric SCA 
matrix was then normalised so that it has a maximum value of 1, to make 
sure that the SCA matrix is not over-emphasised in the final hybrid matrix. 
 
The SCA·MD hybrid correlation matrix for ligand-free MtuDAH7PS was 
plotted using a colour scale (Figure 6. 20), where blue indicated low 
correlations and red indicated high correlations between pairs of residues on 
the tetramer, and the x and y axes represented the positions on the tetramer 
structure of MtuDAH7PS. Most of the pairs of residues show low 
correlations (blue) to each other. However, a few non-adjacent pairs of 
positions (off-diagonal) with medium or high correlations can still be 
observed.  
 
 
Figure	   6.	   20.	   SCA·MD	   matrix	   for	   ligand-­‐free	  MtuDAH7PS	   tetramer	   plotted	   using	   a	  colour	  scale.	  Blue	  indicates	  low	  correlation	  and	  red	  indicates	  high	  correlation.	  
 
As with the SCA method, a clustering analysis was carried out to analyse the 
hybrid matrix, in order to reveal more clearly the coupled amino acids 
(details of clustering iterations are not shown). The final iteration of 
clustering analysis identified two clusters of positions with high correlation 
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values (Figure 6. 21). A total of 169 positions were identified. The two 
clusters contained the following positions: 
 
 
Figure	  6.	  21.	  Sorted	  SCA·MD	  matrix	  after	  the	  final	  iteration	  of	  clustering	  analysis.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  plotted	  using	  a	  colour	  scale,	  with	  blue	  indicating	   low	   correlations	   and	   red	   indicating	   high	   correlations.	   The	   x	   and	   y	   axes	  represent	  positions	  on	  the	  MtuDAH7PS	  tetramer,	  but	   the	  order	  of	   these	  positions	  are	  sorted	  according	  to	  the	  clustering.	  The	  clustering	  tree	  was	  displayed	  on	  the	  top	  and	  left	  of	  the	  correlation	  matrix.	  The	  final	  clusters	  identified	  for	  MtuDAH7PS	  were	  highlighted	  in	  black	  boxes.	  
 
Cluster 1: 
90B+90C+90D+90A+446A+446B+101A+101D+65C+175A+101C+94D+1
75D+100A+278C+278D+412A+412D+412B+65A+175B+94B+262A+262
C+262D+262B+412C+271C+271D+294A+294C+294D+245B+245C+245D
+297A+297C+297D+297B+40B+40C+40D+131A+131D+131B+131C+103
A+103D+103C+298A+298C+298D+298B+25A+25C+25D+25B 
 
 
Cluster 2: 
157C+185D+185A+57A+57C+358D+112B+57D+108B+162C+453A+453B
+120B+414C+363A+84B+84C+84D+62C+61A+61C+60A+60C+186B+186
D+123B+190A+190C+190D+454A+454B+200A+200D+200B+200C+218
A+114D+185B+110B+198D+197B+198A+204B+204D+197A+182C+60D
+61D+57B+454D+192B+192D+99B+99D+157A+451A+451B+144A+162
A+147A+182D+182B+232A+232B+114B+218D+435A+197C+197D+123
A+123C+198C+108C+189A+189B+189D+204C+112A+112C+181A+190B
+414A+453C+120A+120C+227A+227B+454C+228A+228D+228B+228C+
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451C+147C+147D+145A+145B+145D+144B+162B+358B+358C+402C+3
63C+363D+145C+144D+108A+108D+162D+157B+157D 
 
The residues in each cluster were from different chains, to help clarify the 
residues from each chain that were identified, the residues were sorted 
according to the chains in each cluster. The SCA·MD analysis of the 
ligand-free MtuDAH7PS identified the following two clusters of residues 
with high correlation values: 
 
Cluster 1: 
Chain A à  
90+25+262+297+131+298+412+175+446+65+101+100+294+103 
Chain B à  
90+25+262+297+131+298+412+175+446+94+245+40 
Chain C à  
90+25+262+297+131+298+412+65+101+294+103+245+40+278+271 
Chain D à  
90+25+262+297+131+298+412+175+101+294+103+94+245+40+278+271 
 
Cluster 2: 
Chain A à 
57+190+200+157+454+197+162+228+145+108+185+453+363+61+60+218
+198+451+144+147+ 
232+435+123+189+112+181+414+120+227 
Chain B à  
57+190+200+157+454+197+162+228+145+108+185+453+144+232+123+1
89+112+120+227+84+186+110+204+192+99+451+182+114+358 
Chain C à  
57+190+200+157+454+197+162+228+145+108+453+363+61+60+198+451
+147+123+112+414+ 
120+84+204+182+358+62+402 
Chain Dà  
57+190+200+157+454+197+162+228+145+108+185+363+61+60+218+198
+144+147+189+84+186+192+99+182+114+358+204 
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Figure	  6.	  22.	  Cluster	  1	  from	  SCA·MD	  analysis	  of	  ligand-­‐free	  MtuDAH7PS.	  The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  metal	  ions	  Mn2+	  are	  shown	  as	  magenta	  spheres	   to	   indicate	   positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   1	   of	  ligand-­‐free	  MtuDAH7PS	  are	  displayed	  as	  yellow	  spheres	  on	  tetramer	  (A),	  chains	  A	  and	  B	  (B),	  and	  chains	  C	  and	  D	  (C)	  of	  MtuDAH7PS.	  
 
These two clusters of highly correlated residues were mapped onto the 
crystal structure of ligand-free MtuDAH7PS, to examine the locations of 
these residues on the tertiary (and quaternary) structure of the enzyme, and to 
investigate the possible physical meaning of these clusters. 
 
The first cluster contains 57 residues on the tetramer of ligand-free 
MtuDAH7PS (Figure 6. 22). Most of these correlated residues were found 
between helices within the two dimers, and no connectivity was found across 
the tetramer interface. This cluster of residues may be responsible for 
controlling the relative motion of structural elements within the same 
monomer through van der Waals interactions. 
 
The second cluster contains 112 correlated residues on the ligand-free 
tetramer of MtuDAH7PS (Figure 6. 23). Most of these residues are found 
across the tetramer interface (e.g. residues 227, 228 and 120), within the Trp 
binding sites (e.g. residues 123 and 197), across the dimer interface (e.g. 
residues 181 and 184), and some are found on the active site loops (e.g. 
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residues 147, 145, 157 and 162). These correlated residues form a clear 
physical connectivity through van der Waals interactions between the 
tetramer interface (Trp binding sites), the dimer interface (Phe binding sites) 
and the active sites. This suggests that the second cluster of correlated 
residues may be responsible for the communication between allosteric ligand 
binding sites and the active sites. 
 
 
Figure	  6.	  23.	  Cluster	  2	  from	  SCA·MD	  analysis	  of	  ligand-­‐free	  MtuDAH7PS.	  The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  metal	  ions	  Mn2+	  are	  shown	  as	  magenta	  spheres	   to	   indicate	   positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   2	   of	  ligand-­‐free	  MtuDAH7PS	  are	  displayed	  as	  blue	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS.	  
 
A few residues in cluster 2 are located on helices α2a and α2b which are the 
two additional helices to the core barrel structure. Superposition of the 
ligand-free and the Trp+Phe bound crystal structures of MtuDAH7PS also 
show that there is slight shift in position for these two helices upon ligand 
binding (discussed in Chapter 4). This suggests that the motion of helices α2a 
and α2b might play a role in the communication mechanism. Residue 190 
(Gly), located at the beginning of helix α2a, was identified in the second 
cluster in all of the four chains on the tetramer, indicating the movement of 
this residue is very important for the communication mechanism. However, 
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Gly190 does not have a side chain functionality that could mediate the signal 
transmission through side chain conformational fluctuation, so the 
importance of this residue may be due to its unusual flexibility compared to 
all other types of amino acids. Interestingly the end of helix α2b is also a Gly 
residue (Gly232), which was identified in this cluster of correlated residues 
in chains A and B. With the presence of these two Gly residues, helices α2a 
and α2b are capable of greater amount of movement compared to other 
secondary structure elements within the tetramer, and the motion of these 
two helices may be important for communication between the ligand binding 
sites and the active site. Therefore, these two residues could be interesting 
“second-shell” targets for mutagenesis experiments to study the 
communication mechanism. For example, mutating both G190 and G232 to 
Proline would reduce the flexibility at these positions, and the importance of 
the movement of helices α2a and α2b could then be tested. 
 
In summary, SCA·MD analysis was conducted for ligand-free MtuDAH7PS 
tetramer, and two clusters of correlated residues were identified. The first 
cluster may be responsible for maintaining relative movement between 
helices within the same monomer; the second cluster may be responsible for 
communication across the dimer and tetramer interfaces, between allosteric 
ligand binding sites and the active sites. The fact that these communication 
pathways still exist even in the absence of allosteric ligand molecules, 
suggests that the enzyme is always “listening” for signals from the allosteric 
ligand binding sites, so the ligand binding event can be “sensed” immediately. 
This is really an intimate connection between allosteric response and 
catalytic function. 
 
SCA·MD analysis for Trp+Phe bound MtuDAH7PS. As with the 
ligand-free system, the SCA·MD procedure and clustering iterations were 
conducted for Trp+Phe bound MtuDAH7PS tetramer (details of clustering 
iterations are not shown). The correlation matrix from final iteration of 
clustering analysis was plotted on a colour scale (Figure 6. 24). 
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Figure	  6.	   24.	  Sorted	  SCA·MD	  matrix	  after	  the	   final	   iteration	  of	  clustering	  analysis	   for	  Trp+Phe	   bound	   MtuDAH7PS	   tetramer.	   The	   correlation	   values	   between	   pairs	   of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  clustering	  tree	  was	  displayed	  on	  the	  top	  and	  left	  of	  the	  correlation	   matrix.	   The	   final	   clusters	   identified	   for	  MtuDAH7PS	   were	   highlighted	   in	  black	  boxes.	  
 
The SCA·MD analysis for Trp+Phe bound tetramer of MtuDAH7PS 
identified two final clusters of correlated residues including the following 
positions: 
 
Cluster 1: 
Chain Aà 
45+361+294+298+297+25+90+271+146+245+131+28 
Chain Bà 
45+361+294+298+297+25+146+245+175+28+40 
Chain Cà 
45+361+294+298+297+25+386+271+446+40 
Chain Dà 
45+361+294+298+297+25+386+90+271+164+245+94+28+40 
 
Cluster 2: 
Chain Aà 
278+61+200+108+454+84+453+192+398+189+218+262+412+57+123+60+
186+190+228+143+451+147+145+162+230+435+62+182+197+114+99+58
+432+422+184+120+363+185+358+232+65+101+94+175+100+144+157+2
04+227 
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Chain Bà 
278+61+200+108+454+84+453+192+398+189+218+262+412+57+123+60+
186+190+228+378+143+144+162+182+435+114+99+432+414+181+173+1
12+145+147+62+198+120+101+94+100+185+157+204 
Chain Cà 
278+61+200+108+454+84+453+192+398+189+218+262+412+57+123+60+
186+190+228+378+451+230+184+120+112+363+162+185+157+358+402+
182+232+114+227+179+101+65+100+204+181 
Chain Dà 
278+61+200+108+454+84+453+192+398+189+218+262+412+57+123+60+
186+190+228+198+197+378+147+230+435+58+402+358+422+414+184+1
73+363+451+62+232+181+227+179+175+65 
 
 
Figure	   6.	   25.	   Cluster	   1	   from	   SCA·MD	   analysis	   of	   Trp+Phe	   bound	  MtuDAH7PS.	   The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  bound	  ligands	  are	  shown	  as	  green	   spheres	   and	   the	   metal	   ions	   Mn2+	   are	   shown	   as	   magenta	   spheres	   to	   indicate	  positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   1	   of	   Trp+Phe	   bound	  
MtuDAH7PS	  are	  displayed	  as	  yellow	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS.	  
 
These two clusters of highly correlated residues were then mapped onto the 
crystal structure of Trp+Phe bound MtuDAH7PS, to examine the locations of 
 
	   A 
B 
C 
156 
 
these residues on the tertiary structure of the enzyme, and to investigate the 
possible physical meaning of these clusters. 
 
 
Figure	   6.	   26.	   Cluster	   2	   from	   SCA·MD	   analysis	   of	   Trp+Phe	   bound	  MtuDAH7PS.	   The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  bound	  ligands	  are	  shown	  as	  green	   spheres,	   and	   the	   metal	   ions	   Mn2+	   are	   shown	   as	   magenta	   spheres	   to	   indicate	  positions	  of	  the	  active	  sites.	  The	  residues	  found	  in	  cluster	  2	  of	  Trp+Phe	  MtuDAH7PS	  are	  displayed	  as	  blue	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS.	  
 
Cluster 1 of correlated residues in Trp+Phe bound MtuDAH7PS tetramer 
contains 47 residues (Figure 6. 25). Similar to cluster 1 in the ligand-free 
system, the residues in this cluster are mostly found between helices within 
the same monomer. No connectivity was found across the tetramer interface. 
This cluster contains residues at similar positions as those found in cluster 1 
of ligand-free system, e.g. residues 25, 298 and 197. This cluster of residues 
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may be important for maintaining relative movement between helices within 
the same monomer, and is unlikely to contribute to the mechanism of 
allosteric communication.  
 
Cluster 2 of correlated residues in Trp+Phe bound MtuDAH7PS tetramer 
contained 174 residues (Figure 6. 26). This cluster is similar to the cluster 2 
that was found for the ligand-free system, but it is more extended since it 
contains larger number of residues, and the communication pathway between 
allosteric binding sites and active sites becomes “smoother” since the 
residues involved can be well-connected in space through van der Waals 
interactions. The residues found in this cluster are located mostly around the 
tetramer interface (e.g. residues 228 and 227), Trp binding sites (e.g. residues 
123, 114 and 192), and also the dimer interface (e.g. residues 184, 181 62 
and 189), close to Phe binding sites (e.g. residues 94, 175 and 173). Some 
residues are found on the active site loops (e.g. residues 147, 145 and 143). 
This suggests that the second cluster of residues is likely to contribute to 
communication mechanism between the allosteric ligand sites and the active 
sites when both Trp and Phe are bound. 
 
SCA·MD analysis for Trp-only bound MtuDAH7PS. The same SCA·MD 
analysis was conducted for the Trp-only bound system (details of clustering 
iterations are not shown). The correlation matrix from final iteration of 
clustering analysis was plotted using a colour scale (Figure 6. 27). 
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Figure	  6.	   27.	  Sorted	  SCA·MD	  matrix	  after	  the	   final	   iteration	  of	  clustering	  analysis	   for	  Trp-­‐only	   bound	   MtuDAH7PS	   tetramer.	   The	   correlation	   values	   between	   pairs	   of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  clustering	  tree	  was	  displayed	  on	  the	  top	  and	  left	  of	  the	  correlation	   matrix.	   The	   final	   clusters	   identified	   for	  MtuDAH7PS	   were	   highlighted	   in	  black	  boxes.	  
 
The SCA·MD analysis for Trp-only bound tetramer of MtuDAH7PS 
identified two final clusters of correlated residues including the following 
positions: 
 
Cluster 1: 
Chain Aà 
245+40+25+28+202+103+105+102+101+175+94+412 
Chain Bà 
245+40+25+294+298+297+271+446+90+175+65+94+101+262 
Chain Cà 
245+40+25+146+103+101+412 
Chain Dà 
245+40+25+294+28+271+65+262 
 
Cluster 2: 
Chain Aà 
228+186+198+454+200+120+190+185+112+451+435+230+108+192+227+
197+232+123+114+189+173+204+60+61+145+162+147+57+157+144+62+
182+181+84+262+278+90+65+378+398+231+201+143+363+402+221+100 
Chain Bà 
228+186+198+454+200+120+190+185+112+451+435+230+108+192+227+
197+232+123+114+189+173+204+60+61+145+162+147+57+157+144+62+
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182+181+84+378+358+363+100+218+453+412 
Chain Cà 
228+186+198+454+200+120+190+185+112+451+435+230+108+192+227+
197+232+123+114+189+173+204+60+61+145+162+147+57+157+144+62+
182+181+84+143+378+218+453+363+414+221+231+110+358+278+65+94
+262+175 
Chain Dà 
228+186+198+454+200+120+190+185+112+451+435+230+108+192+227+
197+232+123+114+189+173+204+60+61+145+162+147+57+157+144+62+
182+181+84+231+110+100+218+453+358+101+90+412+175+94 
 
Same as before, mapping these two clusters of residues onto crystal structure 
of Trp-only bound MtuDAH7PS tetramer (Figure 6. 28) show that the first 
cluster identified in the Trp-only system contains similar members to that 
found in the ligand-free system, and also in the Trp+Phe bound system, e.g. 
residue 25, 298 and 297. This first cluster contains 41 residues and most of 
these are located between helical structures within the same monomer, but 
not across tetramer of dimer interfaces. Therefore, as was suggested in the 
previously analysed ligand-free and Trp+Phe bound systems, this cluster of 
residues in the Trp-only system may be important for maintaining relative 
movement between helices within the same monomer, and is unlikely to 
contribute to the mechanism of allosteric communication. 
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Figure	   6.	   28.	   Cluster	   1	   from	   SCA·MD	   analysis	   of	   Trp-­‐only	   bound	  MtuDAH7PS.	   The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  bound	  ligands	  are	  shown	  as	  green	   spheres	   and	   the	   metal	   ions	   Mn2+	   are	   shown	   as	   magenta	   spheres	   to	   indicate	  positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   1	   of	   Trp-­‐only	   bound	  
MtuDAH7PS	  are	  displayed	  as	  yellow	  spheres	  on	  (A)	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS.	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Figure	   6.	   29.	   Cluster	   2	   from	   SCA·MD	   analysis	   of	   Trp-­‐only	   bound	  MtuDAH7PS.	   The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  bound	  ligands	  are	  shown	  as	  green	   spheres	   and	   the	   metal	   ions	   Mn2+	   are	   shown	   as	   magenta	   spheres	   to	   indicate	  positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   2	   of	   Trp-­‐only	   bound	  
MtuDAH7PS	  are	  displayed	  as	  yellow	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS.	  
 
Cluster 2 of correlated residues in Trp-only bound MtuDAH7PS tetramer 
contains 182 residues (Figure 6. 29). This cluster is similar to the cluster 2 
that is found Trp+Phe bound system. The residues found in this cluster are 
located mostly around the tetramer interface (e.g. residues 228 and 227), Trp 
binding sites (e.g. residues 123, 114 and 192), and also the dimer interface 
(e.g. residues 182, 181, 62 and 189), close to Phe binding sites (e.g. residues 
94, 175 and 173). Some residues are found in the active site loops (e.g. 
residues 147, 145 and 143). This suggests, as in the unliganded structure, that 
communication pathways between the allosteric sites and the active sites are 
still present even with only Trp binding. 
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SCA·MD analysis for Phe-only bound MtuDAH7PS. The same SCA·MD 
analysis was conducted for the Phe-only bound system (details of clustering 
iterations are not shown here). The correlation matrix from final iteration of 
clustering analysis was plotted using a colour scale (Figure 6. 30). 
 
 
Figure	  6.	   30.	  Sorted	  SCA·MD	  matrix	  after	  the	   final	   iteration	  of	  clustering	  analysis	   for	  Phe-­‐only	   bound	   MtuDAH7PS	   tetramer.	   The	   correlation	   values	   between	   pairs	   of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  clustering	  tree	  was	  displayed	  on	  the	  top	  and	  left	  of	  the	  correlation	   matrix.	   The	   final	   clusters	   identified	   for	  MtuDAH7PS	   were	   highlighted	   in	  black	  boxes.	  
 
The SCA·MD analysis for Phe-only bound tetramer of MtuDAH7PS 
identified two final clusters of correlated residues including the following 
positions: 
 
Cluster 1: 
Chain Aà 
25+298+271+100+90+101+175+262+412+131+327+324+297+103+350+38
6+65 
Chain Bà 
25+298+271+412+131+40+202+386+294+103+297+245+446+101 
Chain Cà 
25+298+271+278+94+28+103+40+105+45+245+90+65 
Chain Dà 
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25+298+271+175+412+131+327+324+28+297+40+245+202+105+350+45+
294 
 
 
Cluster 2: 
Chain Aà 
454+84+453+185+57+162+108+204+112+358+144+145+123+189+200+18
2+230+157+190+227+451+60+186+62+218+114+198+147+120+435+232+
61+228+363+181+110+94+378+278+231+192 
Chain Bà 
454+84+453+185+57+162+108+204+112+358+144+145+123+189+200+18
2+230+157+190+227+451+60+186+62+218+114+198+147+120+435+232+
61+228+231+143+378+398+262+402+278+175+100+338+177+99 
Chain Cà 
454+84+453+185+57+162+108+204+112+358+144+145+123+189+200+18
2+230+157+190+227+451+60+186+62+218+114+198+147+120+435+232+
61+228+181+363+175+197+100+262+412+231+58+192 
Chain Dà 
454+84+453+185+57+162+108+204+112+358+144+145+123+189+200+18
2+230+157+190+227+451+60+186+62+218+114+198+147+120+435+232+
61+228+363+391+100+278+414+378+398+181+262+94+143+402+99 
 
 
Figure	   6.	   31.	   Cluster	   1	   from	   SCA·MD	   analysis	   of	   Phe-­‐only	   bound	  MtuDAH7PS.	   The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  bound	  ligands	  are	  shown	  as	  green	   spheres	   and	   the	   metal	   ions	   Mn2+	   are	   shown	   as	   magenta	   spheres	   to	   indicate	  positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   1	   of	   Phe-­‐only	   bound	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MtuDAH7PS	  are	  displayed	  as	  yellow	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS.	  
 
Mapping these clusters of residues onto crystal structure of Phe-only bound 
MtuDAH7PS tetramer (Figure 6. 31) shows that cluster 1 contains similar 
members to that found for the ligand-free, the Trp+Phe and the Trp-only 
bound systems, e.g. residue 25 and 298. This cluster contains 61 residues and 
most of these are located between helical structures within the same 
monomer, but not across tetramer of dimer interfaces. Therefore, as in the 
previously analysed ligand-free, Trp+Phe and Trp-only bound systems, this 
first cluster of residues in the Phe-only system may be important for 
maintaining relative movement between helices within the same monomer, 
and is unlikely to contribute to the mechanism of allosteric communication. 
 
 
Figure	   6.	   32.	   Cluster	   2	   from	   MD·SCA	   analysis	   of	   Phe-­‐only	   bound	  MtuDAH7PS.	   The	  enzyme	  is	  displayed	  in	  white	  cartoon	  representation;	  the	  bound	  ligands	  are	  shown	  as	  green	   spheres	   and	   the	   metal	   ions	   Mn2+	   are	   shown	   as	   magenta	   spheres	   to	   indicate	  positions	   of	   the	   active	   sites.	   The	   residues	   found	   in	   cluster	   2	   of	   Phe-­‐only	   bound	  
MtuDAH7PS	  are	  displayed	  as	  blue	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  of	  MtuDAH7PS	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Cluster 2 of correlated residues in Phe-only bound MtuDAH7PS tetramer 
contains 175 residues (Figure 6. 32). This cluster is similar to the cluster 2 
found in Trp+Phe and Trp-only bound systems. The residues found in this 
cluster are located mostly around the tetramer interface (e.g. residues 228 and 
227), Trp binding sites (e.g. residues 123 and 114), and also the dimer 
interface (e.g. residues 182, 181, 62 and 189), close to Phe binding sites (e.g. 
residues 94 and 175). Some residues are found in the active site loops (e.g. 
residues 147 and 145). This suggests that communication pathways between 
the allosteric sites and the active sites are still present even with only Phe 
binding. 
 
Mutual residues in cluster 2 of different systems. Since the second cluster 
identified in both the ligand-free and ligand-bound systems may be important 
for communication between the allosteric sites and the active site, analysis of 
the mutual residues in cluster 2 of different systems would give us some idea 
of the most critical members of this communication pathway and provide a 
list of potential mutagenesis targets ( 
Table 6. 2).  
 
It is interesting that residue Gly190 (discussed in ligand-free system) is 
identified in Cluster 2 of all four systems, indicating the movement of the 
two additional helices α2a and α2b is definitely important for communication 
mechanism. The other Gly residue at the end of helix α2b, Gly232, appears 
in this cluster for both single ligand-bound systems. Therefore, mutating 
these two Gly residues to Pro may restrict the potential movement of helices 
α2a and α2b at the tetramer interface, and in turn may terminate the 
communications between different sites on the MtuDAH7PS tetramer.  
 
Residue Met228 is another interesting target. This residue forms part of the 
tetramer interface and interacts with the Met228 from the other monomer. 
Mutating this residue to Ala may eliminate communications across the 
tetramer interface, but may also disrupt the formation of the tetrameric 
complex. Gln108 and Phe454 are both located on the main barrel structure 
with their side chains pointing towards the two additional helices α2a and 
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α2b, while Trp200 is located on helix α2a facing the main barrel. Mutating 
these three residues to Ala may stop the signal transmission from α2a and 
α2b to the main barrel and thus to the active sites. 
	  
Table	  6.	  2.	  Mutual	  residues	  in	  cluster	  2	  of	  different	  systems.	  
Mutual to all 
systems 
Mutual to the 
three 
ligand-bound 
systems 
Mutual to only 
single ligand 
systems 
Mutual to only 
single ligand 
and ligand-free 
systems 
Met228 
Phe454 
Trp200 
Gly190 
Gln108 
Pro57 
Leu186 
Lys123 
Ser189 
Val60 
Pro61 
Gly84 
His198 
Pro120 
Ala185 
Val112 
Glu451 
Arg435 
Ala230 
Phe227 
Gly232 
Thr114 
Phe204 
Tyr147 
Leu144 
Ser62 
Leu182 
Arg145 
Arg162 
Pro157 
	  
The residues mutual to all three ligand-bound systems are mostly located on 
the dimer interfaces (e.g. residues 186, 189, 60 and 61), suggesting they may 
be the critical residues responsible for communication across the dimer, or 
from Trp binding sites to Phe binding sites, upon ligand binding. However, 
mutating these residues needs to proceed with caution, as they may disrupt 
the dimer interface, and may result in total loss of function. 
 
Those residues mutual to only single ligand systems are located in the Trp 
binding sites (e.g. residues 114 and 230), in the tetramer interface (e.g 
residues 227, 120), between the main barrel and the additional helices α2a 
and α2b (e.g. residues 451, 112 and 204), on the dimer interface (e.g. 
residues 182, 185 and 62). Mutation experiments can also be designed 
around these targets. 
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6.4.3 Summary 
 
SCA·MD analysis was conducted for ligand-free and the three ligand-bound 
MtuDAH7PS tetramer systems (Trp+Phe, Trp-only and Phe-only bound). In 
each of the four systems, two clusters of highly correlated residues were 
identified. The two clusters show similarity across the four different systems. 
The smaller cluster (cluster 1 in each system) generally contains residues 
between helices within the same monomer, and has no connectivity across 
the tetramer interfaces or dimer interfaces. Therefore it is unlikely for this 
cluster to contribute to the communication mechanisms between different 
allosteric sites and the active sites. Although members of this cluster may 
change in each system, their general locations remained the same.  
 
The larger cluster (cluster 2 in each system) generally contains residues at the 
tetramer interfaces, Trp binding sites, dimer interfaces, Phe binding sites and 
the active sites. Therefore it is considered to be the dynamic pathway 
responsible for communications between allosteric sites and the active sites 
within the tetramer structure of MtuDAH7PS. The fact that this pathway is 
still present in the ligand-free system suggests that it is always “functional”. 
Even in the absence of ligand molecules, this pathway can be responsible for 
communication and cooperatively between different monomers, and at the 
same time it is listening for signals of ligand binding at those allosteric sites. 
The pathway formed by this cluster of residues is more extended and better 
connected through van der Waals interactions in space in the ligand-bound 
systems compared to the ligand-free system. Binding of single ligand is 
enough to trigger this extension of pathway, suggesting that the pathway is 
responsible for the synergy between the binding events of different ligands.  
 
Several interesting residues were identified as mutagenesis targets to stop the 
communication between different allosteric sites and between allosteric sites 
and the active sites. Among these the most attractive targets are Gly190 and 
Gly232. 
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6.5 SCA·MD analysis for G190P/G232P mutant 
 
The two Gly residues (190 and 232) are located at the beginning and the end 
of helices α2a and α2b. These two residues, especially Gly190, were 
identified in cluster 2 of important residues from SCA·MD analysis, and 
were proposed to be important for signal transmission between the 
monomers in the tetramer structure of MtuDAH7PS and communication 
between Trp/Phe binding sites and the active site. In silico mutations were 
done for this particular double mutant and 20 ns MD simulation was 
conducted on this double mutant to examine whether there is any change in 
molecular motion caused by the mutation and whether the communication of 
Trp binding sites with the Phe binding sites and the active sites is affected. 
 
6.5.1 In silico mutations and set up of MD simulation (20 ns) 
 
To prepare the starting structure of the G190P/G232P double mutant, the last 
frame of the 20 ns MD simulation for ligand-free wild type MtuDAH7PS 
was taken, including water molecules in the water box and also the ions that 
were added to balance the net charge of the system. The in silico mutations 
were then conducted using the “mutate residue” function in VMD (118), to 
change Gly190 and Gly232 in all of the four monomers to Pro residues. The 
structure is then ready for MD simulation because water molecules have 
already been added and the net charge of the system is already balanced 
when preparing the system for the ligand-free wild type simulation. All other 
simulation setups are the same as in the wild type systems. The molecular 
dynamics for the double G190P/G232P mutant was conducted for 20 ns at 2 
fs time steps using NAMD (36). 
 
Protein backbone RMSD values over 20 ns simulation period compared 
to ligand-free wild type MtuDAH7PS. The backbone RMSD values for 
G190P/G232P mutant over the 20 ns of MD simulation were plotted along 
the time scale together with the RMSD values from the ligand-free wild type 
MtuDAH7PS (Figure 6. 33). The plot shows that similar to the wild type 
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ligand-free system, the simulation of the double G190P/G232P mutant 
started to equilibrate after ~2.3 ns. The average structure of G190P/G232P 
mutant during the equilibrated time period (2.3 ns to 20 ns) was compared to 
the average structure from the ligand-free wild type simulation, and these 
two average structures match with each other with RMSD value of 1.540 Å 
(matching 1728 Cα atoms). This suggests that the double mutation of Gly to 
Pro did not cause any major change in the overall conformation of 
MtuDAH7PS tetramer. 
 
 
Figure	   6.	   33.	   Average	   backbone	   RMSD	   values	   of	   wild	   type	   ligand-­‐free	   and	  G190P/G232P	  double	  mutant	  of	  MtuDAH7PS	  during	  20	  ns	  MD	  simulations.	  The	  RMSD	  values	  were	  calculated	  using	  the	  first	  frame	  of	  the	  trajectory	  as	  the	  reference	  structure.	  
 
Chain-averaged residue RMSF values over 20 ns of MD simulation 
compared to ligand-free wild type MtuDAH7PS. Although the double 
mutations did not greatly affect the average conformation of the 
MtuDAH7PS tetramer, it did result in changes in the flexibility of specific 
regions of the structure.  The average RMSF values of individual amino 
acids of MtuDAH7PS were calculated, in order to examine the changes in 
dynamic properties caused by the double G190P/G232P mutation. For this 
analysis, trajectory frames collected from the equilibrated simulation period 
were used (after 2.3 ns), and all non-hydrogen atoms of each amino acid 
(backbone and side-chain atoms) were included in the calculation. The chain 
averaged residue RMSF values from the G190P/G232P mutant system is 
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plotted together with that from the ligand-free wild type system (Figure 6. 
34). In both systems, the residues on the loop regions gave greater RMSF 
values (more flexible) and the residues on secondary structures such as 
helices and sheets showed relatively smaller RMSF values (less flexible).  
 
 
Figure	   6.	   34.	   Chain-­‐averaged	   RMSF	   values	   residue-­‐by-­‐residue	   for	   the	   double	  G190P/G232P	  mutant	  and	  ligand-­‐free	  wild	  type	  of	  MtuDAH7PS	  complexes.	  
 
Comparison of the RMSF values between the mutant and the wild type 
systems shows that the double mutation of G190P/G232P causes increase in 
flexibility around helix α2 (Figure 6. 35), which makes up the tight dimer 
interface (Figure 6. 36). Most residues in the Phe binding sites become more 
flexible (Figure 6. 35), as a result the binding of Phe molecules to this mutant 
might be disfavoured due to increased entropy cost upon binding. The 
flexibility of the loop β2α2 in the active site is also increased (Figure 6. 35, 
Figure 6. 36), and this suggests that the double mutation might inhibit the 
binding of substrates due to unfavourable entropy, similar to that found in the 
Trp+Phe bound system. However, the flexibility of residues on the helices 
α2a and α2b does not decrease as intended with the G190P/G232P mutations. 
Most of the residues on helix α2a show increase in flexibility with the double 
G/P mutation, and only the residues on the α2b helix show slight decrease in 
flexibility. Several residues in the Trp binding sites become less flexible with 
the double mutation, including residues 107, 100, 111, 114, 121 and 123. 
This suggests that the mutation may favour Trp binding, due to less entropy 
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cost upon binding. Another possible effect of the mutations is that they might 
partially mimic the Trp binding signal at the Trp binding sites, because Trp 
binding at the wild type ligand-free MtuDAH7PS will cause the residues 
surrounding it to be less flexible, which is partially observed in the double 
mutant system.  
 
 
Figure	   6.	   35.	   Changes	   in	   residue	   flexibility	   caused	   by	   G190P/G232P	   mutations.	  Positive	   values	   indicate	   increases	   in	   flexibility	   compared	   to	   the	   ligand-­‐free	  wild	   type	  system,	  and	  negative	  values	   indicate	  decreases	   in	   flexibility.	  The	  residues	   involved	   in	  Trp	  and	  Phe	  binding	  sites	  are	  highlighted	  with	  different	  colours.	  
 
 
Figure	   6.	   36.	   Changes	   in	   residue	   flexibility	   (ΔRMSF)	   in	  MtuDAH7PS	   caused	   by	   the	  double	  mutation	  of	  G190P/G232P	  as	  revealed	  by	  molecular	  dynamics	  simulations.	  
 
The loops β7α7 and β8α8 also show large increase in flexibility with the 
double G/P mutations (Figure 6. 35). These loops are located along the side 
of the tetramer complex near the active site (Figure 6. 36). These residues 
may not directly contribute to substrate binding; however, they may play a 
role in the formation of the complex between MtuDAH7PS and chorismate 
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mutase (77). As seen in the crystal structure (Figure 6. 37), the loops β7α7 
and β8α8 are located close in space to the chorismate mutase when it is in 
complex with MtuDAH7PS. Increase of flexibility in these loops may 
diminish the enzyme’s affinity for chorismate mutase.  
 
 
Figure	   6.	   37.	  MtuDAH7PS	   in	   complex	  with	   chorismate	  mutase	   (coloured	   in	   yellow).	  The	   changes	   in	   residue	   flexibility	   caused	   by	   G190P/G232P	   double	   mutations	   are	  mapped	  on	  to	  the	  MtuDAH7PS	  tetramer,	  with	  red	  indicating	  increase	  in	  flexibility	  and	  blue	  indicating	  decrease	  in	  flexibility.	  
 
6.5.2 SCA·MD analysis for G190P/G232P double mutant of MtuDAH7PS 
 
In order to examine the correlation of movements between residues on the 
mutant tetramer and compare the residues involved in the communication 
network to the ligand-free wild type system, the SCA·MD analysis was 
conducted for the double G190P/G232P mutant system with the same 
clustering procedures as used for the wild type systems (details of clustering 
iterations are not shown). The correlation matrix from final iteration of 
clustering analysis was plotted using a colour scale (Figure 6. 38). 
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Figure	  6.	   38.	  Sorted	  SCA·MD	  matrix	  after	  the	   final	   iteration	  of	  clustering	  analysis	   for	  G190P/G232P	  double	  mutant	  of	  MtuDAH7PS.	  The	  correlation	  values	  between	  pairs	  of	  positions	  are	  shown	  using	  a	  colour	  scale,	  with	  blue	  indicating	  low	  correlations	  and	  red	  indicating	  high	  correlations.	  The	  clustering	  tree	  was	  displayed	  on	  the	  top	  and	  left	  of	  the	  correlation	   matrix.	   The	   final	   clusters	   identified	   for	  MtuDAH7PS	   were	   highlighted	   in	  black	  boxes.	  
 
Two clusters of highly correlated residues were identified in the double 
G190P/G232P mutant system, and the two clusters include the following 
residues: 
 
Cluster 1 
Chain Aà 
182+185+57+123+198+181+204+114+61+60+457+391+435+100+62+120+
278+110+363+453+451+232+84+454+227+186+228+200 
Chain Bà 
182+185+57+123+198+181+114+186+189+227+190+192+143+120+84+14
4+112+162 
Chain Cà 
182+185+57+123+198+181+189+200+186+457+452+231+230+190+192+1
97+451+100+112+358+120+108+204+454+227+228 
Chain Dà 
182+185+57+123+198+181+204+200+62+60+189+190+192+218+197+108
+232+61+143+228 
 
Cluster 2: 
Chain Aà 
	  
	  
	  
174 
 
94+412+262+147+157+145+190+144+162+108+197+173+189+230+112+3
58 
Chain Bà 
94+412+262+147+157+145+90+65+454+358+378+278+61+62+435+108+6
0+230+231+110+173+451+453+398+363+228+232+100+204 
Chain Cà 
94+412+262+147+157+145+65+446+90+278+378+61+60+363+143+232+1
62+144+84+435+218+110+173+453+114 
Chain Dà 
94+412+262+147+157+145+65+175+90+101+100+358+363+378+278+414
+453+451+435+162+230+231+120+227+144+186+112+84 
 
The first cluster contains 92 residues in the double G190P/G232P mutant of 
MtuDAH7PS. Most of these residues are found between the tetramer 
interface and the dimer interface (Figure 6. 39). They can be observed to 
form a communication pathway from the Trp binding sites at the tetramer 
interface (e.g. residues 123, 114, 227 and 228) to the dimer interface near 
Phe binding sites (e.g. residues 181, 182, 185 and 57). This communication 
pathway goes around the main barrel structure of each monomer instead of 
passing through the centre of the barrel (Figure 6. 39B and C). This cluster is 
similar to cluster 2 in other wild type systems (with or without ligand-bound), 
except that there are not as many residues found in the active site as in the 
other wild type systems. MD simulation suggests that the communications 
between the dimer and tetramer interfaces and between Trp and Phe binding 
sites are still present. The double mutation of G190P/G232P does not appear 
to eliminate the allosteric communication pathway as intended. 
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Figure	  6.	  39.	  Cluster	  1	  of	  correlated	  residues	  from	  SCA•MD	  analysis	  for	  G190P/G232P	  double	   mutant	   of	   MtuDAH7PS.	   The	   enzyme	   is	   shown	   with	   white	   cartoon	  representation,	   and	   the	  active	   site	  metal	   ions	  Mn2+	  are	   shown	  as	  magenta	   spheres	   to	  indicate	   locations	  of	   the	  active	  site.	  The	  correlated	  residues	   in	  cluster	  1	  are	  shown	  as	  blue	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D.	  
 
  
	  
A 
B 
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Figure	  6.	  40.	  Cluster	  2	  of	  correlated	  residues	  from	  SCA•MD	  analysis	  for	  G190P/G232P	  double	   mutant	   of	   MtuDAH7PS.	   The	   enzyme	   is	   shown	   with	   white	   cartoon	  representation,	   and	   the	  active	   site	  metal	   ions	  Mn2+	  are	   shown	  as	  magenta	   spheres	   to	  indicate	   locations	  of	   the	  active	  site.	  The	  correlated	  residues	   in	  cluster	  2	  are	  shown	  as	  blue	  spheres	  on	  (A)	  the	  tetramer,	  (B)	  chains	  A	  and	  B,	  and	  (C)	  chains	  C	  and	  D	  
 
Cluster 2 contains 98 highly correlated residues in the G190P/G232P double 
mutant system (Figure 6. 40). The residues in this cluster can be found in the 
tetramer interface and Trp binding sites (e.g. residues 230, 114, and 227), 
dimer interface and Phe binding sites (e.g. residues 173, 175, 94, 60 and 186), 
and the active sites, especially on loop β2α2 in the active site (e.g. residues 
145, 147 and 157). The residues in cluster 2 can be observed to form a 
communication pathway between the dimer interfaces (Phe binding sites) and 
the active site, and (to some extend) the Trp binding sites at the tetramer 
interfaces. 
 
In contrast to the wild type system, where only one cluster of residues 
(cluster 2) is found to be responsible for the allosteric communication 
between allosteric sites and the active sites, the G190P/G232P double mutant 
system shows both of the clusters of residues may be capable of transmitting 
signals between the binding sites. The differences in physical significance 
  
	  
A 
B 
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and function between the two clusters found in the mutant system cannot be 
discriminated easily as in the wild type systems. 
 
6.5.3 Proposals for the experimental verification of MD simulations 
 
Although MD shows that the double G190P/G232P mutations did not 
eliminate the pathway of allosteric communications between binding sites, 
the simulation still shows some interesting properties of this mutant system 
that can be tested using experimental techniques. 
 
1. Reaction kinetics experiments. One of the interesting aspects of this 
mutant system is the effect of mutation on the active site loops. Chain 
averaged RMSF analysis showed that the active loop β2α2 that is 
responsible for binding of the substrate E4P, becomes more flexible with 
this mutation, which is similarly observed in the Trp+Phe bound system. 
Therefore, this mutation may inhibit the catalytic function of 
MtuDAH7PS, by disfavouring the binding of E4P. Experiments can be 
done to measure the reaction kinetics and binding constants of E4P in 
order to confirm this. 
 
2. Inhibition studies upon ligand binding. If the experiment above (reaction 
kinetics) showed that the mutant is still catalytically active, then it would 
be interesting to test whether the binding of Trp and Phe, or single amino 
acids will inhibit the mutant. 
 
3. ITC experiments for single ligands. Another good experiment is to test 
the response of this mutant to the binding of Trp and Phe (and maybe 
Tyr). This is because MD simulation shows that the double mutation 
caused the residues at the dimer interface and Phe binding sites to 
become more flexible, and as a result may disfavour the binding of Phe. 
However, part of the Trp binding sites become less flexible, this may 
favour the binding of Trp molecules to the enzyme. Measurement of 
binding affinities for Trp and Phe can test this prediction.  
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4. ITC experiments for combinations of ligands. MD simulation shows that 
the allosteric communications still exist in the mutant system. This can be 
tested by measure binding affinities of Trp alone, and compare to that 
when Phe is present in the background. The same can be done for Phe 
molecules. If communications exist between the allosteric sites, then 
binding of one allosteric ligand may affect the binding affinity of the 
other. 
 
5. ITC experiments for MtuDAH7PS in complex with chorismate mutase. 
From the analysis of residue RMSF values, MD simulation suggests that 
the loops β7α7 and β8α8 become more flexible in the mutant system. 
This may disfavour the binding of chorismate mutase to MtuDAH7PS 
because the entropy cost upon forming the complex is increased (Figure 6. 
37). Measurements of binding affinities for chorismate mutase in the 
mutant system in comparison with the wild type system may verify this 
prediction. 
 
6.5.4 Summary 
 
MD simulation (20 ns) was set up for the double mutant G190P/G232P of 
MtuDAH7PS. The trajectory was analysed using residue RMSF in 
comparison with the ligand-free wild type system, and SCA·MD analysis to 
identify the communication networks in the mutant system. Results suggest 
that the mutant may cause changes in flexibility in the dimer interface, part 
of the Trp binding site, and also the active sites. Changes in flexibility of 
loops β7α7 and β8α8 are also predicted, which may affect the formation of 
complex with chorismate mutase. SCA·MD analysis reveals that the 
allosteric communication between ligand binding sites and the active sites 
may still be present in the mutant system, and the mutation is not predicted to 
work as initially proposed. Several different experiments are proposed that 
may help to verify predictions made from the MD simulations. 
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Chapter 7: Summary 
Protein molecules are dynamic in nature. The flexibilities within a protein 
molecule give rise to ensembles of slightly different protein conformations 
that constantly interconvert via dynamic motions. The importance of protein 
dynamics to function and regulation has been largely recognized recently 
(94-98, 100, 101). In this thesis, the dynamic behaviour of different enzyme 
systems was investigated by the application of different molecular modelling 
techniques.  
 
Part A of this thesis describes a computational study on the dynamic 
conformational preference of a small peptide CP1B (20-mer), which is a 
calpain specific inhibitor peptide. Both MCSD and MD simulations were 
employed, and results showed that in the absence of the enzyme calpain, 
despite the large flexibility and lack of secondary structures within the 
peptide, there is a region (residue 10 to 13) that prefers a folded loop like 
conformation similar to what is known to bind in the active site of calpain. 
By adopting this folded loop like conformation, the peptide is prearranged to 
the binding mode, thus decrease the entropy cost upon binding to the enzyme 
calpain. This conformational preference of the loop region is shown to be one 
of the significant contributing factors to the inhibition potency of the peptide 
CP1B. 
 
Part B of this thesis describes the computational study for a large enzyme 
system (DAH7PS) from M. tuberculosis. This tetrameric enzyme exhibits an 
unusual synergistic allostery by combinations of aromatic amino acids 
(Trp+Phe, or Trp+Tyr). The binding sites of different allosteric inhibitors 
(Trp, Phe and Tyr) were revealed by crystallography. Structures of the 
ligand-bound and ligand-free enzyme indicate that there is no change in gross 
conformation of the enzyme upon ligand binding, which suggests a change in 
protein dynamics as the mechanism of inhibition. MD simulations for both 
the ligand-free and the three ligand-bound systems were conducted in order 
to identify dynamic changes upon ligand binding. Simulation results showed 
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that binding of both Trp+Phe results in an increase in flexibility of the E4P 
binding loop in the active site. The increase in flexibility will increase the 
unfavourable entropy cost for E4P binding, thus achieves inhibition. MD 
simulation results also revealed that when MtuDAH7PS is bound with only 
Trp or only Phe molecules, the dynamics of the binding sites of the other 
ligand is altered, and the entropy for subsequent ligand binding event is 
therefore decreased. The residues involved in the communication pathway 
between the ligand binding sites and the active sites were identified, by 
combining the MD results with that from the SCA method. Based on these 
results several targets were proposed for future mutagenesis studies.  
 
The work in this thesis illustrated how a range of molecular modelling 
techniques can be combined with experimental findings to investigate the 
molecular basis of enzymic actions. Different modelling methods can be used 
depending on the questions under investigation. For the small peptide CP1B, 
due to its flexibility, it is important to have more efficient sampling of the 
conformational space in order to fully investigate the dynamic 
conformational preference of this peptide. Therefore, the faster stochastic 
dynamics simulation with enhanced sampling method (Monte Carlo) was 
applied. In contrast, for the tetrameric enzyme MtuDAH7PS, only slight 
changes in conformation and dynamic changes over short time period need to 
be explored, so the method full atom molecular dynamics simulation was 
employed.  
 
Computation is a powerful tool as it allows understanding and interpretation 
of properties of single molecules, allowing intermediate states and 
transitional conformations to be visualized. The combination of 
computational techniques and experiments therefore becomes a robust 
approach that can explain observations from experiments at atomic resolution, 
predict outcomes from designed experiments, and provide guidance to future 
research directions.   
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Appendices 
 
Appendix 1: Sample Configuration script for setting up molecular 
dynamics simulations with NAMD 
 
############################################################# 
##ADJUSTABLE PARAMETERS##                               
############################################################# 
structure          mcsd_wb.psf 
coordinates        mcsd_wb.pdb 
outputName         mcsd_wb_eq_5ns 
set temperature    310 
firsttimestep      0 
############################################################# 
## SIMULATION PARAMETERS##                                 
############################################################# 
# Input 
paraTypeCharmm     on 
parameters         
/hpc/home/wji20/cp1b/5nsMD/par_all27_prot_lipid.prm 
temperature         $temperature 
# Periodic Boundary conditions 
# NOTE: Do not set the periodic cell basis if you have also  
# specified an .xsc restart file! 
if {1} { 
cellBasisVector1    60.    0.   0. 
cellBasisVector2     0.   60.   0. 
cellBasisVector3     0.    0   63. 
cellOrigin           16.0    11.0   -29.1 
} 
wrapWater           on 
wrapAll             on 
# Force-Field Parameters 
exclude             scaled1-4 
1-4scaling          1.0 
cutoff              25. 
switching           on 
switchdist          20. 
pairlistdist         30 
# Integrator Parameters 
timestep            2.0  ;# 2fs/step 
rigidBonds          all  ;# needed for 2fs steps 
nonbondedFreq       1 
fullElectFrequency  2   
stepspercycle       10 
182 
 
#PME (for full-system periodic electrostatics) 
if {1} { 
PME                 yes 
PMEGridSizeX        40 
PMEGridSizeY        40 
PMEGridSizeZ        42 
} 
# Constant Temperature Control 
langevin            on    ;# do langevin dynamics 
langevinDamping     5     ;# damping coefficient (gamma) of 5/ps 
langevinTemp        $temperature 
langevinHydrogen    no    ;# don't couple langevin bath to hydrogens 
# Constant Pressure Control (variable volume) 
if {1} { 
useGroupPressure      yes ;# needed for 2fs steps 
useFlexibleCell       no  ;# no for water box, yes for membrane 
useConstantArea       no  ;# no for water box, yes for membrane 
langevinPiston        on 
langevinPistonTarget  1.01325 ;#  in bar -> 1 atm 
langevinPistonPeriod  100. 
langevinPistonDecay   50. 
langevinPistonTemp    $temperature 
} 
restartfreq         100    ;# 500steps = every 1ps 
dcdfreq             2500 
xstFreq             2500 
outputEnergies      100 
outputPressure      100 
############################################################# 
## EXECUTION SCRIPT##                                         
############################################################# 
# Minimization 
if {1} { 
minimize            5000 
reinitvels          $temperature 
} 
run 2500000 ;# 5ns 
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Appendix 2: Number of hydrogen bonds and van der Waals contacts from 
modelling of inhibitors into intermediate-adapted receptor grid (“good”, 
“bad” and “ugly” van der Waals contacts are defined with cut off ratio of 
1.3, 0.89 and 0.75 respectively) 
 
Number Structure Hydrogen 
bonds 
Good 
vdW 
Bad 
vdW 
Ugly 
vdW 
S-5.1 
O-
O
OPO32-
2-O3PO
 
14 284 18 11 
R-5.1 
O-
O
OPO32-
2-O3PO
 
15 291 27 11 
S-5.3 
R-5.3 O O-
O
OPO32-
2-O3PO
 
14 
14 
291 
283 
17 
20 
10 
11 
S-5.4 
R-5.4 O-
O
OPO32-
2-O3PO
 
16 
15 
292 
283 
18 
19 
8 
12 
5.5 
O-
O
Br
P
OHO
-O
 
11 291 18 7 
5.6 
O-
O
2-O3PO
P
O
OH-O  
13 287 22 4 
5.7 
O-
O
2-O3PO
P
OHO
-O
 
16 316 26 11 
5.11 
O-
O
F
P
OHO
-O
 
10 279 16 6 
5.12 
O-
O
F
P
OHO
-O
F
F
 
11 265 21 5 
S-5.13 
R-5.13 O-
O
2-O3PO
P
O
OH-O
Me
 
12 
11 
313 
324 
17 
23 
8 
8 
5.14 
O-
O
P
O
OH-O
Me
P
O
-O OH
 
11 289 20 9 
5.15 
O-
O
P
O
OH-O
Me
P O
O-
HO
 
10 311 14 5 
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S-5.16 
R-5.16 O-
O
2-O3PO
P
OHO
-O
Me
 
17 
16 
312 
302 
30 
33 
10 
11 
5.17 
O-
O
P
OHO
-O
P
MeOH-O
O
 
17 310 29 9 
5.18 
O-
O
P
OHO
-O
Me
PHO
O-
O
 
14 334 26 11 
R-5.19 
CO2-
OPO32-
 
11 184 17 7 
S-5.19 
CO2-
OPO32-
 
10 164 11 7 
22s 
2-O3PO
CO2-
OPO32-OH
OH
OH  
17 305 25 10 
R-5.30 
2-O3PO
2-O3PO
CO2-
Me
 
14 352 28 12 
S-5.30 
2-O3PO
Me
CO2-
OPO32-
 
16 319 24 13 
R-5.31 
2-O3PO
HO
CO2-
PO32-
 
19 321 31 13 
S-5.31 
2-O3PO
HO
CO2-
PO32-
 
15 326 32 12 
R-5.32 
2-O3PO
OPO32-
CO2-
OH
 
16 309 20 13 
S-5.32 
2-O3PO CO2-
OPO32-OH
 
16 318 26 10 
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Appendix 3: Number of hydrogen bonds and van der Waals contacts from 
modelling of inhibitors into wild type receptor grid based on crystal 
structure 2B7O (“good”, “bad” and “ugly” van der Waals contacts are 
defined with cut off ratio of 1.3, 0.89 and 0.75 respectively) 
 
Compound 
number 
Compound structure H-bonds Good 
vdW 
Bad 
vdW 
Ugly 
vdW 
S-5.1 
O-
O
OPO32-
2-O3PO
 
8 231 13 6 
R-5.1 
O-
O
OPO32-
2-O3PO
 
10 230 11 5 
S-5.3 
R-5.3 O O-
O
OPO32-
2-O3PO
 
8 
8 
230 
230 
13 
11 
6 
4 
S-5.4 
R-5.4 O-
O
OPO32-
2-O3PO
 
8 
9 
240 
233 
12 
11 
5 
4 
5.5 
O-
O
Br
P
OHO
-O
 
6 239 10 5 
5.6 
O-
O
2-O3PO
P
O
OH-O  
7 222 10 3 
5.7 
O-
O
2-O3PO
P
OHO
-O
 
9 253 14 7 
5.11 
O-
O
F
P
OHO
-O
 
6 214 7 2 
5.12 
O-
O
F
P
OHO
-O
F
F
 
7 216 8 4 
S-5.13 
R-5.13 O-
O
2-O3PO
P
O
OH-O
Me
 
7 
7 
281 
248 
8 
10 
6 
4 
5.14 
O-
O
P
O
OH-O
Me
P
O
-O OH
 
9 248 15 6 
5.15 
O-
O
P
O
OH-O
Me
P O
O-
HO
 
8 224 12 6 
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S-5.16 
R-5.16 O-
O
2-O3PO
P
OHO
-O
Me
 
9 
8 
263 
282 
11 
12 
5 
4 
5.17 
O-
O
P
OHO
-O
P
MeOH-O
O
 
9 257 13 7 
5.18 
O-
O
P
OHO
-O
Me
PHO
O-
O
 
8 286 9 6 
R-5.19 
CO2-
OPO32-
 
8 154 7 4 
S-5.19 
CO2-
OPO32-
 
7 145 7 6 
R-5.30 
2-O3PO
2-O3PO
CO2-
Me
 
7 268 15 5 
S-5.30 
2-O3PO
Me
CO2-
OPO32-
 
8 259 11 7 
R-5.31 
2-O3PO
HO
CO2-
PO32-
 
12 250 21 6 
S-5.31 
2-O3PO
HO
CO2-
PO32-
 
9 231 20 5 
R-5.32 
2-O3PO
OPO32-
CO2-
OH
 
11 251 14 5 
S-5.32 
2-O3PO CO2-
OPO32-OH
 
10 254 11 7 
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Appendix 4: Plot of components of the docking scores for the best poses of 
intermediate mimicking structures 
 
Note: “docking score” is the total score obtained from docking of structures 
into intermediate-adapted receptor; “lipo” is the score from lipophilic 
interactions; “hbond” is score from hydrogen bonding interactions; “vdw” 
indicates score from van der Waals interactions; and “coul” indicates score 
from electrostatic interactions. 
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Appendix 5: Amino acid sequences used in SCA 
 
CME2            
MLPGAAASEAVAGSVASKRPSSAITCTIRSMEGFVVSNPFRRRVSGRAAWQAV
RRCGSVALSSRVYYVERGAEVCVRLGDGCGAFGLRNSVSIGGRQVGSEPWSPS
SWRQRPAHQLPVYPDKDQLALVEAGLRTLPGLVTPKSIRSLHEHLAAACHGEA
FVIQGGDCAETFSSRTLEYNISLYHLLAAQAAILSSTGSKRRIVRIGRIAGQFAKP
RSAPVDADGLPSFRGDIVHSAAPNGRARTPDPQRLLQAYRHASASLEHLRVLEH
LHASPMESLRILSEKLAWDSVVDSNLVKAIQNLVQGIDEEIIVMSSTGRHVTSID
TNVIENVFTSHEALLLPYEEGLVRLADWSPSGNAHTLEHLNRDAGSPIDLLSAPQ
YYATSAHFLWIGERTRQIDGAHVEFLRGVSNPIGVKLSGNATLEQVFALAEILNP
ANTPGRLTLITRMGVDALQRKLPPLMAAVKRSGLAVVWMCDPMHANTQSVR
DKNGNSFKTRDCEQVLDEMRLFFEITAAEGVPAGGIHLEMSGEAVTECLGGAT
RTAVHDLARAYHSACDPRLNYAQALMLTLALKDSLQWREALPNASSAVLSA 
 
CRE1            
MKLQTSQGQALRTSRPAVRGLPALSRRPVRVSAIAAPEKQSTPASLNGTSNWQP
TSWRSKPVVQQPEYLDKQEVVKACEEIARMPPLIFAGECRTLQSRLAKASTGDA
FVLFGGDCAEAFSQFSANRIRDLYRLLLQMSIVLAFGGGVPIVKLGRIAGQFAKP
RSASTETIGGVTLPAYRGDIINGPEFTEEARRCDPWRLVRAYNQSAATLNLLRGF
SYGGYAGLSRVSQWELEFMKNTPEGHAYMDIAKRVDEAIQFMIACGMDTNMP
FMRETEFYTCHECLLLDYEEALTRLDSTTDKWYGCSAHFLWCGERTRQLDHAH
VEFLRGVNNPIGVKVSDKMDPNDIVSLIASVNPSNTPGRLSIIVRMGAKALRAKL
PALIEAVQRSGQVVTWVCDPMHGNTETVSGFKTRRYENIRSEIEAFFDVHEKM
GTVPGGVHLEMTGDNVTECIGGGASISEDDLNSRYHTHCDPRLNAEQSLEIAFY
VAQRLRQRRENLAAKTA 
 
OLU1            
MGRGRTTTNARTNPERGARDASRAQATASKSKARSADVSATGANLKEWNPKS
WRQREALQQPNYENQAELEEALKVIANRPPLVFAGEARDLQEKLANAAAGNA
FVLFGGDCAESFRDFTSDNVRDTYRVLLQMSVVLMYGSGVPVVKLGRMAGQF
AKPRSEDLETIDGLSLPSYRGDNINSCEFTPEARRPDPSRLVKAYDQSCATLNLL
RAFSNGGYAAMTRVSDWNLDFMENTERGSQYEDLAQRVDAAIDFMAACGIDE
THPSMQETSFFTAHEALHLGYEESLTRLDSTTEEHYGCSAHFLWCGERTRQPEG
AHMEYFRGISNPIGIKISDKSDGEGVVSLVKKLNPDNVPGRITLISRMGAAKLRE
HLPRLITAIEDAGLNVLWVTDPMHGNTIKTDNGFKTRPFEAVRDEIMAFFEVHE
KMGTYPGGVHLEMTGQNVTECTGGIMDVSVSDLEKRYLTHCDPRLNASQAIEL
AFLMASELNDMRRRRAAQ 
 
PTI1            
MMLKLASALLLLASSEAFTPQSLVGRRQSALSVATEPPASTAATTGGNTDWSPR
SWREREVQQGPNYEDEEELEQAIDTIKKFSPLVFAGEVRSLHEQLARACSGQGF
LLMGGDCAEAFNEFNVDHVRDSFRVLLQMALVLTFGSAMPVIKVGRMAGQFA
KPRSEPDEVRDGVALPSYRGDIINREEFTPEARRHNPNNMVEAYHQSAQTLNIL
RAFSTGGYADMSRLHAWNLDFVETTDEGSRYRKFATKVDESLRFMKAIGVDTS
SPTFTKTEFYTAHECLLLPYEEALTRKDSTTGRYYDCSGHMLWVGERTRQLDG
AHLEFVRGIGNPLGVKISDKCTPEELIRIIDTMNPQNIPGRLTIVVRMGAEKVRKN
LPALIRAVQREGKSVLWISDPVHGNTYKTDSGIKTRNFDAIRDELRAFFDVHDE
MGSHPGGVHLEMTGEDVTECTGGISGVSEDTLNDRYHTFCDPRLNGAQALELA
FLIAERMRLRTGLPPIE 
 
TPS1            
MVSSAPKVANGSTSSGEGGEWSPSSWKNAVAKQMPIYEDEAELEDAIKALDRV
APLVFAGEVRSLHEKLARVSQGQGFVLMGGDCAESFKEFHVNHIRDTFRVIMQ
MALVMTFGSSMPVVKIGRMAGQFAKPRSEPNEVIDGVSLPSYRGDNVNREEFT
PEARRNDPHLMVDAYYQSAQTLNILRAFSTGGFADISRLHAWNLDFVENTEEG
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SRYRLLAAKVDESLRFMKAIGIDTSKPEFTSVDFYTAHECLLLPYEQALTRQDST
TGKWYDCSSHMLWVGERTRDLDGAHLEFTRGIGNPLGVKVSDKCTPEELIRIIE
TMNPQNVPGKLSIIVRMGAEKLRKNLPGLIRAVQREGKAVVWISDPVHGNTRK
TESGFKTRDFDNIRAELRAFFDVHDEMGSHPGGVHIEMTGEDVTECTGGVSSVT
DETLKTRYNTACDPRLNGSQALELAFLIAERMRLRTGLPPLTSREAVSWRRLLG
IY 
 
AMC1            
MSNWQVDSWRNKPILQQPEYEDKVRLKEVEQTLSSYPPLVFAAEARELRRQLG
EVSLGKGFLLQGGDCAESFDEFNAPKIRDTFKVILQMAIVLTFAGRCPVTKVAR
MAGQYAKPRSSDFETRGGVKLPSYRGDIINNFEFTEAARRPDPERLLEAYHRSA
STLNLLRAFAQGGLADLHEVNRWNMAFVENNPLKDRYSDMANRIQDTLEFMD
VIGINAQTSSTLHETSLFTSHEALLLNYEQALTRVDTLTGKPYDCSAHMVWIGE
RTRQLDHAHVEFFRGIHNPIGVKVGPSMQEDELIRLIDALNPLNDPGRLTLITRM
GADNLADNLPRLLRKVKAERRHVVWSSDPMHGNTFSASSGYKTRNFDSILREI
KQFFQAHEAEGTHAGGIHLEMTGQHVTECTGGAYQISDDDLAQAYKTQCDPRL
NADQVLEMAFLVADHLRNA 
 
GEM1            
MPSQKWTKSSWRSFRALQQPVWPAGSALEETQKTLSQLPPLVFAGECQTLKAQ
LADAVEGRAFVLQCGDCAEDFSRCTGPDIRELLKVILQMSVVLAFAGEKRVIKI
GRIAGQYAKPRSSDTEMVHGIELPSYRGDMVNSPEPTLEARTPDPRRMLEGYYR
AAATLNLVRSFTLGGYASLERVQAWHRASLDALPAGQKYEDLVRQIWKTINF
MTAIGLDPQHTPQLNQVTLYTSHEALLLDYEEALTRMDSTSGGWYDCSAHML
WIGDRTRQLDGAHVEFLRGVKNPLGMKVGPSYDIDTVKALAQRLNPDNEPGRL
TLITRFGADKIDSYLPRLLKEMKQEGFKVVWSCDPMHGNTYQNEYGQKSRKFE
DILREIKNFQQIHKAEGTVAGGVHLELTGDHVTECTGGSRQLLDKHLHLNYQT
NCDPRLNAEQSVELAFELAEMLHPCK 
 
DPS1            
MSQSQKEWNKGSWKNYTALQQPNWPNEGAVEKVLANLSQLPPLVFAGEIRNL
KQQLAKAVTGEAFLLQGGDCSENFSQVTAPKIRETLRVLLQMAVVLTYAGDKP
VIKVGRLAGQFAKPRSSDTETINGVTLPSYRGDMVNCPDFTETCRVPNPKLMLK
GYNMAASTLNLVRAFTRGGFGSLHRVQAWNQEFVAQSPMGRSYDRLAKQIDQ
TIKFMGNIGIAADNPLIEQTQLFTSHEALLLQYEEAMTRVDSTAGGWYDCSAHM
LWIGERTRQLGGAHVEFLRGVLNPIGIKVGPNNDPDDIKRLCETLNPENEAGRIT
LITRLGVKEIEKSLPPLLREMKREGHNIVWSCDPMHANTYTATSGHKTRNFNDI
LSELTCFFESHWSEGTIPGGVHFEMTGEDVTECTGGARNIVDEELARNYLTTCD
PRLNAEQSLEVAFQIADMIRS 
 
DAT1            
MVNTKEWTKSSWKNHTALQQPNWPDKKKLDKVIDDLTLMPPLVFAGEIRALK
EMLGKASKGEAFLLQGGDCSEDFSQVTAPNIRESLKVLLQMAVVMTYAGGKPT
IKVGRIAGQFAKPRSSDTEMVNGVELPSYRGDMVNKVTPTIKDRTPNPKFMLK
GYYMAAATLNLLRAFTRGGYAALHRVQSWNHEFVVQSPMGRSYDRLARQIDK
AIKFMNTIGIPTDIPQVNQTQFFTSHEALLLPYEEALTRIDSTTGGWYDCSAHML
WIGERTRQVDGAHVAFLKGVLNPIGVKIGPNYDMDNVKQLIETLNPENEAGRL
TLITRMGCNNIEKKLAPLLRETKKQGYHIVWNCDPMHANTYTSESGHKTRDFN
DILKEITRFFEIHWAEGTIPGGVHLEMTGKNVTECVGGARNIVSEELHNRYDTTC
DPRLNAEQSLEVAFQIADMIKH 
 
MGM1            
MSNPWQPDSWRKFNALQQPEWPNQDELQQVCKNLSSYPPLVFAGEVRSLSGH
LKRVANGKAFLLQGGDCAESFGEFNANAIRDKLKILLQMAVILTYGGGRPIVKV
GRIAGQFAKPRSSPTETQGDQTLPSFRGEMVNDPDFSESSRNPEPNRLERVYFQS
ASTLNLLRAFTSGGFADLHSLNNWTRDFVSNSPQGKRYAEIADKLTDALKFMD
TVGINSTNTPVLHEVEYFTSHEALILDYEQALTREDSLTNEYYCCSAHMLWIGE
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RTRQLDGAHVEFLRGVKNPIGVKLGPSATAEDALRLCDALNPQNIPGRLTFITRF
GHNKVEENLPKLIRSIKQAGRSVIWSCDPMHGNTFTASSGYKTRNVDHVMSEIR
SFFAVHKAEGTCPGGVHFELTGDAVTECVGGSHQVTEAHLPERYETTCDPRLN
ATQSLDIAFLITETLQDFKK 
 
GOX1            
MHPSSQTPTSTNTMSWSPASWRSRPIVQAPSYADEAALAAVEARLHRYPPLVFA
GEARRLKTRLAAASRGEAFVLQGGACAESFDEFTADIVRDTFRVLLQMAVVLT
FAAKVPVVKIGRMAGQYAKPRSSNTETVDGVTLPCYRGDIINGPEFTPEARIPDP
ARMETGYFQSAGVMNLLRAFAHGGYANLHQVHRWNLGFVERSPLAARYQDL
AHRIDETLSFLRACGFDGSASQIDETEFYTSHEALLLPYEQALTRVDSTSGDYYD
CSAHFLWIGDRTRQPDGAHVEFLRGVQNPIGIKVGPTTTVADLEKLLEILNPKDE
AGRITLISRMGKDKVRDHLPPLLDAVNRTGRTVTWLCDPMHGNTTTTASKIKT
RSFDNILGEVLGFFDVFEAIGRRPGGIHLEMTGQDVTECIGGAQCLTEADLGGR
YETFCDPRLNAEQSLEMAFLLAQELTGRAGKKE 
 
GBE1            
MCRVAWKDCPAGAIEKCRLRLDRTEFAGTRYAMDTIMTAGPSAPGAAKAWTP
QTWRERPILQVPVYPDPAALSEVEQRLHRYPPLVFAGEARRLKAQLAEAAQGR
AFVLQGGDCAESFGDFTANIIRDTFRVLLQMAVVLTFGAGLPVVKVGRMAGQF
AKPRSSDTETVNGETLPSYRGDIINGPAFTAEDRVPDPARMETAYFQSAGRMNL
LRAFASGGYADLHEVHRWNLGFVERSPLASQYRDMASRIDETLRFMGACGLK
DTAQVRETEFYTGHEALLLPYEEAFTRIDSTTGEYYGCSAHFIWIGERTRQPDGA
HVEFMRGIHNPIGIKLGPNADPDEVVRLCELLNPRAEPGRITLISRMGADKVRDR
LPPLLRAVKRSGVPVVWVCDPMHGNTISTTSKVKTRNFDSILGEVRGFFDAHAQ
EGTWAGGIHVEMTGRDVTECIGGAHRLTETDLGRAYETFCDPRLNAEQSLELA
FLLASELKQRLHHVSKSIP 
 
ACR1            
MNDADTTMHDPAGWSPESWRAKPIKQVPTYPDAAKLAAMEARLHGYPPLVFA
GEARRLKASLALATEGKAFILQGGDCAESFGDFTANVIRDTFRVLLQMAVVLTF
GGSVPVVKLGRMAGQFAKPRSSDSETIDGVTLPSYRGDIINGPDFTAEARIPDPA
RMEFGYFQSAGTLNLLRAFASGGYADLHQVHRWNLDFVRRSPLAERYRDLAA
RIDETLQFMAACGMTSQSTPQIHETEFYTSHEALLLPYEQALTRVDSTTGDHYA
CSAHFLWIGDRTRQLDGAHVEFMRGVKNPIGMKVGPSMDEDDMLRLIERLDPA
NEAGRLTLIARMGAEQIAAKLPKLVRATKREGRNVAWLCDPMHGNTITTSGKV
KTRRFDAILSEVRGFFDIHEAEGTTPSGVHVEMTGQDVTECVGGARQLSEADLG
ARYETFCDPRLNAEQSLELAFLIAAELKTRRAPRGTAIAAE 
 
MAG1            
MSENWSPESWRAKPIHQAPTYPDSAKLAEVEESLRNFPPLVFAGEARRLKASLA
DVADGKAFLLQGGDCAESFAEFHANNIRDTFRVLLQMAVVLTYGAAMPVVKV
GRMAGQFAKPRSADTETIDGVTLPSYRGDNVNGSEFTAEARVPDPLRMIRAYN
QSAATLNLLRAFAQGGYADLHKVHQWTLGCVAGTLQAARYQDLCDRLDETL
AFMEACGMTSDTTPQLRETDFFTSHEALLMPYEQALTRIDSTTGDWYDCSAHM
LWIGERTRQMDAGHVEFLRGVKNPLGFKAGPGMSPDDLLRLIDRLNPENESGRI
TVITRMGAEKVEQVLPGLIRAVEREGRKVVWSCDPMHANTIKAAGGYKTRPFD
AILAEVRAFFAVHKAEGSHAGGVHFEMTGQDVTECIGGMTGVAEEDLGDRYQ
TACDPRLNATQSLELAFLIAEQLKDERALLRAKAKAKRKD 
 
RCE1            
MTGLAASSGARSGKRCEMATETAMGTGGRWTPESWRAKPAMQMPTYPDPAK
LQAAAARLAGYPPLVFAGEARSLKECLGRATQGQAFLLQGGDCAESFSEFHPN
NIRDTFRVLLQMAIVLTFGGATPVVKVGRMAGQFAKPRSADMEVVDGVELPA
YRGDIINGFDFTPEARVPDPDRMVQAYNQSAATLNLLRAFAQGGYADLHKVHQ
WTLGFVEKSPQGERYRDLAGRLDEALAFMAACGITGATTPQIRETEFFTSHEAL
LLPYEQALTRIDSTTGDWYAVSAHMLWVGDRTRQPDGAHIEYLRGIRNPLGLK
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CGPSLDPDELIRLIDLLNPADEPGRLTLICRMGHDKVEDKLPALVRKVKREGRT
VVWSCDPMHGNTIKSSTGFKTRPFDRVLAEVRGFFEVCRTEDVHPGGVHFEMT
GQDVTECTGGAQAITEHSLALRYHTACDPRLNASQSLELAFLVAEELKRTRRGL
KLSQQAAAE 
 
ELI1            
MARNWTPDSWKNFEARHLPTYEDAAALRDAEATLAAYPPLVFAGEARALKAD
LAEVANGEAFLLQGGDCAESFAEFHPNNIRDTFRVILQMAVVLTFAGKLPVVK
VGRMAGQFAKPRSSDTETQGDMTLPSYFGDNVNGIDFDPAQRRNDPERMVKA
YSQAAATLNLLRAFAGGGYANLRQVHQWTLDFMGRSPWADRFGEMADRITE
ALDFMEACGVDPATVPQLQGTSFYTSHEGLLLPYEQAMARQDSLTGDWYDTS
AHMLWIGDRTRFEGSAHVEFMRGIGNPLGVKCGPSLEPDVLLKLLDDLNPARE
AGRITLISRFGHDKVEAGLPRLVRAVTREGHPVVWSCDPMHGNVIKSDSGYKT
RPFDRIKTEVRGFFDVHRAEGTHAGGIHLEMTGQDVTECVGGAVAITDEALGD
RYHTHCDPRLNAAQSIELAFAIADMLQLAAKEQQQADAA 
 
SWI1            
MATNWTPASWRQQQAVQMPDYPDAAALAAAEQELSSFPPLVFAGEARELTAS
LAQVAAGKAFLLQGGDCAESFAEFHPNNIRDTFRVLLQMAVVLTFASKLPVVK
VGRMAGQFAKPRSAPTEEIGGVTLPSYRGDIINDIGFSEESRIPDPRRMVRAYSQS
AATLNLLRAFAQGGYANLHQVHAWTLDFMGRSPWAAQYGEVAARIGDALDF
MAACGINPETVPQLKGTQFYTSHEALLLPYEQAMTREDSLNTGQYFDTSAHFL
WIGDRTRFEGSAHVEYLRGVGNPIGLKCGPSLEPDALLRLLDTLDPQRQPGRITL
ITRYGHDKIEKHLPALVRAVKREGRPVVWSCDPMHGNVVKAANGYKTRPFDRI
LAEVRGFFAVHRAEGTHGGGIHAEMTGQNVTECTGGAMAVTDENLADRYHTH
CDPRLNAGQSLELAFLLAEMLNQEMKERDRAAA 
 
PLA1            
MADTWKPESWRAKPAKHLPSYPDEAALAAVEARLRSYPPLVFAGEARKLKAD
LAEVCEGRAFLLQGGDCAESFAEFSADNIRDTFRVLLQMAVVLTFAAASPVVK
VGRIAGQFAKPRSSATETIGDVTLPSYLGDNINGIEFDEKSRVPDPERLLRAYSQS
ASTLNLIRAFANGGYADLDFVHRWNLGFVSDSAEGARYEELANRITEALDFMR
ACGIDSATQPQLHTTDFYTSHEALLLGYEQAMTRIDSTTGDWYDTSAHMLWIG
DRTRQPDHGHVEYMRGIKNPIGMKCGPSLDPEELVRLTDILNPKNEPGRLTLICR
FGAENVEKHLPQLIRAIEREGKKVVWSCDPMHGNTIKASSGYKTRPVDRILAEV
QAFMAVHRAEGTHAGGVHFEMTGQNVTECIGGAQAISETQLGDRYHTHCDPR
LNASQSLELAFLIAEGLKKERLEALRAEPVAALGAW 
 
SIT1            
MSDWQKTNWRSKPRVQMPDYTDQAALQAVEAQLAKYPPLVFAGESRRLKAQ
LGAAGRGEAFLLQGGDCAESFEQFSADGIRDTFKVMLQMAMVLTYGAKVPVV
KVGRMAGQFAKPRSAPTETVDGVELPSYRGDIINELAFTPEARIPDPRKMLQAY
TQAAATLNLIRAFSTGGYADVHQVHAWTLGFTEGDKAEAYRDMANRITDTLD
FMKAAGVTADNAHTLQTVEFYTSHEGLLLEYEEALTRLDSTSGKWLAGSGHMI
WIGDRTRQPDGAHVEFCSGVLNPIGLKCGPTTTADDLKVLMQKLNPENEEGKL
TLIARFGAGKVADHLPRLIQAVKDEGANVTWVCDPMHGNTIKSASGYKTRPFD
SVLREVRDFFGVHQAEGTIPGGVHFEMTGQDVTECTGGVREVTDEDLSDRYHT
ACDPRLNADQSLELAFLVAEELSRLRTPDDTRAAI 
 
DSH1            
MTKAWSKSDWRTKPRIQMPEYMDPAALAAVEARLTQYPPLVFAGEARSLRRE
LADVANGKGFLLQGGDCAESFGEFGADLIRDTFKVMLQMAMVLTYGAKVPVV
KVGRMAGQFAKPRSAPTEVKEGVELPSYRGDIINDLDFTPESRIPNPEKMLQAY
TQAAATLNLLRAFSKGGYADIHQVHAWTLGFTDRDEAEKYREMATRIADALD
FMKSAGLTSENNSELATVDFYTSHEALLLEYEEALCRIDTTTGLPLAGSGHMLW
IGDRTRQPDGAHVTFCAGVQNPIGLKCGPSITTDDLKVLMARLNPKNEAGRLTL
IARFGAGSVGDHLPRLVKAVQEEGANVVWSCDPMHGNTIKSASGYKTRPFESV
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LREVQEFFAVHNAEGTYPGGVHFEMTGKDVTECTGGVRAVSDEDLSSRYHTA
CDPRLNASQALELAFLVAEEIETHRGATGAAKRTA 
 
PDE1            
MAGTDCMKDRIMAPTNSSSATPAQAWDKRGWRAYPRVQMPDYPDQPGVAAV
EAQLAKYPPLVFAGEARRLKASLGEVAAGRAFLLQGGDCAESFAEFSADNIRDT
FKVMLQMAVVLTWGAQLPVVKVGRMAGQFAKPRSAPTEKMGEQELPSYRGD
IINGFDFTPEARIPDPQRMLAAYTQAAASLNLLRAFSTGGYADIHRVQSWISDFT
GGEEAARYRDIAERISDAMAFMAAAGVTSETAHDLGKVDFYTSHEALLLEYEE
ALARIDSTTGLPVAGSGHMIWIGDRTRQVDGAHVEFCRGVQNPIGLKCGPSISD
SDLKALIAKLNPENEPGRLTLIARFGAGSVGDHLPRLIRAVREEGANVVWSCDP
MHGNTIKSASGYKTRPFDSVLREVREFFAVHRAEGTIPGGVHFEMTGQDVTECI
GGVRAVTDEDLSNRYHTACDPRLNASQSLELAFLVAEELRNRRVNGASKQAK
AG 
 
MXA1            
MTNPTWTPDSWRHKPVKYMPEDYPDAQALVQTEAELSRLPPLVFADETRQLT
ARLARVAEGKAILLQGGDCAESFKEFTTDNIRDTYRLLLQMAMVLTFAGNRPV
VKVGRIAGQFAKPRSSPMETLGGVTLPSYRGDIINGMEFDAQARTPDPRRLLKA
YHQSSATLNLLRAFAQRGYEELAEPQRWPQGGINRLLADRILESLSFMRALGVS
PEPRSGSNAIDFFTSHEALLLNVEEAMTRAEPDGSGWYDSSAHMLWIGERTRQL
DGGHVEFMRGIQNPIGIKCGPTMEPDEVLRLMDLLNPQGIPGRITLIGRFGADLV
AERLPRLMAATRRDGRPVIWSIDPMHGNTHKAGNGYKTRSFDRILTEVCGFMD
AAAAEGVHPGGLHLEMTGQNVTECLGGPQPVTEDDLSSRYHTHCDPRLNADQ
ALQLAFLVAESMPSLRTHEARAA 
 
HNE1            
MTWHPSDWRNLPAKHIPQDYPDAAALAAVETRLRSYPPLVFAGEARRLKTRLA
EVAAGKAFLLQGGDCAESFKEFHPDNIRDTFRVILQMAVVLTFAAAKPVVKVG
RIAGQFGKPRSEPIETIDGVTLPSYRGDNINGMEFTPESRIPDPERLIQAYSQSAAT
LNLLRAFSQGGYASLANVQRWMLGFVDRSPQGERYQKLADQISASLRFMEAV
GLNAESVPQMSQVEFYTSHEALLLGYEEAMTRIDSTSGDWYDTSAHMLWIGHR
TRQIDHAHVNFCKGVKNPIGIKCGPGMETDELLRLIDTLNPADEPGRITLISRFGS
EGVKAGLPPLARAVKKSGRTVVWSCDPMHGNTLKTGTGFKTRPVDRILSEVRQ
FIDVLSAEGCYPGGVHFEMTGQNVTECIGGAQAISEEDLSSRYHTHCDPRLNGE
QALELAFLVAEKLQAAEVEAATARKAG 
 
HBA1            
MTKWAPDSWRAKPAKHIPEDYPNSAALADVEATLSQYPPLVFAGEVRRLKARL
GDVAAGRAFLLQGGDCAESFKEFNSNNIRDTFRVILQMAVTLTFAASKPVVKV
GRIAGQFAKPRSSPVEVKDGVTLPSYRGDIINGMEFTPESRTPDPQRLIRAYNQS
AATMNLVRAFSRGGYADLHNLNKWMLSFVDRSPQGERFQKIATQINEAVDFM
EAIGLTPDNTPIMSETEFYTSHEALLLGYEQAMTREDSTIPNQTVDTSAHMLWIG
DRTRQLDGAHVEFCRGVINPIGMKCGPTLDPDELIRLIDTLNPEDEPGKMVLIAR
FGADKVEDGLSKLVRRVEQEGRSVIWSCDPMHGNTLTSESGYKTRPVDRILSEV
AQFIDVVSTEGAYPGGVHFEMTGQNVTECLGGAQDITDADLSSRYHTHCDPRL
NGEQALELAFLVAEKLRSKKSSVALAAQ 
 
MMR1            
MTWSPQSWRSKPVSQMPNYKDAAKLDAAIAELSARPALVFAGEARRLRRQLA
DVTAGKAFLLQGGDCAESFKEFSTEGVRDTFRVLLQMAVVMTFAASKPIVKVG
RIAGQFAKPRSADMETIDGVSLPSYRGDSVNGPEFTPEAREPDPQRLIRAYDQSA
STLNLLRAFASGGYADLHNVHQWTQDFVSDSPAAERYAETAARISEALAFMKA
CGIGRDSAPSLEAVDFFTSHEALHLPFEEALTRRDPNTGQWYATSAHMIWTGER
TRQLDGAHVEYARGIANPVGVKCGPTMQPDDLLPLIDALNPDNEAGRLVLIVR
MGADNVVKNLPKLAAAVTKAGRKVVWSSDPMHGNTHKTSNGYKTRDFDRIL
SELEGFMDVLYAEGAYPGGVHFEMTGRDVTECVGGAKTVTEADLAARYHTHC
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DPRLNADQALDMAFRIAESLKRVRNNNSAANAA 
 
PIN1            
MTQWTPSSWRNKPVQQLPSYPDQDKLQQTEHYLANQPPLVFAGEARALREDL
AKVAKGEAFLLQGGDCAESFDEFRTSHIRDTFKALMQMAVVLTFGGQKPVVKI
GRIAGQFAKPRSADMETINGLSLPSYRGDIINGIDFNEKSRLPDPQRMVTAYNQS
TSTLNLLRAFAQGGLADLNQVHQWNLDFIKKSPLGKRYETLAGSIEDSLAFMN
ACGINPATAPQLRETTLYTSHEALLLPYEQALTRCDSLTGKWYDCSAHMLWIG
DRTRQIDHAHIEFLRGVENPIGIKVGPSTVPEELLRIIDIVNPNNEAGRLNLIVRM
GADKVADHLPALIGAIEREGKNVVWSSDPMHGNTIKAPNGYKTRRVNDILREV
QQFFQIHKAEGSYAGGVHFEMTGRNVTECVGGAFQITEHDLAQRYHTYCDPRL
NADQALELAFLIAEHIKAAR 
 
MMW1            
MSQWNLTSWREKTALQQPVYPNAEHLAQVENTLGKMPPLVFAGEARQLKKAL
AQVANRQSFLLQGGDCAESFAEFHANNIRDTFKVMLQMAVVLTYAGKCPVVK
VGRMAGQFAKPRSSGSEVIGGIELPSYRGDIINGIDFTEQARVPDPERLVQVYNQ
SASTMNLLRAFAQGGFADLHQVHQWNLDFLNASPAGSRFQGVADKIDDALQF
MEACGIGPGLAQLKETDFYTSHEALLLPYEQALTRKDSLTGDWYDCSAHMLWI
GDRTRQLDGAHVEFLRGVQNPIGVKAGPTMDPEDLLRLCDVLNPNNEAGRLNII
VRMGADKVEDGMPKLIQAIQREGKQVVWSSDPMHGNTVKASTGYKTRRVDD
VLKEVQQFFQVHNAEGSYAGGVHFEMTGQNVTECVGGAFEVTEADLADRYHT
HCDPRLNADQSLELAFMISETLKKARS 
 
TDN1            
MSNWSASSWRQKPIVQQPTYPNQDELNRVLEELRNYPPLVFAGEARSLKAQLA
NASEGRGFLLQGGDCAESFSEFHAHNIRDTFKAILQMAVVMTYAGGVPVVKVG
RLGGQFAKPRSSDTETIDGITLDAYRGDIINGVDFTKEMRVPDPQRMIKAYNQS
AATLNLLRAFASGGLADLHVVHKWNLDFTNQSEISKKYEDLAEEIGKSLKFME
ACGITSKTHRTLRETDFYTSHEALLLPYEEAFTRKDSITNEWYDTSAHMLWIGD
RTRQLDGAHVEYMRGINNPIGVKAGPSMDPEDLLRLCDVLNPQNEAGRLNIIVR
MGADKVADGMPKLIRAIEREGRKVLWSCDPMHGNTVKSSNNFKTRPVDSILTE
MKQFFQVHKSEGTFAGGVHLEMTGKNVTECIGGSFVVTEEDLSSRYHTHCDPR
LNADQALELAFLIADTLREAQK 
 
WSU1            
MQNEWNPQSWREKPIRQQPTYKDREHLKNIERELKQYPPLVFAGEARSLKKRL
ADVTEGRAFLLQGGDCAESFSEFNAINIRDMFKVILQMAVVLTFAGSCPIVKVG
RLAGQFAKPRSSDEEVMDGVSLPSYRGDIINSIEFTPEAREPNPKRMLKAYNQSA
ATLNLIRAFAQGGLADLHEVHRWNLGFIESSFGERYQALCDRITETLSFMEACGI
TSATTPMLHETEFYTSHEALLLNYEEALTRKDSLTGDWYDCSAHMLWIGERTR
ELEGAHMEFLRGVNNPVGVKVGPGATKEELLGICDILNPLNEAGRLNFIVRMG
AEKIGEKLPALLRIIKEEGRKVLWSIDPMHGNTVKASSGYKTRAFNQVLSEVRSF
FDIHKAEGTYAGGIHLEMTGQDVTECIGGSQKITEEGLACNYNTQCDPRLNATQ
ALELAFLIAEILKKR 
 
CHA1            
MQWNRESWQNFNILQQPIYENSDKLQSCKNQLKKLPPLVFAGEVRALKDELKS
ATLGKSFLLQGGDCAESFSNFSANNIRDMFKLMLQMAIILTFAGGVPVVKIGRIA
GQFAKPRSSDFEEIDGVELPSYRGDIINGFEFTKEARKPDPNRMIEAYNQSTSTLN
LLRAFSRGGLADLHEVHKWNLGFLKRGELAKKFQNLANEITRTLNFMEACGIN
SANTQNLRETVLYTSHEALLLHYEECLTRIDSLTGDPYDCSAHMLWIGERTRGI
NDAHVNFISGIKNPVGIKIGPNGTASEILALCDKINPNNEIGKMNIIIRMGADKIG
DRLPKILRELKKENRAILFSIDPMHGNTIKTANNYKTRKFNQILSEVKSFFEICEA
ESVYAGGIHLEMTGLDVTECTGGAFNVTEETLKKRYETQCDPRLNADQALELA
FLIADNLKKRVIKEQ 
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NIS1            
MSWSPSSWRNFPIKQQPDYKDKELLRKIEEEIKTFPPLIFAGEARELKSKLAKVA
KGEAILLQGGDCAESFANFNAANIRELFKVLLQMNMVMMYATGKPVVKIGRIA
GQYAKPRSSDFEEINGIKLPSYRGDIVNDVEFTPEAREPKPQKLLEAYYKSAATL
NLIRAYARGGFADLRAIHKWNLEFLKGNELENKFKELADKITQALHFMEACGV
DPDNTPQLKQTTLYTSHEALLLGYEEALTRKDSFTGEWYDCSAHFLWIGDRTR
ALDGAHVEFFRGIKNPIGVKVGPSMQKDELLALIDKLNPENEPGRLTLIVRMGA
EKIADIFPPLLRAVKEAGKEVVWSIDPMHGNTYKTESGLKTRDFEKILSEVKQFI
QIHQSEGTIPGGMHLEMTGSDVTECTGSISASITEEGLQSRYHTQCDPRLNANQA
LELAFMVAETFKDLQK 
 
SUN1            
MSWTPGSWRDFPIKQQPTYQDQETLQKVEAELSSYPPLIFAGEARNLKRKLAAA
GRGEAFLLQGGDCAESFADFNAETIKNLFKLMLQMNMVLMYSTGKPVVKVGR
IAGQFAKPRSSDFEEVDGVKLPSYRGDIINGIEFTEEARIPNPHNMIRAYNQSAAT
LNLVRAFSRGGLADLNKVHQWNLDFIKDNPLGKRYDELSDKIDHAMKFMSAC
GLTSETMPQLHQTTLYTSHEALLLNYEEALTRLDTETGEWYDCSAHMLWIGDR
TRDLNEAHIEYFRGIKNPIGCKVGPSMGEDELIELIDALNPDNEEGRLNLIVRMG
AEKIAEFFPPLLKKVRDAGKNVVWTIDPMHGNVEKSSSGFKTRDFDNILSEVKQ
FFSIHKEMGTVAAGIHLEMTGNDVTECTGSTSCAITAEGLASRYHTQCDPRLNA
SQALELAFMLSDTISGADQ 
 
ABU1            
MNNWTPSSWRNFPIKQQPTYNDVETLAQVEKELASYPPLIFAGEALNLKKQLA
KVVNKEAFLLQGGDCAESFNVFNATNIKDLFKVMMQMAVVLTFSGGCPVVKV
GRVAGQFAKPRSADFEDINGLSLPSYRGDIINDIDFSLESREPKAKKLLKAYNQS
AATMNLLRAFARGGMADLNQVHLWNLDFVKDNTLGTKYEELANKISESLAFM
KACGITSENTPQLNQTTLFTSHEALLLNYEQALTRRDSITGDWFNCAAHMLWIG
DRTRELDGAHIEYFRGINNPIGCKVGPSMKEDELLKLIDTLNPNNEAGRLNLIVR
MGANKIADHFPKLLKRVEEEGKKVLWSSDPMHGNTIKAENGYKTRDFEAILSE
VKQFFQIHRAQGSYAGGIHLEMTGQNVTECTGSKSSAVTQGDLASRYHTQCDP
RLNADQALELAFMIADTLKEARK 
 
NAM1            
MKWTKESWRDKPIKQQPTYEDIEKLKQVEKELSKYPPLVFAGEVRNLKSKLEN
VCEGKAFLLQGGDCAESFAEFDGNNIRDMFKVMMQMAVVLTFAGGLPVVKIG
RIAGQFAKPRSSDFEERDGVKLPSYRGDIINSIEFTPEARKADPERMLKAYNQSA
ATMNLLRAFAKGGMADLRKIHKWTLDFVKESPEGHRFEELADRITESLKFMEA
VGITPENTPVLRETTLYTSHEALLLNYEEALTRQDSLTGDWYDCSAHMLWIGD
RTRDPNEAHVEFLRGVKNPIGIKAGPSMTPEGLIELIEKLNPENEAGRLNVIVRM
GADKIEKEFPKLLKAVVDTGKKVIWSIDPMHGNTIKTSSNIKTREFDKILAEVKG
YFAVHESFGTFPGGVHLEMTGRDVTECIGGSYSISEKDLEKSYETHCDPRLNAK
QALELSFLIADLLKQSINKNPQI 
 
PUB1            
MKNWKINSWRNYPVKHIPEYPDQKELDGVLSKIKDFPPLVFAGETRHLKEQLA
DVVDGKAFLLQGGDCAESFAEFHPDNIRDTFKLILQMSLVLTYSASLPVIKLGRI
AGQFSKPRSSPVENIDGVELPSYLGDNINGMEFNEKSRVPDPKRLFKAYSQSAST
LNLIRAFSHGGFADLKKVHTWNLGFIKNSPAAKKFKDLEDRIADALAFMDACGI
NSDFNRRLKTVNFWTSHEALLLPFEQAMTRVDSTTGEYHDTSAHFVWIGDRTR
QLDGGHVEFCRGIENPIGIKCGPTLKAEDLINLCNKINPNNEKGKITLISRFGHEN
VSKFLPKLIRAIKKEGLNVIWSCDPCHGNTIKATTGFKTRPFNSVVKEVKNVFEC
HQSEGSYAGGLHIEMTGQNVTECTGGAQKISDQDLSSRYHTHCDPRLNANQAL
ELAFLISDEIKKNAAYSKKNIKAAS 
 
CME1            
MAVCFVLPHNGLAAVAGRRAQSGWKPSGALFRETRMVISAKPDSKKNTGGRV
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WRPSSWREMPVKQVPTYPDEARLQDVEARLHKALPLVYTGECEHLKKLIAKAS
RGEAFVLQGGDCAESFEEFEKYGGDNIRDTFLLLIQMSIVLMYALGLPVVKIGR
MAGQFAKPRTSPMEREKNKKLELPSYRGDMINGPEFEARARVPDPERMLRAYH
QSTATINLVRALAYGGFVDLHRIHEINLEFVNGTPQGKRFFEYAARITDALRFMS
SCGIQANSPMIKQAEFFVSHEALLLPYEEALVRQDRETGKYYATSGHMIWCGD
RTRQPDGGHVEFLRGIANPIGIKCGPSLTEAELIELLDILNPDNEPGRITLISRVGA
GRVREHLPRFIECVQREGRIVTWSCDPMHGNTVTTASGVKTRRFDDILSEVKEF
FEVHREMGSIPGGIHLEMTGQNVTECIGGMYELSDADLATRFESRCDPRLNASQ
SLELAFLLSEYMSGKRTD 
 
ZMO1            
MVTDWTPDSWRDFEARQLPIYPDNDKLDKALDQLSSYPPLILGSEARLLKEKLA
DVAKGKAFVVQGGDCAESFRDFSAESVRATLSALLWMDAVVSYASGKPVVRI
GRIAGQFAKPRSSNMEEKDGVSLPSYRGDNVNDISFTEEARLPDPDRLLAGHAQ
SAITLNLIRAYTQAGDDKWEYAFNGLHDFVNSRSWADDSWRGLVAEMGDAFR
FAQSCGGFGNGYAAPCFTSHEALHLPYEEAMVRSDCDYGLDYATSGHFLWIGD
RTRFEGSAHVEFLRGVDNPIGLKCGPNLEADELLRLLDVLDPSREAGRITLITRY
GADKIEKHLPTLVRAVKAEGRPVAWICDPMHGNGTTTSEGQKTRPFERILDEVK
GFFAVHQAEGTYAGGIHLEMTGLDVTECIGGSAGLSEEDLKRRYMTHCDPRLS
RDQALEMAFQVADLF 
 
YLI1            
MPPKVVITDPTPLKASEGAKSAAKLRSKSKEAAQLPKPNLGDAWAPTSWQSKPI
TQDVVYDDYTGVEAALEKLESLPPLVSPFEIEKLRTKLAHAANGKAFVLQGGD
CAELFDYCTQDRIESKLKVLMQMSLVLLWGTGLPVVRIGRIAGQYAKPRSKLTE
EVDGKTINSFRGDNINGFDVSDRKPDPARLVSSYFHSAATLNYIRCVLASGFADL
RKVDWSLEHVQNPETKERYQKTLDAITEGLQFMHTIGADTAQDMQTIDFFTSH
EALLLEYEQSLTREANGHHYNTSAHFIWIGDRTRQLDGAHVEFFRGVRNPIGIK
VGPTMKADELVRLLDIVDANHEDGRVTLITRYGASKVKELLPAHIKAVQSSGH
KVVWMSDPCHGNTQTSTVTKLKTRHVDDIVEELRQALEIHRECGSKLNGAHLE
LTGDAVTECIGGSAGLCDEDLVVRYDTVCDPRLSLSQSLDVSFLIADSMRAQK 
 
CNB1            
MAPAPAPWHPSSWREKPIAQDVVYEDKDQLETVLNKLRRLPPLVSPVEIDRLRT
QLADVAAGKAFLLQGGDCAELFDDCSQDPIEHKLSLILLMSLIILHGSRLPVVRI
ARIAGQYAKPRSKPTEIVEFPTKDGKTEKKEVLSFRGDNVNGYDPTDRAPDPQR
LLGSYFHSTATLNYIRTLLSSGFANLHNPVDWSFSHVRSPELQQAFSSVIESLQDS
LEFMKVATGAVGGGERGGMETVDFYTSHEALLLEYEEAFTRSWDSTTLSPPAT
GDSTPILSRSASRIREASSSSSYPHSPARRPKSPKNLSDSINSLSMSVGDLGKKEA
KKWYNTSAHFIWIGDRTRQLDGAHVEYFRGIANPIGIKIGPSMQPEEIVRVLDIV
NPDKIPGKVTLIGRYGAAKVDQFLPKHIDAVLRTDHPVVWQCDAMHGNTKSSV
HDPTLKTRHFVDVITEITRSMEIHKEKNTILGGVHLELTGEVNDDGYSVTECIGG
SMELEDKDLSFNYRTHCDPRLNYEQSLDVAFLLADYLKSKRRGERPHDILLASL
RGRKNDVEK 
 
UMA1            
MASASNAAGTSASAREYHANPTWKSKKEAQQVDYPSPEAFQSVMKRIERLPGL
VSPNEIDRLRSQLASVAEGNAFLLQTGDCAELFDYCNPEQIQAKLKLSLLMSLIL
LWGARKPVVRIGRIAGQYAKPRSKPTEIITKIDAATGVASQHEIMSFRGDNINAF
SAEPASGRIPDPERLLQAYFHSAATLNHIRSELASGLADLHAPRQWSFQHVQSR
ALQAEFESVVDSLTDALDFMKTIGADPSAFSSSSVLNSVDYFISHEGLSLAYEEA
LTRLIRKSTSVSPNPTRNAASSDSADDDLNGDVLERYDLSAHTIWLGDRTRQLD
GAHVDFFASIRNPVGVKVGPSMKPEELIQILDILNPDIPIPKATSSARASEWSTPS
AAAPEVVYGKEKGRVMVIIRLGAAKVASHLPPLLEAIAASNHKDSIILLCDPMH
GNTQTSPYPPASSDPNAQPLKTRSFGDIISEILSFLEIISADFPTLHLGGVHLELTG
DKDVTECFGGSMRLDPKHLERGYKSHCDPRLNFEQSLDVAFLLSHYFRNQRLG
NKRHAPAKTEDEIKKQQAIIASGSGDELLAELICGITNRAQMS 
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MGL1            
MPSDSWRSKSIAQDVPYDDPKQLENVTKQLSSLPGLVTPAEIDRLHEQLARVAD
GKAFLLQCGDCAELFSYCNANQIEAKIKLILLMSLIIIYGARLPVVRVGRMAGQY
AKPRSKPYETITLPSGETKEVLSFRGDVVNSAEVDHRSPDPERLLSAYFHAAATL
NYTRGCLASGIADLHTPGTWRFHHVQSKSLQQEFERIADAISDALDFMKTVGA
DPTGDSNVLNTVDFFTSHESLILEFEHALTRDTPQGSYDLSAHTVWLGDRTRQP
DGAHVEFARHVRNPIGVKVGPSMKPEELITLLDTVNPHVQKGHVTLITRYGESK
VKDLLPEHIKAVQNSKHAKAVIWCCDPMHGNTVTSPSDPKLKTRMFSAVVSEL
TSCLQIHASLGSVMGGVHLELTGDEGVTECMGGSMELSDEDLKRCYLTHCDPR
LNYEQSLDIAFLISDVLKSQRRGIPVNNALSQALLRSNRVEGNP 
 
SMT1            
MSLSAVPPVPEPAATAAGAAWSPESWRGKTALQMPTYPDPVALDAALHELKR
LPPLVTSWEILALKQQLAEAQEGKRFLLQGGDCAENFSDCESGTISNRLKVLLQ
MSLVLVHGLRQPVIRVGRFAGQYAKPRSADTETRDGVTLPSYRGDVINAPAFTE
AARLPDPKRMLQAHAHSAMTMNFVRALIDGGFADLHHPEYWNLEWVSHSPLA
ADYQKMVASIGDAVHFMETLAGARVHNLNRIDFYTSHEALLLPYEQALTRQVP
RQQGWLNLSTHYPWIGMRTAALDGAHVEYLRGVRNPIAIKVGPSVTPDQLLRL
IDVLNPHDEPGRLSFIHRMGAAQIAEKLPPLLDAVKRDGRRVLWVCDAMHGNT
ESTANGFKTRRFDNVRGEVEMSFDLHAAAGTRLGGVHLELTGEDVTECTGGAR
ELTERDLERAYRSTVDPRLNYEQSLEIAMAIVRKQEQVR 
 
BGL1            
MECNLSSARVAENWTPASWKTKPALQQPVYRDAAALDRALTQLQALPPLVAA
WEVLTLKRKLVDAAEGRCFLLQGGDCAESFADCTAPIIANRLKVLMQMSLVLV
HGLMLPVVRVGRFAGQYAKPRSADTETRDGVTLPCYRGDIVNARAFTKDAREP
DPQRLLEAHSRSALTMNFVRALSDAGFADLHHPEHWDLAWASHSPLYGEYRK
MTHSIGESLRFMEALAGEPSDSDARVDFFTSHEVLLLNYEEAMARQAHRHWG
WFNLSTHFPWIGMRTAQLDGAHVEYCSGIRNPIGLKIGPGLSTDQLLRTIDALNP
TNEAGRLTLITRMGAAKIEAELPKHLHAVKTEGRRVLWCCDPMHGNGETTPGG
VKTRRFENINAELEAAFDIHAACGTHLGGVHLELTGEDVTECLGGARNLTEADL
ARAYKSTVDPRLNYEQSLEIAMLIVRKLGTTPVAEIGAERHTAYA 
 
SRU1            
MSEPTIQDWSLHSWREKDALQQPTYPDEAALEEKLDHVAALPPLVTSWEVENL
KAEIARAAQGDRFLLQGGECAESFGNCRADVITGRLKILMQMSLVLTYGLNTSI
VRVGRFAGQYAKPRSSDTETHDGTTLPSYRGDIINGPEFSAEARRPDPERMVEA
YSSSSLTLNLVRALAEGGFADLRHPEYWDLDFMDHSPLAEEYHALVDAIGDTID
FVEAVTEQELDSLESVTFYTSHEALLLPYEEALSRSVPHKDGIYNLGTHLPWVG
KRTNQVDNAHVEYARGIENPVGLKVGPDMTPSRLKTLVRTLDPEDEPGKLTLIS
RLGADTIGDRLPALVEAVQATGQSVLWIADPMHGNTETTDDGTKTRHFDNILG
ELEQALDVHAAEGSHLGGVHFELTGRDVTECIGGARGLSEADLGRAYESRVDP
RLNYEQSLEMAFSIVRKYRQLHG 
 
SCL1            
MYVPAQPWSPDSWRERFNAAPLPYDDPDAVQVAVEKLRALPPLVTSWEVERL
KGYLAEAQLGRRFVLQGGDCAETLDDCRPNIVTNKLKILLQMSLVLVHGARRP
VVRLGRFAGQYAKPRSSPVETRDGVSLPSYFGDLINRAPFDATARRPDPNLMIA
GYQHAAITLNFIRSLSEGGFADLHHPEYWDLSFLERADLPGELRERYQRMTEQV
GEALRFMEALAEVPVGELSRVEFFTSHEGLNLHYESAQTRKVARRPGFYDLTTH
LPWIGERTRQPDGAHVEFFSGVENPLGIKLGPKTLRDDVIRLLDRLNPADEPGKI
VLIVRMGAGRVRDGLPPLIEAVRSAGRKVLWMSDPMHGNTLTTSSGIKTRNFE
DILTEIEANFEVHESMGSNLGGVHFELTGDDVTECVGAGLTESDLDQRYASLCD
PRLNYRQSLEMAFRIAHRMAESSRRARG 
 
SUS1            
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MGHRAPPHQRWLACDVISCGLPMWVPDSWRQRTALQQPEYADAAEVERVLA
EIRTLPPLVTSWEILHLREQLAEAAEGRQFVLQAGDCAERFVDCTPVRITNTLKV
LLQMSLVLVIGARRPVIRIGRFAGQYAKPRSTNDEVRDGITLPSYRGDNINRPEF
TAEARRPDPQLLLRGYERASLTLNFVRALVKGGFADLHHPEYFDLDWAKDSPL
AHEYHRMVQTIKDSLQFVENVLGVRAGDTDKIDFYTAHEALHLGYEAAQTRR
VPRRPGYFNLMTHFPWVGLRTNDPDGAHLEYFRGIENPIGIKVGGSATREQVAR
WFEMLDPERSPGRLTLIHRFGAGKISDALPRLIEHVRAEGGKPVWVCDPMHGN
THMTAGGIKTRNFEDIYAEVEKAFDIHASLGQKTGQKLGGVHIELTGENVTECV
GGARGPNEEGLARAYESEVDPRLNYEQSMELAFLIARKMKNGNG 
 
MTU1            
MNWTVDIPIDQLPSLPPLPTDLRTRLDAALAKPAAQQPTWPADQALAMRTVLE
SVPPVTVPSEIVRLQEQLAQVAKGEAFLLQGGDCAETFMDNTEPHIRGNVRALL
QMAVVLTYGASMPVVKVARIAGQYAKPRSADIDALGLRSYRGDMINGFAPDA
AAREHDPSRLVRAYANASAAMNLVRALTSSGLASLHLVHDWNREFVRTSPAG
ARYEALATEIDRGLRFMSACGVADRNLQTAEIYASHEALVLDYERAMLRLSDG
DDGEPQLFDLSAHTVWIGERTRQIDGAHIAFAQVIANPVGVKLGPNMTPELAVE
YVERLDPHNKPGRLTLVSRMGNHKVRDLLPPIVEKVQATGHQVIWQCDPMHG
NTHESSTGFKTRHFDRIVDEVQGFFEVHRALGTHPGGIHVEITGENVTECLGGA
QDISETDLAGRYETACDPRLNTQQSLELAFLVAEMLRD 
 
SAQ1            
MRHEWHQLSHPAVGSPVLQTSRPTVDSVEDAALGLDRWRDLPRAQTPPWPDD
AQVAEVCKVLENVPSVVAPYEVDQLRQRLALVCEGKAFLLQGGDCAETFADN
TESHLLANARTLLQMAIVLTYGASLPVVKVARVAGQYTKPRSLPTDARGLPAY
RGDMINSLDATPEARVADPQRMIRAYANSAAAMNMLRAYLAGGLADLHAVH
DWNKGFVRNSPAGERYEAIAREIDRALAFIRACGMTEDEALRTVTLYCSHEALA
LEYDRALTRVSDNRAYGLSGHLLWVGERTRQLDGAHVDFISRIANPIGVKLGPT
TKPDDVIELCEKLNPDNVPGRLTLISRMGNHRVRDALPPIVAKVTAAGAKVVW
QCDPMHGNTHESSNGYKTRHFDRIVDEVLGYFEVHRGLETHPGGLHVELTGED
VTECLGGAQGIDDIDLPDRYETACDPRLNTQQSLELAFLVAEMLRG 
 
STP1            
MYGTRMRPGVERSIRHSPPATNDGDRELCLDRWRELPRRQVPPWPDPAEVAAV
CATLGKMPPIVTPYEVDELRHRLAEVCEGRAFLLQGGDCAETFTGNTESHLLGT
TRTLLQMAMAITYGGSVPVVKVARLAGQYGKPRSSATDSLGLPAYRGDIINAR
HPAESARAADPQRMIDAYANSAVAMNLIRAYPPDDLTDLEELYDDTYDLIRASP
AGARYQVISGEIDRARGFVRAWGPSERHALRESKVYCSHEALVLEYDRALTRIN
DGRAYALSGHFLWVGERTRQLDHAHVDFVARIANPIGVKLGPAASPHAAIELC
ERLNPENLPGRLTLISRMGNRQVRDVFPAIVDKVTAAGAKVVWQCDPMHGNT
EQSSHGFKTRRLDRVVDELLGYFDVHRSLGTHPGGVHVELTGENVTECLDGIR
GVEDQHLPDRYETACDPRLNMRQSLELALLVAEILRG 
 
FRE1            
MSNDLDIWRSLPARQQPSWPDGEELAAAFAELSALPPLVTAPEVRSLTDRLAM
VARGEAFLLQGGDCAETFAANTADKIRDKVKTLLQMAVALTYGASTPVVKVA
RIAGQYAKPRSADIEASTGLPSYRGDAVNDIAPNAQARRPNPRRMVDAYHQSA
VALNLVRAFATGGFADLSKVHEWNKAFVRDSAAGRRYELMAVDIERALAFMA
ACGIDLDRTAALTGVEMFTSHEGLLMEYERALTRTEESTGEVYDLSAHMIWIGE
RTRDLDGAHVDFLSRVGNPIGCKIGPTATPDEVVALTERLNPDHIPGRLTLIARM
GAKRVRDALPPIIDKVNAAGHPVVWSCDPMHGNTRDVGGVKTRHFDDVLDEV
FGFFEVHKGLGTHPGGLHIELTGENVTECLGGAEMIGEADLGGRYETACDPRLN
TGQALELAFLVAESLQQARAERDTHTR 
 
ACE1            
MLLSDPPLESWRQLPAAQQPIWPDPDELAAVRSQLTALPPLVVPEECDVLRQRL
AEVARGRAFLLQGGDCAETFADATVDRIRSKIKILLQMAVVLTYGASVPVVKV
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GRLAGQYAKPRSRDVEVVDGVELPSYRGDAVNSIERTLAARVPDPRRLLEAYH
RAAMTLNLIRAHATGGFADLRKVHAWNSDFVRRSPAGERYESIATDIDRALRF
MEACGFDLENSEVAHQVELYASHEALLLDYESALTRYDTERRAYYDLSAHMV
WIGERTRDVGGAHIEFARYIANPIGVKLGPTTTPETAVALVEKLDPERRPGRLTF
ITRMGAGRIRDVLPPIVEKVTAAGAEVIWSCDPMHGNTIESSGGLKTRHFDDIVE
EVMGFFEVHQALGTIPGGLHVELTGEDVTECLGGADDIADADLADRYETACDP
RLNAGQSLELAFLAASMLQDIRRRADESANPREAS 
 
SGR1            
MLVTVNANTSVAGGNTWRDLPAAQQPEYPDSEALRDVLADLASYPPLVFAGE
CDQLRARLGAVAKGEAFLLQGGDCAEAFDAVSAEHIRAKLKTLLQMSAVLTY
AASVPVVKVGRIAGQYSKPRSKSTETRDGVTLPTYRGDSVNGFAFTEEARVPDP
QRLKQMYHASSSTLNLVRAFTTGGYADLRQVHAWNQDFVKSSPSGQRYEALA
REIDNALNFMKACGTDPAEFKAVEFYASHEALLLDYESALTRTDSRTGELYDTS
AHMVWIGERTRQMDGAHIEFAARIRNPIGIKLGPTTTVDEALGYIDRLDPEREPG
RLTFVVRMGADKVRDKLPELVEKVTASGATVAWVTDPMHGNTFEAASGHKT
RRFDDVLDEVKGFFEVHKALGTHPGGIHVELTGDDVTECVGGGHEIFVDDLHQ
RYETACDPRLNRSQSLDLAFLVAEMYRDQ 
 
SEN2            
MRNLDAWRGLPAAQQPEWHDPAELSSVLDELSQLPPLVFAGECDQLKDRLAA
AQRGESFVLQGGDCAETFAGATASAVQNKLKTLLQMAVVLTYAAQVPVVKIG
RMAGQFAKPRSSPDETSDGVTLPAYRGDAVNGFEFTAESRRPDPRRLIRAYHSS
ATILNLCRAFANGGYADLRQVHAWNQDFVATSPAGKDYEHLASEIDRALAFM
RACKAEPAEVHTVEFWSSHEALLLDYESALTRVDPRTSWPYAVSAHMVWIGER
TRQLDHAHLEWASRIRNPLGVKLGPSTTPDDALAIIERLNPSAEPGRLTFVTRMG
ADRVRDTLPLLVEKVTASGAPVTWVCDPMHGNTFRSPSGYKTRRVDDIFDEVT
GFFEVHRALRTHPGGIHIEFTGDEVTECVGGGHGLLEADLHHRYETVCDPRLNR
RQSLDLAFKVAELYRLST 
 
SEN3            
MPAAQQPDWPDPVGLRRVVDELRAAPPLVFPSECDRLRSRLAVVARGGGFLLQ
GGDCAETFDGVSPAQVRAKLRTLAQMALVIGYACAAPVVKVGRIAGQYSKPRS
SPTETRDGRTLPSYRGDSVNGPEFGEQARTPDPERLLRMYHSSMATLNVLRAFG
GGGRSDLRRVHGWNEEFVSASPSGKHYQRLWEEIGAALGFMRSLGAAPETVGE
TEFFTSHEALVLEYESALTHGGGRPGEAYDLSGHMVWIGERTRRIDGAHVEFAS
RIRNPIGIKLSAAAEPDEVLALIDKLDPHREPGRLTLITRMGAQRVRAELPALVE
KVTAAGAPVVWVCDPMHGNTFEAANGYKTRRFDDVLDELRGFLEVHRALGT
HPGGVHLELTGDDVTECLGGGDDIGPDDLPERYRTACDPRLNRSQALDLAFRL
AEMYRGA 
 
PAC1            
MAGSRIPAMSQSVPSLEALNALPRVQQPSYPDPQATVEVVNQLRSLPPLVFAGE
CDDLRAYLAAVANRKAFLLQGGDCAETFAGVNADNIKGKLRVLLSMAVVMT
YAGQLPVVKVGRIAGQYAKPRSKDTETRRGLTLPSYRGDAVNGFEFTPEAREH
DPKRLIGVYNASAATLNLVRAFATGGFADLRGIHAWNADFVRNSNVETRYEAL
AAEIERALVFMMACGVEGDQLSTVDFYASHEALLIDYEHAMTRIDSRSQLPYD
CSGHLLWIGERTRQIDGAHVEFLRHVRNPLGVKLGPTTTGEDAVAIADALDPDH
EPGRLTFITRMGSKAVRTNLPRVIEAVEATGRKVVWSCDPMHGNTFETNDGYK
TRSFADMCDEVNGFFDVHEELGTWPGGVHIELTGDDVTECLGGVDKLAESDLT
NRYETACDPRLNRNQSLELAFIIAERLADSRIKRDAVSPLARFRSIDL 
 
NCA1            
MSTIPDLATLHAMGAAQQPSYPDRAAVDSAVQRLRTAPPLVFAGECDDLKGKI
AQVARGEAFLLQGGDCAETFAGVTADNVRNKLRVLLQMAVVLTYAASVPVV
KVGRIAGQYAKPRSSDFETRDGVTLPAYRGDAVNGYDFTAESRVPDPQRLVDV
YNSSAATLNLVRAFVTGGYADLRQVHTWNTDFVRESPVGQQYEAMANEIERA
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LTFMRAIGADPDEFHRVDFHSSHEALVLEYEQALTRIDSRTSTPYDVSGHFLWIG
ERTRQLDGAHVELLSHIRNPIGVKLGPTTTPDDALALAAKLNPDNEPGRLTFITR
FGAGKIRDGLPTLVEKVTAAGLEVAWVCDPMHGNTFEASSGYKTRRFGDVIDE
VQGFFDVHRSLGTWPGGLHVELTGDDVTECVGGGEDLMEVDLGNRYESVCDP
RLNRVQSLELAFLVAEMLRQA 
 
TWS1            
MPGSNRVNPFIKNSVDVSLETINAWRGLPIEQQPEWPDSVLLSEVSCTLSQLPPL
VFAGEVDKLRLHLQEAAEGRAFILQGGDCAESFRDITADNISRKLKTILQMAAIL
TYAAGVPIIKMARMAGQYAKPRSEQFELVDGRSLPVYRGDMVNGHELHDRVP
DPKRMLKAYELSAATLNLIRAFTRGGFADLRALHVWNRGFAESCENEQYEELA
RKIDKAIAFMNACGVDCSNLTQTEVFVCHEGLLLDYEHALTRCDSRTGFFYDTS
AHFLWIGERTRQIDGAHIDFFSKIENPIGVKLSSKVTARQVLELANRLDPGRTPG
RLTFITRMGAGNIRQCLPGIIEAVRDGGFNPAWVCDPMHGNTITSSSGYKTRRF
MDILDEVRGFFDVHRSVGTHPGGLHVELTGDDVTECTGGFDSISDDDLKDRYES
LCDPRLNHRQSLELAFFLADCMK 
 
LXX1            
MMEGLDYWRTLPIKQQPEWPDKDAVTAVSAELATLPPLVFAGEVDQLRTRLA
RAAEGNAFLLQGGDCAEKFADATADQIRNRVKTVLQMAVVLTYGASVPVIKM
GRMAGQFAKPRSSDTETRGEVTLPAYRGDIVNGYDFTPESRQADPRRLVQGYH
MAASTLNLIRAFTQGGFADLRQVHSWNRGFAANPANQRYEGLAREIDRAIKFM
EAAGADFDELKRVEFYSSHEALLMDYERPMTRIDSRTGTPYNTSAHFVWIGERT
RDLDGAHVDFLSRVRNPIGVKLGPTTSPDDMLRLIDKLDPEREPGRLTFVTRMG
AGRVREALPPLLEAIKRSDACPLWVTDPMHGNGLTTPTGYKTRRFEDVVDEVK
GFFEAHRAAGTNPGGIHVELTGDDVTECLGGSEHIDEATLATRYESLCDPRLNH
MQSLELAFLVAEELSQP 
 
RSA1            
MQDQTNSPFMTLDDSAVRLGQAGAANYPGLDAWRSLPISQQPTWQDEAVYQS
SIKELSSLPPLVFAGEVDILRDRLAAAAQGKAFLLQGGDCAETFDGATADKISAR
VKTILQMAVVLTYGASLPVIKMGRMAGQFAKPRSSNDETRDGVTLPAYRGDM
VNDYEFTPESRGHDAQRLVRAYHTSASTLNLIRAFTQGGFADLRLVHHWNKGF
TQNPAHARYESLAGEIDRAIRFMEACGSDFEALKRTEFFASHEALLLDYERSLTR
IDSRTGTPYATSGHFLWIGERTRQLDAAHVDYLSQVRNPIGVKLGPSTSGDDAL
RLIDKLDPNREPGRITFITRMGAKNIREKLPALVQKVTDSGAQVLWVTDPMHGN
TVTSPNGYKTRNFDDVMDEVRGFFEVHQALGTFPGGLHVEMTGDDVAECLGG
ADPIDQEAFLTRYESVCDPRLNHMQSLEMAFLVSGALAQR 
 
KRH1            
MSAETLSDQFRSVMTPSPSAADYPGLDEWRDKTIGQHPQWAQHPDFAGSIQEL
NAVPPLVFAGEVDRLRSRLAQVANGEAFFLQGGDCAETFAGATADKISGRVRT
LLQMAVVLTYGASLPVVKMGRMAGQFSKPRSSNEETRDGVTLPSFRGEMVNG
FDFTEQSRVHDPKRMVRGYHTSASTLNLIRAFTQGGFADLRRVHAWNMGFAA
NPAYARYESMAREIDHAVKFMAACGSDFDALKTTEFFAGHEALLLDYERALTR
IDSRTNLPYGTSAHFLWIGERTRDLDGAHVDLLSRLRNPIGVKLGPGTTGEDAL
RLIDALDPQREPGRLTFITRMGAQNIREKLPPVIQAVEASGAKPVWVTDPMHGN
TVSLPSGYKTRKFEDVVDEVRGFFEVHRELGTFPGGIHVEMTGDDVAECLGGS
DPVAESSFAERYETLCDPRLNHMQSLEIAFLVAEYLSAQN 
 
MLU1            
MTEDPREKILAFGTAISEGAADIPGLDHWRSLPIAQAPSWADEADHHAAVAELS
ALPPLVFAGEVDLLRARLADVAQGRAFLLQGGDCAETFAGSTANRISARVKTIL
QMAAVLTYGASMPVVKMGRIAGQFAKPRSSDTETRDGVTLPSFRGEIVNGYEF
TEQARRHDARRMVQAYHTSASTLNLVRAFTQGGFADLRSVHQWNQGFMANP
AYAQYEEMAAEIDRAVRFMNAAGVDFEAMRRTEFYSAHEALLLDYERALTRV
DSRSGDPCATSAHFLWIGERTRQVDGAHVDFLSRVRNPIGVKLGPTTTVADALE
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LAERLDPEREPGRLTFITRMGAERIRDVLPGIVEGVRDAGLEPVWVTDPMHGNT
VTAANGYKTRRFEDVMDEVSGFFEVHRELGTHPGGMHVELTGDDVAECLGGS
DPINEADFDARYETLCDPRLNHQQSLEMAFKVTEALSHPERRAPRA 
 
BCV1            
MTIPADPQVLAGLDAWRRLPAVQQPEWPDAAVLASIGAELAAAPPLVFAGEAD
ALREKLAAASRGEAFLLQGGDCAETFAESSADNIRNKVKTILQMAVVLTYGAS
LPIVKMGRMAGQYAKPRSTGTETRDGVTLPAYRGDTINGHEFTAASRTPDPAR
LLKAYHTSAATLNLIRAFTMGGFADLRRVHEWNRGFMTNPSYKQYDELASEID
RAIRFMAAAGADFDALRTVEFFSSHEGLLLDYERPLTRIDSRTGLPYDCSAHFL
WIGERTRQLDGAHVDFFSRVHNPIGVKLGPTTSGDDALALMDALNPDGVAGRL
TFITRMGAGRIRDALPGVVEKVAADGRPVVWVCDPMHGNTITSANGYKTRRFT
DVIDEVRGFFEVHAATGTVPGGLHVELTGDDVTEVLGGAEEIDDVGLARRYTT
LVDPRLNHQQSLEMAFLVAEMLRERPTA 
 
KRA1            
MSTPTTTSPLSSGQSSITWPDLPAAQQPQWPDAAALAEVQAELASYPPLVFAGE
ADQLRAQLAKAARGEAFLLQGGDCAETFAGATADGIRRRLKTMLQMSAVLTY
GASLPVIKVGRMAGQFSKPRSSNDETRDGVTLPAYRGDAVNDYAFTPESRVPD
PQRLLRAYHTSSATLNLIRAFTTGGYADLRKVHEWNRGFAATAANAKYDSLAR
DIDKAMRFMAACGADFDALQTVQFWSSHEALLLDYERPLTRTLDEEPPLAGAA
PDDVRQGGPYDVAAHMVWIGERTRQLDGAHVDFAARIRNPIGIKLGPKTSVDD
ALALIDKVDPYREPGRLTFITRMGASTIREALPALVEGVTRSGAQVTWVCDPMH
GNTITSTSGYKTRRFDDVVDEVRGFFEVHRALGTVPGGLHVELTGDDVTECLG
GAYDIDDAALATRYESLCDPRLNHQQSLELAFLAAEMLAER 
 
SCO2            
MTASDTYTQPRTAPAGTGTAAPGPTGPAADAGRGGWTPGSWRSRPAAQQPEW
PDPGELRGVEDTLALRPPLVLPDEILDLRRSLAQVAAGEGFLLQAGDCAERFGS
CTEAGVRGKLRVILQVAILLTYGSGLPVVKVGRIAGQFGKPRSRPTEAVDGVEL
PVYRGDIVNGPEFTAEARRPDAGRLLSAYHHASAALNVLRALTLGGYADLGQV
HEWNQEFVRRSPAGQRYEKAADDITWALRFMSACGLDTRSQAALHQVQLYTS
HEALLPQYEQALIRYDEKRRGWFDTSAHLLWIGDRTRRVDGAHVELLAGVDNP
VGVKVGPTMGVDDLRELCERLDPDRAPGRLVLISRLGAGRGAELLPPLLRAVR
DAGHAPVWACDPMHGNTFVSASGYKTRRLSDITTEVAEFFAVHREEGLHPGGI
HLELTGDDVTECLGGDLDEVLDTHLASRYETACDPRLNAAQSIELAFGVARLLR
ELRGGA 
 
SEN4            
MPRTQQAALSAVPAAQQPVWPDPAALRTALAELAVQPHLVSPRECDLLRDQL
AFVAGGGAFLLQGGDCAETFAGAASEAVGRKVRLLGQMAEILAERMGLPVVT
VGRIAGQYAKPRSWPTESHLGQTLPSYRGDAVNGLAFTPAARTPDPRRLLQAY
RTAAGTLAVLRKQDEPASPGDSLLPHPRTSDGGPGGNDFFTSHEALLLPYEEAL
CRTDPLTGQRYGTSGHLLWIGERTRNLDGAHVRFAAGISNPVGVKLGPAVNPD
DVLALVDKLDPQRQPGRLSLIIRMGARKIRDLLPPLVEKVAAEHAPVTWVCDP
MHGNTFTAASGHKTRLFDDVFDEVAGFFEVHRTLGTHPGGLHLELTGEAVTEC
VGGTPAVLMEDLDRRYETACDPRLNADQARELAVAVGGLAARP 
 
PTM1            
MNQDKEWSLDSWKNYSAVQLPIYSDVQLYQDTLQKIKKLPEILNFEDINAFKTQ
MIKVSKGEKFVLQLGDCAEVFDECTEEHWKEKFSFYDRMGQILDAIVIGRTCGQ
FAKPRSQLLEKDGTLNYRGDLINSLSRDEREPDPSRLLLGAHYTKKGLESLKQY
EGQQIWVSHECLHLGYESAFVKQNEDQQYYLSNTHFPWIGDRTRLHDHAHSNF
IRGIYNPVGIKIGQTINKTEFINVFKLINPKNEDGRSFAIIRLGKNKLDKLKDIINW
KQEEKLNISFFLDPMHGNNQDKSGCKIRKIEDIMYEIQQFFTIMEQQNEVPAGLH
LECTPYDVTECIENDEDINPKKYTTACDPRLNFRQTRKIIIFVNTLLKKLRNKQ 
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PTM3            
MNQDKEWSIDGWKKHSALQLPIYADAQLYQDTLQKIKNLPGILNFEDINAFKN
QMIRVSKGEKFVLQLGDCAEVFDECTEKHWKEKFSFYDRMGQILDAIVIGRTC
GQFAKPRSQLLEKDGTLNYRGDLINSLSRDERDPDPSRLLLGAHYTKKGIETLK
QYEGSQIWVSHECLHLGYESAFVKQNQDKQYYLSNTHFPWIGDRTRLHDHAHS
NFIKGIYNPVGIKIGQTINKTEFVNVFKLINPNNEDGRAFAIIRLGKNKLDKLKDII
QWKQEEKLNISFFLDPMHGNNLDKGGRKIRKIEDIMYEIQQFFAILEQENESPAG
LHLECTPYDVTECIENDEDINPIKYTTACDPRLNSRQTRKIIIFVNTLLKKLRNKQ 
 
PTM2            
MNQEKEWNLDSWKKYPALQQPLYQDLHFYQETLQKLRKLPGILNFEEINKFKN
EMIKVSQGDKFVLQLGDCAEVYNECTEEHWKEKFSFYDSMGQILNAIVIGRTC
GQFAKPRTQLHEKDGTLNYRGDLINSLSRDERDPDPLRLLLGAHYSKKGIDTLR
KYEGKQLWVSHECLHIGYESAFARQHEEDHYYLSNTHFPWIGDRTRLCEHAHS
NFAKGIYNPIGIKIGSSINKNEFVNLIKLLNPKNEDGRVFAIIRLGKNKLDKLKDII
NWKHEEKLNVSFFLDPMHGNSLEQNGYKIRRIEDIMFEIQQFFNILEQSNEKPAG
LHLECTPYDVSECVENDEEIDPKKYTTACDARLNFRQTRKIVIFVNTLLKKLKK
KQQ 
 
TET1            
MIESSVLLESELQNKWDGSEIRFSIGAKTNPVNSKQHVLQQKRSFIEDEGTGSET
SEEISHNEIPETWLPSSWRSYPALQQPVYENTNLLSQQLQMINEMPSIVSVNEIES
LQADLRQVETGSAFFIQMGDCAERFAEMNNSFMEKKIKAITAASRIFANMLNK
KCVKIGRIAGQFAKPRSQEFEKLPDGTLQYNYRGDNVNSLESRKPDPLRLSQGY
FHSVAAMNFIRAQQKHIMHNKLNIQQLLEEKSYPQKQQISAEQQQKLNDNQIEA
IENVNLNNDDLYISHEGLLLNYEEAMTKKYNNKYYNTSTHLLWMGERTRQLD
GAHVNFFSGIQNPIAVKVGPTTDGKILKQLVNKLNPQNLQGRLIIICRMGNKNIS
NVLPTLVQAKKEYNLNFIWSCDPMHGNTFSTNENIKTRSVKDILEELTKFATILH
ENKENIGGIHLETSPNQVTECLGLEIEDQDLNICYTSACDPRLNISQTLYITYQFA
LLLQSLYNKKNTGYTPELDN 
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